[
  {
    "header": "4 Materials And Methods",
    "id": "TOC-535",
    "data": [
      {
        "id": "4.1-Subjects",
        "header": "4.1 Subjects",
        "data": [
          [
            "",
            "Unmapped",
            "header",
            "4.1.1 Number of Subjects",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "09469d57-9567-4b21-886a-57610e6ba568",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Number of Subjects",
            "4.1.1",
            "3",
            537,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "A total of approximately 800 infants will be randomized in a 2:1 ratio to receive a single IM dose of nirsevimab (N = 530) or placebo (N = 270).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 102,
                  "end_idx": 111,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "e01d76b9-5ba1-40c9-9ad3-5f03e968a7bd",
                "childbox": "7aaae46e-1a85-494c-b030-2dc7e4b4ac88",
                "subtext": "05114afc-f350-4eec-9b94-b579425f6463"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Number of Subjects",
            "4.1.1",
            "3",
            538,
            ""
          ],
          [
            "2",
            "Inclusion Criteria",
            "header",
            "4.1.2 Inclusion Criteria",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "73ca006c-fe0e-4519-a654-10bf46f8343c",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Inclusion Criteria",
            "4.1.2",
            "3",
            539,
            ""
          ],
          [
            "2",
            "Inclusion Criteria",
            "text",
            "Subjects must meet all of the following criteria:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "fbd0abd2-41b1-4776-8724-e93aae0d02e1",
                "childbox": "35372b85-9afa-41be-b3a6-45206c40baf0",
                "subtext": "60bacfc7-7c67-4539-89e7-053620c52773"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Inclusion Criteria",
            "4.1.2",
            "3",
            540,
            ""
          ],
          [
            "2",
            "Inclusion Criteria",
            "text",
            "1 Healthy Chinese preterm and term infants in their first year of life and born ≥ 29 weeks",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f3a557f5-151b-4e8c-a09e-45c3b4dbd4e6",
                "childbox": "4b428a32-1a93-441f-9327-bb37bd5fac13",
                "subtext": "84084b63-eb12-4ec4-8492-194560c5780c"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Inclusion Criteria",
            "4.1.2",
            "3",
            541,
            ""
          ],
          [
            "2",
            "Inclusion Criteria",
            "text",
            "0 days GA (infants who have an underlying illness such as cystic fibrosis or Down syndrome with no other risk factors are eligible)",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "bbe352d0-f87e-4e36-99a9-20707ddf2348",
                "childbox": "fdbb7b57-227b-40c3-bd02-4fc36c3d73dc",
                "subtext": "1d0195fd-7d53-46ce-9cdd-6421e8a58971"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Inclusion Criteria",
            "4.1.2",
            "3",
            542,
            ""
          ],
          [
            "2",
            "Inclusion Criteria",
            "text",
            "2 Infants who are entering their first RSV season at the time of screening",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "670724e4-6e7e-4dcc-ab2d-8561dd5c9507",
                "childbox": "07c9f0b0-9bd0-45ee-9d77-0ef62092bb47",
                "subtext": "b61db47a-b210-4558-8f0b-d9e16218195e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Inclusion Criteria",
            "4.1.2",
            "3",
            543,
            ""
          ],
          [
            "2",
            "Inclusion Criteria",
            "text",
            "3 Written informed consent and any locally required authorization obtained from the subject's parent(s)/legal representative(s) prior to performing any protocol-related procedures, including screening evaluations",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "870d5003-5e48-42f8-9447-c8294e9e33ee",
                "childbox": "20eedd88-ed6d-4074-9d14-afac672f111a",
                "subtext": "335c9344-ab52-4154-9f92-4d973b4c77d1"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Inclusion Criteria",
            "4.1.2",
            "3",
            544,
            ""
          ],
          [
            "2",
            "Inclusion Criteria",
            "text",
            "Subject’s parent(s)/legal representative(s) able to understand and comply with the requirements of the protocol including follow-up visits as judged by the Investigator",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c1606a59-c585-4b2b-a49a-5fabd5b58c28",
                "childbox": "2aa7bedc-e405-4550-bb61-0609c40686fd",
                "subtext": "2d43defa-b28a-460d-89e3-86e5d0615d31"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Inclusion Criteria",
            "4.1.2",
            "3",
            545,
            ""
          ],
          [
            "2",
            "Inclusion Criteria",
            "text",
            "5 Subject is available to complete the follow up period, which will be approximately 1 year after receipt of investigational product",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d3d01772-08ca-421c-823a-842d13522818",
                "childbox": "08950c35-7f02-4e8b-b059-269bb8f0cf04",
                "subtext": "4e112f29-d569-4c05-889c-4b08c6d6dccf"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Inclusion Criteria",
            "4.1.2",
            "3",
            546,
            ""
          ],
          [
            "2",
            "Inclusion Criteria",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "35657cd6-8af0-4180-9229-829fef837b4f",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Inclusion Criteria",
            "4.1.2",
            "3",
            547,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "header",
            "4.1.3 Exclusion Criteria",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "3c45aa44-094b-4d9c-a7e0-2edb32874abd",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            548,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "Any of the following would exclude the subject from participation in the study:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "049d2cb0-d416-4b9a-b4e7-c419079b3c1c",
                "childbox": "ccee175f-a8b5-4287-a31c-258a83a8649e",
                "subtext": "d1e40614-59c2-4777-a4c1-307e1a97db33"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            549,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "1 Any fever (≥ 100.4°F [≥ 38.0°C], regardless of route) or acute illness within 7 days prior to investigational product administration",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2b0f49d8-6fa8-4053-b3ee-c40c3faa3bff",
                "childbox": "fd84ba23-9bbc-48af-850c-0504c163ba25",
                "subtext": "e7244a4d-a0ba-4580-a9f0-1a9ea2f6256a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            550,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "2 Any history of LRTI or active LRTI prior to, or at the time of, randomization",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "31869b1a-f4fa-43ea-87d1-28858690515b",
                "childbox": "888029c5-a0c8-41fe-ab42-567cc0bdb010",
                "subtext": "c432f89f-791a-4006-9b2b-59cc43325177"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            551,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "3 Known history of RSV infection or active RSV infection prior to, or at the time of, randomization",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "750569e0-d1c5-4016-904f-60ea47e6b154",
                "childbox": "0ad68cd3-b718-4445-8ecf-d965ef072294",
                "subtext": "3da42764-abb0-42b9-b763-660a8bf9b32a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            552,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "4 Any drug therapy (chronic or other) within 7 days prior to randomization or expected receipt during the study with the exception of: a) multivitamins and iron; b) infrequent use of over-the-counter (OTC) medications for the systemic treatment of common childhood symptoms (eg, pain relievers) that may be permitted according to the judgment of the Investigator",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3cd9606d-b877-4206-84d9-af069dfa79f5",
                "childbox": "273c3868-fd7c-4997-8c57-6e53f686e43f",
                "subtext": "e31341da-9435-4872-b5b7-74fccb60426d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            553,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "5 Any current or expected receipt of immunosuppressive agents including steroids (except for the use of topical steroids according to the judgment of the Investigator)",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "39849141-2af8-4180-bee2-f4ae588b4b73",
                "childbox": "943fc9d2-21b9-4a33-b3a3-9edbfbf59f9c",
                "subtext": "06a60ed4-abea-452a-8a77-0b0400b49e28"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            554,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "6 History of receipt of blood products, or immunoglobulin products, or expected receipt through the duration of the study",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ee0774a4-c963-41fa-8e47-9401cff702e5",
                "childbox": "1eab8611-b3d4-4222-8f80-6362293ecd9e",
                "subtext": "0648c8f6-69ac-40f3-a581-27f957c82d94"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            555,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "7 Hospitalization at the time of randomization, unless discharge is expected within the 7 days after randomization",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "527fb718-2543-4649-aad4-3a441f97dd0c",
                "childbox": "6bcf5610-fee6-4554-bd0e-4d2d1f13d00c",
                "subtext": "17036d7f-5590-401b-8c04-9bc380152711"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            556,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "8 Known renal impairment",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f7c9dc74-4ad0-485a-a803-74be8945a543",
                "childbox": "cf7b2c11-152f-43a6-8084-52819f155d52",
                "subtext": "a724b52d-8b06-4596-9508-f184e568777b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            557,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "9 Known hepatic dysfunction including known or suspected active or chronic hepatitis infection",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a0e66f4c-47e1-4919-8dfe-14f19692f3ea",
                "childbox": "9a165f69-b900-4820-820c-0b88cc87e1d5",
                "subtext": "c281e12a-25ce-40e6-9d74-f5bb51919442"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            558,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "10 History of CLD/bronchopulmonary dysplasia",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4177cfe9-b550-405d-9782-7b3c692129a5",
                "childbox": "8fec6086-41e9-4549-a02c-03884eb20fe2",
                "subtext": "eefcab60-02f4-45a3-b40a-8bef06626193"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            559,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "11 Clinically significant congenital anomaly of the respiratory tract",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d3f81900-0092-4f41-a367-4ed9ba8a78f3",
                "childbox": "671b1943-a463-4c54-85e5-873d2396184d",
                "subtext": "04a69e63-b82d-482f-899b-b5cf17cbf334"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            560,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "12 CHD, except for children with uncomplicated CHD (eg, patent ductus arteriosus, small septal defect)",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c7558f4d-60fb-4fb5-abef-c927472e2e9c",
                "childbox": "034898b7-9b60-4bb8-a94b-3afc4bfd0f4c",
                "subtext": "134aa6b8-0c0a-4c63-a5f5-562947763e23"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            561,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "13 Chronic seizure, or evolving or unstable neurologic disorder",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "04310c3c-7c5a-42c0-b341-9f11f41aba90",
                "childbox": "d4d80094-e551-48af-a581-8e5afee903dd",
                "subtext": "f0c64683-2bcd-4f8a-84fd-0165c617fd1d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            562,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "14 Prior history of a suspected or actual acute life-threatening event",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f2228314-e744-4833-852e-50c612f8ffe5",
                "childbox": "ea9a0ee7-1700-429e-9f42-77b6bde8d94e",
                "subtext": "c6d75919-492f-4c44-9a46-5b55ce920b59"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            563,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "15 Known immunodeficiency, including human immunodeficiency virus (HIV)",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6a4eaa37-a1f5-4383-88a2-a295df5bf3c7",
                "childbox": "edeefbd2-999a-4ad8-aeed-ccbe083505ec",
                "subtext": "bbb7d870-e75a-4bc2-b7e5-da44c7fad865"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            564,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "16 Mother with HIV infection (unless the child has been proven to be not infected)",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "b82277a8-bf92-4894-bccd-1123d9d98901",
                "childbox": "e902fe56-b5e4-4dd2-8ca9-6403431ce1a3",
                "subtext": "a8c8cd96-48e4-4c35-a5b7-bbd8491127eb"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            565,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "17 Any known allergy or history of allergic reaction to immunoglobulin products, blood products, or other foreign proteins, or history of allergic reaction",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4040342b-1719-43fc-91c7-0c0512f3837a",
                "childbox": "da838edb-b276-479c-8fd7-d6fa7fb41cb8",
                "subtext": "9220d759-7762-4549-98d4-c1cddec28a45"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            566,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "18 Receipt of palivizumab or other RSV mAb or any RSV vaccine, including maternal RSV vaccination",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "82800f61-2499-4289-be3a-80213151f08f",
                "childbox": "720f5826-f6a8-4be2-a160-9ef036d07ae8",
                "subtext": "7f96c0b0-2e0f-4014-ae26-cbcfbccbcde9"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            567,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "19 Receipt of any monoclonal or polyclonal antibody (for example, hepatitis B immune globulin, IV immunoglobulin) or anticipated use during the study",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ceccf15c-0941-4c91-ba70-e3c49a5a0ca0",
                "childbox": "c8b80df7-49cf-4bbb-9556-673bd5e10a07",
                "subtext": "8d001227-6df2-4bdb-8f7c-e811a6a34e29"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            568,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "20 Receipt of any investigational product",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "b3fbe268-aa88-4fc6-9156-ce259b1e0d86",
                "childbox": "c707af56-9876-44df-9d9d-d0370c52c77d",
                "subtext": "33a4fc46-970a-4070-9c96-6abf0192ac1e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            569,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "Concurrent enrollment in another interventional study",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a7a301ec-3b6d-49f9-a4a3-971faa5b60fe",
                "childbox": "46bc00d4-77b0-46f4-b06c-4acc51bf7e30",
                "subtext": "8a5dfe0e-0846-4814-b730-ca7602a546b3"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            570,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "22 Any condition that, in the opinion of the Investigator, would interfere with evaluation of the investigational product or interpretation of study results",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a8a7a1f4-9432-4282-be36-5bbc9d9134b5",
                "childbox": "b253925d-3541-440c-8d9f-c7e89cc7c411",
                "subtext": "33e7eec9-5522-4530-ba71-fef73acbe983"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            571,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "23 Children of employees of the Sponsor, clinical study site, or any other individuals involved with the conduct of the study, or immediate family members of such individuals",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1a368c5b-9cf0-420e-a9f3-6a26dbc2395a",
                "childbox": "a28ba3c8-1dd6-4a9d-8582-7e1d0e605f1e",
                "subtext": "a87a0e65-9ce9-4753-9701-4d552a5b31b3"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            572,
            ""
          ],
          [
            "2",
            "Exclusion Criteria",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "7559795a-44dd-462a-abed-36869563a8cb",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Exclusion Criteria",
            "4.1.3",
            "3",
            573,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.1.4 Subject Enrollment and Randomization",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "f7cdca23-a965-4d97-a88f-c8dea958af41",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Subject Enrollment and Randomization",
            "4.1.4",
            "3",
            574,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Study participation begins (ie, a subject is “enrolled”) once written informed consent is obtained.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1363e927-08f9-47cf-95aa-86345fcf44e9",
                "childbox": "b03a7588-eb2d-435a-98b5-73e6520229c2",
                "subtext": "003d00f6-2267-4bee-99a0-44d3ca77e029"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Subject Enrollment and Randomization",
            "4.1.4",
            "3",
            575,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Once informed consent is obtained, a subject identification (SID) number will be assigned by a central system (eg, an interactive web response system [IWRS]), and the screening evaluations may begin to assess study eligibility (inclusion/exclusion) criteria.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1363e927-08f9-47cf-95aa-86345fcf44e9",
                "childbox": "1954cc9f-a63c-494c-a1a6-1dabfe1a1885",
                "subtext": "4c5b4526-ba48-4664-b43b-cdb485787dbf"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Subject Enrollment and Randomization",
            "4.1.4",
            "3",
            576,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The SID number will be used to identify the subject during the screening process and throughout study participation, if applicable.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1363e927-08f9-47cf-95aa-86345fcf44e9",
                "childbox": "fbb0c0a7-1272-448a-9575-43400bb41c01",
                "subtext": "0f6d0df9-513b-47fd-a536-654d34a969c3"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Subject Enrollment and Randomization",
            "4.1.4",
            "3",
            577,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "A master log of all consented subjects will be maintained at the site and will document all screening failures (ie, subjects who are consented but do not meet study eligibility criteria and/or are not randomized), including the reason(s) for screening failure.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "8100dbfa-8959-4d93-9635-dc04787be4e9",
                "childbox": "7662cfb9-4db5-4faa-8632-0e18a0827891",
                "subtext": "b2ee2942-409f-42c8-9d42-a8e1540c4b51"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Subject Enrollment and Randomization",
            "4.1.4",
            "3",
            578,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subjects who fail to meet the inclusion/exclusion criteria (ie, screening failures) should not be randomized or administered investigational product.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f0194087-5c7e-42f8-80b8-a6226b77ee05",
                "childbox": "9abcd5d8-d1ad-441e-9dce-e434b939a887",
                "subtext": "9dd8848f-9b29-4da9-b3c6-c64d4cd03a52"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Subject Enrollment and Randomization",
            "4.1.4",
            "3",
            579,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The Investigator must consult with the Sponsor before a subject who has failed screening may be considered for rescreening.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f0194087-5c7e-42f8-80b8-a6226b77ee05",
                "childbox": "0d3644fa-a65f-4cf1-88c1-440f112609f3",
                "subtext": "ed3cbf20-1a35-431f-bfba-3da60f6d9317"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Subject Enrollment and Randomization",
            "4.1.4",
            "3",
            580,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.1.5 Withdrawal from the Study",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "69e14968-b81e-46e3-8f75-42b91294720d",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal from the Study",
            "4.1.5",
            "3",
            581,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subjects may at any time be withdrawn from the study without prejudice to further treatment (withdrawal of consent).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e4248a48-1b76-42a0-8013-3f54634c9380",
                "childbox": "3eda426e-68b6-4eff-b181-7a33ede9e0fc",
                "subtext": "9c787373-a2a0-4184-b5fc-39380a99ef5b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal from the Study",
            "4.1.5",
            "3",
            582,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The caregivers of such subjects will always be asked about the reason(s) for withdrawal and the presence of any AEs.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e4248a48-1b76-42a0-8013-3f54634c9380",
                "childbox": "cce21075-39b3-4511-9e14-54f658fc9124",
                "subtext": "9c787373-a2a0-4184-b5fc-39380a99ef5b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal from the Study",
            "4.1.5",
            "3",
            583,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If possible, the subject will be seen and assessed by the Investigator.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e4248a48-1b76-42a0-8013-3f54634c9380",
                "childbox": "21406c9c-746d-439f-b5e7-b491a0ec6fcf",
                "subtext": "5f263787-e6ec-462d-9826-a814662c494d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal from the Study",
            "4.1.5",
            "3",
            584,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "AEs will be followed up.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e4248a48-1b76-42a0-8013-3f54634c9380",
                "childbox": "abd14fe1-16a9-4a30-ab2a-5ca75bbcded2",
                "subtext": "5f263787-e6ec-462d-9826-a814662c494d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal from the Study",
            "4.1.5",
            "3",
            585,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If a subject withdraws from further participation in the study, then no further study visits or data collection should take place.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e4248a48-1b76-42a0-8013-3f54634c9380",
                "childbox": "3b4c6f65-860a-4dc2-81fb-16f489b0e896",
                "subtext": "5f263787-e6ec-462d-9826-a814662c494d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal from the Study",
            "4.1.5",
            "3",
            586,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The reason for withdrawal must be recorded in the electronic case report form (eCRF).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e4248a48-1b76-42a0-8013-3f54634c9380",
                "childbox": "ce36f876-9de5-4cf5-9118-4df9ed69a5fe",
                "subtext": "5f263787-e6ec-462d-9826-a814662c494d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal from the Study",
            "4.1.5",
            "3",
            587,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subjects who have received investigational product will be followed for protocol-specified assessments including follow-up of any AEs unless consent is withdrawn from further study participation or the subject is lost to follow-up (Section 4.1.7).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2947bbba-6c19-474f-9493-0a1c28cac66c",
                "childbox": "93718ff7-5bb6-4168-b19a-00fb4abccb94",
                "subtext": "5f41b69b-30db-42e4-832b-351bfe4bb25f"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal from the Study",
            "4.1.5",
            "3",
            588,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subjects who have not received investigational product, regardless of reason, will not be followed.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2947bbba-6c19-474f-9493-0a1c28cac66c",
                "childbox": "8ef2ef52-86f8-4cfb-bc7c-982cf2cad3af",
                "subtext": "b1252222-950d-4181-9c03-d7d85a758888"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal from the Study",
            "4.1.5",
            "3",
            589,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.1.6 Discontinuation of Investigational Product",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "b699d7de-c4cc-4997-bbdb-c975d0e329d8",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Discontinuation of Investigational Product",
            "4.1.6",
            "3",
            590,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Not applicable as each subject will receive a single dose of investigational product.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "219e6bf3-0265-4600-a1ca-845ebe8b5236",
                "childbox": "8af71552-3f1c-451e-9900-22be3ddad6e8",
                "subtext": "cd956d53-f8a1-451d-afee-b177b79758b1"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Discontinuation of Investigational Product",
            "4.1.6",
            "3",
            591,
            ""
          ],
          [
            "2",
            "Lost to Follow up",
            "header",
            "Lost to Follow-up",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "69895775-f595-4370-a3b7-c063c931f5e6",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lost to Follow-up",
            "4.1.7",
            "3",
            592,
            ""
          ],
          [
            "2",
            "Lost to Follow up",
            "text",
            "A subject will be considered potentially lost to follow-up if the subject’s parent(s)/legal representative(s) fails to return him or her for scheduled visits and is unable to be contacted by the study site.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6a5069d9-222d-4e9f-a7d1-af7fa400ca0c",
                "childbox": "70e636b9-76b2-4d30-87a2-d8e9ab5c01b8",
                "subtext": "cbde4dac-00ee-47f3-bd2b-0defaba502da"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lost to Follow-up",
            "4.1.7",
            "3",
            593,
            ""
          ],
          [
            "2",
            "Lost to Follow up",
            "text",
            "To prevent the subject from being lost to follow-up, it is recommended that the study sites maintain up-to-date contact details for subjects, including next of kin or other emergency contacts (if allowed by national regulation).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "56c0dc71-df73-4fd1-8659-e0cb20739a95",
                "childbox": "6c660d8c-70c3-40a2-bcb6-bf1318681d29",
                "subtext": "1d2fd1ef-cc0d-40bf-8a46-268d42c09492"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lost to Follow-up",
            "4.1.7",
            "3",
            594,
            ""
          ],
          [
            "2",
            "Lost to Follow up",
            "text",
            "The Investigator should educate the subject’s parent(s)/legal representative(s) on the importance of maintaining contact with the Investigator/study site throughout the study.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "cf8ed5eb-025c-4c6c-b7e8-d06125244f26",
                "childbox": "56a10b58-eaa9-4666-a2c1-5718ca7eedf7",
                "subtext": "21686ce1-4327-4317-ab15-e2b7c97ee33a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lost to Follow-up",
            "4.1.7",
            "3",
            595,
            ""
          ],
          [
            "2",
            "Lost to Follow up",
            "text",
            "The following actions must be taken if a subject fails to return to the site for required study visits:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "53420ba0-11ed-42fc-8c10-45606c24c428",
                "childbox": "27d5703b-5767-431a-a432-0f9025a5d3fe",
                "subtext": "2677fa92-0140-4648-ba2f-3f99a2030cfc"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lost to Follow-up",
            "4.1.7",
            "3",
            596,
            ""
          ],
          [
            "2",
            "Lost to Follow up",
            "text",
            "• The site must attempt to contact the subject’s parent(s)/legal representative(s) and reschedule the missed visit as soon as possible and counsel the subject’s parent(s)/legal representative(s) on the importance of maintaining the assigned visit schedule.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "938167c5-5fde-400c-bf6f-05028531348c",
                "childbox": "22e1a30d-dec6-4874-8d67-c2593ef14c1b",
                "subtext": "a4caba56-35d3-4526-8205-a720d60db42b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lost to Follow-up",
            "4.1.7",
            "3",
            597,
            ""
          ],
          [
            "2",
            "Lost to Follow up",
            "text",
            "• Repeated attempts must be made to regain contact with the subject’s parent(s)/legal representative(s) by repeat telephone calls, emails, and/or certified letter.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0c4e2973-225f-4a4e-b605-4bbbae4a50e7",
                "childbox": "af6d8955-d7a7-42c3-995a-729e0fc97aad",
                "subtext": "baed60b6-d962-40c2-a2ad-98ce5ddece23"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lost to Follow-up",
            "4.1.7",
            "3",
            598,
            ""
          ],
          [
            "2",
            "Lost to Follow up",
            "text",
            "These contact attempts should be documented in the subject’s medical record.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0c4e2973-225f-4a4e-b605-4bbbae4a50e7",
                "childbox": "894a9b94-f770-47a7-b05b-e0462e69d5b8",
                "subtext": "ac8312cf-bf3c-4e5d-a3f3-76f326dce846"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lost to Follow-up",
            "4.1.7",
            "3",
            599,
            ""
          ],
          [
            "2",
            "Lost to Follow up",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1b28aedc-3ffe-4e05-a577-41eb59fc33c1",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Lost to Follow-up",
            "4.1.7",
            "3",
            600,
            ""
          ],
          [
            "2",
            "Lost to Follow up",
            "text",
            "Efforts to reach the subject’s parent(s)/legal representative(s) should continue until the end of the study.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "60568b5e-4289-4563-afb3-27cd6972d480",
                "childbox": "14eb62dc-0385-47a1-82ea-f0e637f0015d",
                "subtext": "f0615481-6525-4615-acf9-9cffd684b03f"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lost to Follow-up",
            "4.1.7",
            "3",
            601,
            ""
          ],
          [
            "2",
            "Lost to Follow up",
            "text",
            "The subject will be classified as lost to follow-up only if his/her parent(s)/legal representative(s) fail to return his/her for the required study visits and his/her vital status remains unknown at the end of the study, despite all above listed efforts.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "910062c4-b36e-484e-ab7a-cf39879166fb",
                "childbox": "802c4a23-5e1a-4a32-8d38-739331140a8f",
                "subtext": "0029404b-a555-4958-a240-2c979ccad505"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lost to Follow-up",
            "4.1.7",
            "3",
            602,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.1.8 Replacement of Subjects",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "fa1bbe04-ddaa-410b-b927-0203fdd15c86",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Replacement of Subjects",
            "4.1.8",
            "3",
            603,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subjects will not be replaced.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "b3f23b31-9241-4478-8356-b674dedeaf6f",
                "childbox": "33a8fe96-d936-4bfe-acc3-5da2616466ba",
                "subtext": "5ce93b6c-549b-473c-9b32-2bf669b656f5"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Replacement of Subjects",
            "4.1.8",
            "3",
            604,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.1.9 Withdrawal of Informed Consent for Data and Biological Samples",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "1b303362-a9f0-43f5-a003-46078aa500a2",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal of Informed Consent for Data and Biological Samples",
            "4.1.9",
            "3",
            605,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The Sponsor ensures that biological samples are returned to the source or destroyed at the end of a specified period as described in the informed consent.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9e6f6f90-d770-465b-9ca7-56e96c5c81d7",
                "childbox": "191b0d17-dc46-4015-be85-c0b783eb287b",
                "subtext": "3892d5c0-e2a7-4b4f-a468-404745d50da0"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal of Informed Consent for Data and Biological Samples",
            "4.1.9",
            "3",
            606,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If a subject’s parent(s)/legal representative(s) withdraws consent for further study participation, any samples collected prior to that time may still be given to and used by the sponsor but no new data or samples will be collected unless specifically required to monitor safety of the subject.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "88aa0031-216a-4def-bd4c-4d964ac2a2cf",
                "childbox": "380750e5-2a65-4da8-9b8d-f749db915123",
                "subtext": "bd1083b1-fa8b-429e-85f6-47c4e48038ad"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal of Informed Consent for Data and Biological Samples",
            "4.1.9",
            "3",
            607,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If a subject’s parent(s)/legal representative(s) withdraws consent to the use of donated biological samples, the samples will be disposed of/destroyed, and the action documented.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "5d1adb03-377b-43dc-acab-f018181b4518",
                "childbox": "ef9afeb3-eb91-4196-89fe-5a0a8a6051d4",
                "subtext": "4aeed4fc-6975-4ed3-ba8d-220afe2c088d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal of Informed Consent for Data and Biological Samples",
            "4.1.9",
            "3",
            608,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If samples are already analyzed, the Sponsor is not obliged to destroy the results of this research.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "5d1adb03-377b-43dc-acab-f018181b4518",
                "childbox": "15937f62-8122-446e-903d-e22db5385c4e",
                "subtext": "9241b60c-e3a0-4170-81b5-093a04a94d4b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal of Informed Consent for Data and Biological Samples",
            "4.1.9",
            "3",
            609,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The Principal Investigator:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6800ca56-b62e-4b2b-ae3f-1445e1bc865f",
                "childbox": "d0df0469-5780-49fe-96c3-a42a7cc797c7",
                "subtext": "8af9fd71-64d3-4119-b5ea-3c4b7236c913"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal of Informed Consent for Data and Biological Samples",
            "4.1.9",
            "3",
            610,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Ensures subject’s parent(s)/legal representative(s) withdrawal of informed consent to the use of donated samples is notified immediately to the Sponsor.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "89354f6c-a2f1-4d83-ab51-a7a6a3a05cee",
                "childbox": "a3b82c67-5f94-4d90-956d-2eb0d7847fca",
                "subtext": "8d3a2044-ea42-4fea-b424-fbe193e0a40b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal of Informed Consent for Data and Biological Samples",
            "4.1.9",
            "3",
            611,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Ensures that biological samples from that subject, if stored at the study site, are immediately identified, disposed of/destroyed, and the action documented.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "11076195-78d1-468a-8a58-46c4d94c8898",
                "childbox": "9af784bd-95cc-43f9-aaad-8e816fd3318e",
                "subtext": "aad34465-7c12-410c-8529-a4a076cdbd1a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal of Informed Consent for Data and Biological Samples",
            "4.1.9",
            "3",
            612,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Ensures the organization(s) holding the samples is/are informed about the withdrawn consent immediately and that samples are disposed of/destroyed, the action documented, and the signed document returned to the study site.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "761c8070-f708-4cda-a90f-86aa8c7ef24b",
                "childbox": "92332f39-88cb-4fb8-b001-e04a362d686d",
                "subtext": "e6e3e2c2-60c9-45e4-bfeb-ccdff3148ab7"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal of Informed Consent for Data and Biological Samples",
            "4.1.9",
            "3",
            613,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Ensures that the subject’s parent(s)/legal representative(s) and the Sponsor are informed about the sample disposal.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "28fe3d60-7627-4af6-9ebf-540f70f0bec2",
                "childbox": "8989345e-7346-4675-83bc-f569c58ccfde",
                "subtext": "4d541588-eb08-4948-825e-1158d7804b49"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal of Informed Consent for Data and Biological Samples",
            "4.1.9",
            "3",
            614,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "cc759dff-bcec-4b4f-9c9f-5e0db385d5a6",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Withdrawal of Informed Consent for Data and Biological Samples",
            "4.1.9",
            "3",
            615,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The Sponsor ensures the organization(s) holding the samples is/are informed about the withdrawn consent immediately and that samples are disposed of/destroyed and the action documented and returned to the study site.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "606821b2-b5cf-4e7f-bdd8-eedc4529db27",
                "childbox": "0d886bce-0b45-484c-98b4-8263a784417f",
                "subtext": "96c5f8e0-79b3-4921-b74e-fa925a1951a6"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Withdrawal of Informed Consent for Data and Biological Samples",
            "4.1.9",
            "3",
            616,
            ""
          ]
        ]
      },
      {
        "id": "4.2-Schedule-of-Study-Procedures",
        "header": "4.2 Schedule of Study Procedures",
        "data": [
          [
            "",
            "Unmapped",
            "text",
            "Whenever vital signs and blood draws are scheduled for the same nominal time, vital signs should occur prior to blood draws.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "06046761-6992-48cd-8db8-c1c383cf070f",
                "childbox": "94ef0eea-1c7f-4590-825b-50ae9a59e1f4",
                "subtext": "0e98ff19-6a9c-4e93-8c0b-9cd91af7cd86"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Schedule of Study Procedures",
            "4.2",
            "2",
            618,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.2.1 Enrollment/Screening Period",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "0d3ce292-e1f1-4bf0-a0b8-42de55c63873",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Enrollment/Screening Period",
            "4.2.1",
            "3",
            619,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Table 4 shows all procedures to be conducted at the screening visit.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "eb1098a4-a7c1-4a5d-abad-81e615d6d2a1",
                "childbox": "febc0323-6bd6-4e65-aebb-b0cf1c80fb2f",
                "subtext": "445dd23a-cb8d-4c60-a642-21d099691ab7"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Enrollment/Screening Period",
            "4.2.1",
            "3",
            620,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Table 4 Schedule of Screening Procedures",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading7",
              "entity": [],
              "roi_id": {
                "para": "41f0a31f-fc9e-4619-bac9-ba94836b1deb",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Enrollment/Screening Period",
            "4.2.1",
            "3",
            621,
            ""
          ],
          [
            "",
            "Unmapped",
            "table",
            {
              "Table": "<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th>ColIndex</th>\n      <th>1.0</th>\n      <th>2.0</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>Study Period</td>\n      <td>Screening</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>Visit Number</td>\n      <td>V1</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>Procedure / Study Day</td>\n      <td>Day -30 to Day 1</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>Written informed consent/ assignment of SID number</td>\n      <td>X</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>Medical history</td>\n      <td>X</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>Physical examination</td>\n      <td>X</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>Weight</td>\n      <td>X</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>Vital signs</td>\n      <td>X</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>Assessment of AEs/SAEs</td>\n      <td>X</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>Concomitant medications</td>\n      <td>X</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>Verify eligibility criteria</td>\n      <td>X</td>\n    </tr>\n  </tbody>\n</table>",
              "TableProperties": "[{\"1.0\":{\"entities\":[],\"content\":\"Study Period\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"d313709e-cb51-4ba4-8f8d-54edcfbeaa23\",\"column_roi_id\":\"ba43d82e-e7f1-4252-a217-5b5bd0b222bc\",\"datacell_roi_id\":\"ad31c75d-fa71-4a62-b88d-2f405ef80c51\"},\"table_index\":12.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"Screening\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"d313709e-cb51-4ba4-8f8d-54edcfbeaa23\",\"column_roi_id\":\"1dc695a8-31fe-4008-98e6-fdad32feb66b\",\"datacell_roi_id\":\"2354f016-ea5b-4356-899a-9d7bc1cfeb8e\"},\"table_index\":12.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Visit Number\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"3a972cfd-af1e-47a8-bd76-a41664018fc8\",\"column_roi_id\":\"c35e229f-24ef-439e-b66d-73a5c6e9f4da\",\"datacell_roi_id\":\"b3e6c3af-f2be-4715-983d-a8551241bcdf\"},\"table_index\":12.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"V1\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"3a972cfd-af1e-47a8-bd76-a41664018fc8\",\"column_roi_id\":\"4d76af8b-de5e-48f7-80c2-cd258ec21aab\",\"datacell_roi_id\":\"83fb8473-3259-480f-80eb-5992aed24e89\"},\"table_index\":12.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Procedure \\/ Study Day\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"d67c272b-bfde-466f-9e06-547e769d87e4\",\"column_roi_id\":\"c153921d-be79-4501-ba36-ec10d92072c0\",\"datacell_roi_id\":\"ab470cad-7028-46bf-9448-416dea4797e8\"},\"table_index\":12.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[{\"start_idx\":0,\"end_idx\":2,\"standard_entity_name\":\"OTHER: Person Name\",\"subcategory\":\"OTHER: Person Name\",\"confidence\":100.0,\"text\":\"Day\"},{\"start_idx\":11,\"end_idx\":13,\"standard_entity_name\":\"OTHER: Person Name\",\"subcategory\":\"OTHER: Person Name\",\"confidence\":100.0,\"text\":\"Day\"}],\"content\":\"Day -30 to Day 1\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"d67c272b-bfde-466f-9e06-547e769d87e4\",\"column_roi_id\":\"ca76f88f-4ba8-4430-9e41-1046c6818cdf\",\"datacell_roi_id\":\"1e78665a-5761-4089-89e8-09355042bf31\"},\"table_index\":12.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Written informed consent\\/ assignment of SID number\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"afda6bdc-57fd-4cd8-bb7c-d8c3d80d7eff\",\"column_roi_id\":\"16f86393-13f5-4f54-b7c4-a828644e42a8\",\"datacell_roi_id\":\"b372b40c-68b3-4758-9c40-e0094e734ddd\"},\"table_index\":12.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"afda6bdc-57fd-4cd8-bb7c-d8c3d80d7eff\",\"column_roi_id\":\"0d3eea1c-1711-4a06-8439-abf9fd380283\",\"datacell_roi_id\":\"1c5be1a4-64c8-4287-ac68-712ab5d34255\"},\"table_index\":12.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Medical history\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"1fd4bb4d-54e2-4ed1-98a0-40afd070a546\",\"column_roi_id\":\"dbe34d3f-2b3a-49fb-b627-74593be1776f\",\"datacell_roi_id\":\"298c589d-139d-456f-ab8a-84c5ddb8e9bb\"},\"table_index\":12.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"1fd4bb4d-54e2-4ed1-98a0-40afd070a546\",\"column_roi_id\":\"6edb6028-77c9-4deb-8f4c-c3892f003d1b\",\"datacell_roi_id\":\"cf3ecbae-96bf-4350-ba45-95b55fd98b2f\"},\"table_index\":12.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Physical examination\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"3d50c7a3-4a73-4b6d-b747-c09a41449a67\",\"column_roi_id\":\"b4daacf5-4980-43a1-90e7-49b70c8fee23\",\"datacell_roi_id\":\"bb52afbf-baf2-4109-a783-3f5756bc573d\"},\"table_index\":12.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"3d50c7a3-4a73-4b6d-b747-c09a41449a67\",\"column_roi_id\":\"381a5afb-0838-4f8d-9730-babefc9209d8\",\"datacell_roi_id\":\"a27e10c8-dd41-486d-bea4-71708759c1cc\"},\"table_index\":12.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Weight\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"f9eda5cf-58f7-4017-9a63-d5cf6df2b6bb\",\"column_roi_id\":\"710aa933-3b49-45f8-8fd5-aa5da223b03b\",\"datacell_roi_id\":\"0b9bf9b7-92e2-4062-899d-1556aaa38094\"},\"table_index\":12.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"f9eda5cf-58f7-4017-9a63-d5cf6df2b6bb\",\"column_roi_id\":\"f5792ef8-0310-4623-a756-698ec7e74dff\",\"datacell_roi_id\":\"88bf8dd3-a9f2-4068-8ac6-8b5dc3f83a6c\"},\"table_index\":12.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Vital signs\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"574e1272-e3a6-4faa-9a15-9953a975c69e\",\"column_roi_id\":\"e4bac3f0-5d1e-4b48-b12a-21ebcdab106f\",\"datacell_roi_id\":\"93d559a8-03aa-4768-9cf9-4fb91d4356a1\"},\"table_index\":12.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"574e1272-e3a6-4faa-9a15-9953a975c69e\",\"column_roi_id\":\"c6fe08c0-135f-4b09-a331-ff40ef3bda93\",\"datacell_roi_id\":\"51b09860-dc5f-404e-bc8d-bc24a20c4314\"},\"table_index\":12.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Assessment of AEs\\/SAEs\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"57f3719a-15fe-4836-a4df-98c5f97ac1c8\",\"column_roi_id\":\"7f4900da-3294-4923-84fe-ebf0c1ee5c68\",\"datacell_roi_id\":\"0bdc04cf-766d-4320-b1ae-8a2b58d9030b\"},\"table_index\":12.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"57f3719a-15fe-4836-a4df-98c5f97ac1c8\",\"column_roi_id\":\"efface6f-9863-43eb-9510-18b57a1118bd\",\"datacell_roi_id\":\"aca34850-8366-48bb-a56e-60cc0fb47487\"},\"table_index\":12.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Concomitant medications\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"867983a3-9863-4272-af08-2d5b85dc22b6\",\"column_roi_id\":\"2efed1e4-2ef4-4db1-894b-157c8cfbf515\",\"datacell_roi_id\":\"c87aa80e-b11f-4802-aa2e-1d8f9c0d2db2\"},\"table_index\":12.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"867983a3-9863-4272-af08-2d5b85dc22b6\",\"column_roi_id\":\"35f9677a-4d43-456b-8ef1-127d69aef54a\",\"datacell_roi_id\":\"8f007b19-dcaf-4108-89dc-98075ee9f141\"},\"table_index\":12.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Verify eligibility criteria\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"7d9326dd-3af6-487c-91e1-bf5f5c4b424f\",\"column_roi_id\":\"f01d3bcc-844f-40cf-976a-3664138e8aa2\",\"datacell_roi_id\":\"5e1ac629-9513-4940-b195-8f68333f88f1\"},\"table_index\":12.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"ace62451-e91a-4878-96d5-3a7a66985ec0\",\"row_roi_id\":\"7d9326dd-3af6-487c-91e1-bf5f5c4b424f\",\"column_roi_id\":\"047bcdba-615b-4192-89d5-812842f0fcac\",\"datacell_roi_id\":\"cb6bd82d-7fb5-4334-b362-0f03e356e8e6\"},\"table_index\":12.0,\"qc_change_type\":\"\"}}]",
              "SectionHeaderPrintPage": "30",
              "TableIndex": "13",
              "TableName": "4.2.1 Enrollment/Screening Period(Schedule of Assessment)",
              "Header": [0, 1, 2]
            },
            {
              "IsBold": true,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ad31c75d-fa71-4a62-b88d-2f405ef80c51",
                "childbox": "aca51693-8745-454f-be14-fb629313aad6",
                "subtext": "d82205b0-8bcd-474e-9881-366e77a7e5d5"
              },
              "Bold": true,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Enrollment/Screening Period",
            "4.2.1",
            "3",
            622,
            ""
          ],
          [
            "",
            "Unmapped",
            "table",
            "",
            {
              "IsBold": true,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "774d78c6-3ad1-48cc-baa0-b6f3ddaa1bd9",
                "childbox": "8dc3ef1d-cb1d-442f-9a95-15cf2b11b3a5",
                "subtext": "04cdc8f2-9ded-43bb-9580-9cce86a23266"
              },
              "Bold": true,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Schedule of Screening Procedures",
            "Table 4",
            "1",
            624,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "AE = adverse event; SAE = serious adverse event; SID = subject identification; V = visit.",
            {
              "IsBold": false,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "24ff00b1-8451-43db-a1b5-d3a0e657a100",
                "childbox": "ee21f4a6-ec5f-4fb6-8ebd-814625f64373",
                "subtext": "dc384aeb-53ea-44d6-93f0-dc51f4bccb8d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Schedule of Screening Procedures",
            "Table 4",
            "1",
            625,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1f5f9c99-0294-4a15-bba8-52ef9d6797f9",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Schedule of Screening Procedures",
            "Table 4",
            "1",
            626,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.2.2 Treatment and Follow-up Periods",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "5ab8d23b-353d-42d2-abff-a6dd8dc14b0c",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            627,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Investigational product is administered on Day 1.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 43,
                  "end_idx": 45,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                }
              ],
              "roi_id": {
                "para": "486b983b-e053-438d-8f38-611dc7220860",
                "childbox": "42392549-d0ea-4249-baff-22b1cee56c8e",
                "subtext": "ab1a5832-6dcd-4ead-9fc2-1833185f2e96"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            628,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Table 5 shows all procedures to be conducted during the treatment and follow-up periods.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "486b983b-e053-438d-8f38-611dc7220860",
                "childbox": "d0ee22f1-07f2-4fb0-8888-67988d799e9d",
                "subtext": "ab1a5832-6dcd-4ead-9fc2-1833185f2e96"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            629,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "bd65b2b8-9c61-4b0a-a7e7-3ce555ea81be",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            630,
            ""
          ],
          [
            "",
            "Unmapped",
            "table",
            {
              "Table": "<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th>ColIndex</th>\n      <th>1.0</th>\n      <th>2.0</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>AstraZeneca</td>\n      <td>Protocol D5290C00006</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>Nirsevimab (MEDI8897)</td>\n      <td>07Jun2020; Final</td>\n    </tr>\n  </tbody>\n</table>",
              "TableProperties": "[{\"1.0\":{\"entities\":[{\"start_idx\":0,\"end_idx\":10,\"standard_entity_name\":\"ANY: Organization\",\"subcategory\":\"ANY: Organization\",\"confidence\":75.0,\"text\":\"AstraZeneca\"},{\"start_idx\":0,\"end_idx\":10,\"standard_entity_name\":\"Sponsor Name\",\"subcategory\":\"Sponsor Name\",\"confidence\":100.0,\"text\":\"AstraZeneca\"}],\"content\":\"AstraZeneca\",\"roi_id\":{\"table_roi_id\":\"24c53956-74aa-4674-8c54-0e9bb729a830\",\"row_roi_id\":\"be008838-11ca-4aad-a2ec-db954db8e06c\",\"column_roi_id\":\"68e8ffee-5820-4a63-9ede-857cd4a9d082\",\"datacell_roi_id\":\"5d92279c-c3ab-400f-95b9-faf47ffedd01\"},\"table_index\":14.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"Protocol D5290C00006\",\"roi_id\":{\"table_roi_id\":\"24c53956-74aa-4674-8c54-0e9bb729a830\",\"row_roi_id\":\"be008838-11ca-4aad-a2ec-db954db8e06c\",\"column_roi_id\":\"6c9d7ee1-adc7-48e6-9c9f-fcb3bbfc48e0\",\"datacell_roi_id\":\"fec3d53e-f452-494b-b343-d68775e0ba9a\"},\"table_index\":14.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[{\"start_idx\":0,\"end_idx\":9,\"standard_entity_name\":\"Molecule\",\"subcategory\":\"Molecule\",\"confidence\":75.0,\"text\":\"Nirsevimab\"},{\"start_idx\":12,\"end_idx\":19,\"standard_entity_name\":\"Molecule\",\"subcategory\":\"Molecule\",\"confidence\":87.0,\"text\":\"MEDI8897\"}],\"content\":\"Nirsevimab (MEDI8897)\",\"roi_id\":{\"table_roi_id\":\"24c53956-74aa-4674-8c54-0e9bb729a830\",\"row_roi_id\":\"f21d99a3-90cd-4fab-8ccc-0208d3a056f8\",\"column_roi_id\":\"0614b1ab-b92d-43f0-a738-b486137ab1e2\",\"datacell_roi_id\":\"e58c8726-dfd9-4e69-a158-1826a5f94df9\"},\"table_index\":14.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"07Jun2020; Final\",\"roi_id\":{\"table_roi_id\":\"24c53956-74aa-4674-8c54-0e9bb729a830\",\"row_roi_id\":\"f21d99a3-90cd-4fab-8ccc-0208d3a056f8\",\"column_roi_id\":\"8fa2c16c-b60e-4ce6-affa-8474a4cc1179\",\"datacell_roi_id\":\"eedb0a88-312d-44cc-b347-0f293ed4ad07\"},\"table_index\":14.0,\"qc_change_type\":\"\"}}]",
              "SectionHeaderPrintPage": "31",
              "TableIndex": "15",
              "TableName": "4.2.2 Treatment and Follow-up Periods",
              "Header": []
            },
            {
              "IsBold": false,
              "font_size": 20,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 0,
                  "end_idx": 10,
                  "standard_entity_name": "ANY: Organization",
                  "subcategory": "ANY: Organization",
                  "confidence": 75,
                  "text": "AstraZeneca"
                },
                {
                  "start_idx": 0,
                  "end_idx": 10,
                  "standard_entity_name": "Sponsor Name",
                  "subcategory": "Sponsor Name",
                  "confidence": 100,
                  "text": "AstraZeneca"
                }
              ],
              "roi_id": {
                "para": "5d92279c-c3ab-400f-95b9-faf47ffedd01",
                "childbox": "4cf533d9-9484-4860-9d9f-2d0677d3bc64",
                "subtext": "0593c3f4-a54e-4e29-bf48-c8de731c6c97"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            631,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Table 5 Schedule of Treatment Period and Follow-up Period Study Procedures",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading7",
              "entity": [],
              "roi_id": {
                "para": "7ddcd595-1499-4b9a-bd49-8551aafbb167",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            632,
            ""
          ],
          [
            "",
            "Unmapped",
            "table",
            {
              "Table": "<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th>ColIndex</th>\n      <th>1.0</th>\n      <th>2.0</th>\n      <th>3.0</th>\n      <th>4.0</th>\n      <th>5.0</th>\n      <th>6.0</th>\n      <th>7.0</th>\n      <th>8.0</th>\n      <th>9.0</th>\n      <th>10.0</th>\n      <th>11.0</th>\n      <th>12.0</th>\n      <th>13.0</th>\n      <th>14.0</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>Study Period</td>\n      <td></td>\n      <td></td>\n      <td>Treatment Period</td>\n      <td>Treatment Period</td>\n      <td>Treatment Period</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td>Follow-up Period</td>\n      <td>Follow-up Period</td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>Visit Number</td>\n      <td>V2 <sup>a</sup></td>\n      <td>TC</td>\n      <td>V3</td>\n      <td>V4</td>\n      <td>V5</td>\n      <td>V6</td>\n      <td>V7</td>\n      <td>V8</td>\n      <td>V9</td>\n      <td>TC</td>\n      <td>TC</td>\n      <td>LRTI</td>\n      <td>Skin Reaction</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>Procedure /  Study Day</td>\n      <td>D1</td>\n      <td>D8 (± 2 days)</td>\n      <td>D15 (± 2 days)</td>\n      <td>D31 (± 2 days)</td>\n      <td>D61 (± 2 days)</td>\n      <td>D91 (± 2 days)</td>\n      <td>D121 (± 2 days)</td>\n      <td>D151 (± 7 days)</td>\n      <td>D361 (± 7 days)</td>\n      <td>D1-151 Q2W (± 5 days)</td>\n      <td>D152-361 monthly (± 5 days)</td>\n      <td>D1-361  as needed</td>\n      <td>D1-361  as needed</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>Medical history update</td>\n      <td>X</td>\n      <td></td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>Physical examination</td>\n      <td>X</td>\n      <td></td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>Weight</td>\n      <td>X</td>\n      <td></td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>Vital signs</td>\n      <td>X <sup>b</sup></td>\n      <td></td>\n      <td>X</td>\n      <td>X</td>\n      <td>X <sup></sup></td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>Blood sample for PK, ADA</td>\n      <td>X <sup>c</sup></td>\n      <td></td>\n      <td>X<sup> (PK only)</sup></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td>X</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td>X <sup>d</sup></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>Assessment of AEs/SAEs, AESIs, NOCDs</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>Concomitant medications</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>Verify eligibility criteria</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>Randomization</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>12</th>\n      <td>IP administration</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>13</th>\n      <td>Assessment of LRTI or any respiratory infection that requires hospitalization</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td>X <sup>d</sup></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>14</th>\n      <td>Nasal swab collection</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td>X <sup>d</sup></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>15</th>\n      <td>Assessment of skin reaction</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td>X <sup>e</sup></td>\n    </tr>\n    <tr>\n      <th>16</th>\n      <td>Telephone  contact <sup>f</sup></td>\n      <td></td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td>X</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>17</th>\n      <td>HRU <sup>g</sup></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td>X</td>\n      <td></td>\n    </tr>\n  </tbody>\n</table>",
              "TableProperties": "[{\"1.0\":{\"entities\":[],\"content\":\"Study Period\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"f6f6dd23-fcb9-4a77-ad03-8b7bd76364f5\",\"column_roi_id\":\"274a1ac4-e960-4962-95c8-366a6fbbc5b5\",\"datacell_roi_id\":\"9ba6d309-cda2-44d5-82ed-6923a151ea77\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":\"\",\"4.0\":{\"entities\":[],\"content\":\"Treatment Period\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"f6f6dd23-fcb9-4a77-ad03-8b7bd76364f5\",\"column_roi_id\":\"47c28626-6b52-4ce9-b377-8a7673a0f3d9\",\"datacell_roi_id\":\"bda2bb2e-7267-45c6-9946-4fb78749aa14\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"Treatment Period\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"f6f6dd23-fcb9-4a77-ad03-8b7bd76364f5\",\"column_roi_id\":\"47c28626-6b52-4ce9-b377-8a7673a0f3d9\",\"datacell_roi_id\":\"bda2bb2e-7267-45c6-9946-4fb78749aa14\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"Treatment Period\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"f6f6dd23-fcb9-4a77-ad03-8b7bd76364f5\",\"column_roi_id\":\"47c28626-6b52-4ce9-b377-8a7673a0f3d9\",\"datacell_roi_id\":\"bda2bb2e-7267-45c6-9946-4fb78749aa14\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":{\"entities\":[],\"content\":\"Follow-up Period\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"f6f6dd23-fcb9-4a77-ad03-8b7bd76364f5\",\"column_roi_id\":\"e1c983be-20a8-4433-9fec-e6e21082c60d\",\"datacell_roi_id\":\"f47fcb26-7e59-477a-a70d-91fa38c89d35\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"12.0\":{\"entities\":[],\"content\":\"Follow-up Period\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"f6f6dd23-fcb9-4a77-ad03-8b7bd76364f5\",\"column_roi_id\":\"e1c983be-20a8-4433-9fec-e6e21082c60d\",\"datacell_roi_id\":\"f47fcb26-7e59-477a-a70d-91fa38c89d35\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Visit Number\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"ac67a448-2be1-4e63-a973-93d8e3c103c8\",\"datacell_roi_id\":\"ee9edca0-67e2-442a-8c72-75516ed9e7a3\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"V2 <sup>a<\\/sup> \",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"2ef0bdc0-048f-486f-adcd-b8a24778225d\",\"datacell_roi_id\":\"d6a96440-9f8a-4e87-8fbe-441ee290484b\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[],\"content\":\"TC\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"4b9053b7-ed6a-4d45-8870-ba9db7750801\",\"datacell_roi_id\":\"5d6561b0-4130-4a0d-aa83-b8790396a850\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"4.0\":{\"entities\":[],\"content\":\"V3\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"ee5db90d-82a8-45fa-9365-0c0c419091ff\",\"datacell_roi_id\":\"b3469b55-8bca-418c-88b4-52b5daf1fd82\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"V4\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"9a1b69b4-9cf8-47f2-bae3-2e461eb5f780\",\"datacell_roi_id\":\"cd1c3ccf-43b6-450d-a39b-f33160543019\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"V5\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"d52043c5-66d1-4c6c-bad4-1281824843f6\",\"datacell_roi_id\":\"6c180b09-4cd8-41d5-8306-0d81c2a014d1\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"V6\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"565929e5-f9f6-495a-9b51-1e0eb3ac8833\",\"datacell_roi_id\":\"878ee7c5-5d7f-41aa-b27d-a8825f7dad33\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"V7\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"7e0089b9-b693-4b4a-b39a-1a4319b6ed40\",\"datacell_roi_id\":\"883a3515-e9f8-47bb-a7bf-8ff2971b8522\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"V8\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"771b9ad0-2b9b-4654-84b9-11ae50ba61b1\",\"datacell_roi_id\":\"0367ae3b-c074-483f-9cbe-36eb959e6d81\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"V9\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"6c176d1e-7a05-49cb-92e6-798edf2154d2\",\"datacell_roi_id\":\"a6dc15c4-faed-4443-b377-a57bf3d18863\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"11.0\":{\"entities\":[],\"content\":\"TC\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"259ef8f4-a51b-4428-a44c-a78f433de1b5\",\"datacell_roi_id\":\"a291e2f3-5766-493b-995e-f92caae1c28e\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"12.0\":{\"entities\":[],\"content\":\"TC\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"259ef8f4-a51b-4428-a44c-a78f433de1b5\",\"datacell_roi_id\":\"a291e2f3-5766-493b-995e-f92caae1c28e\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"13.0\":{\"entities\":[],\"content\":\"LRTI\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"09952bd1-c176-4d9d-a0dd-033421513f03\",\"datacell_roi_id\":\"bc85100a-e2a6-4cae-ac80-4ceae482afba\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"14.0\":{\"entities\":[],\"content\":\"Skin Reaction\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"b597e449-3a5e-40b7-9d69-1eb500887e75\",\"column_roi_id\":\"fbe7f7ed-1240-4f48-97da-edf538177622\",\"datacell_roi_id\":\"1d868fcb-62f4-4208-b2ca-ede0bef4e9df\"},\"table_index\":15.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Procedure \\/  Study Day\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"5fab1ea7-648f-4938-be0d-9444de77296e\",\"datacell_roi_id\":\"f0fea28b-3e53-4a9f-8484-bf15fda5aadc\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"D1\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"2c67ab0e-ee01-4c12-b776-84143bed8878\",\"datacell_roi_id\":\"54b2c3e8-c7e4-4e7c-a98f-9d9ab95578c0\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[],\"content\":\"D8 (\\u00b1 2 days)\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"769d416a-55ac-4130-bbca-615e89318bd5\",\"datacell_roi_id\":\"189873e8-41a5-4454-9083-b7df52765f52\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"4.0\":{\"entities\":[],\"content\":\"D15 (\\u00b1 2 days)\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"a40d90ab-ac72-48d9-a0b9-ee40c9e2f7ea\",\"datacell_roi_id\":\"c2db6dcf-12db-4045-b1a5-9428f6c8338e\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"D31 (\\u00b1 2 days)\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"9cb52e19-8fa1-4a19-9a88-207f11c3a76a\",\"datacell_roi_id\":\"d6934d51-8a03-4c0c-bfe0-a5d11669852c\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"D61 (\\u00b1 2 days)\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"0bf0a398-fb05-4748-9419-c7457f231d7a\",\"datacell_roi_id\":\"85dd35d9-4af0-4a8b-b04c-ee6e30771007\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"D91 (\\u00b1 2 days)\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"273e3b08-99cb-4202-a96f-c70b7be1214d\",\"datacell_roi_id\":\"f0c7a61d-bee3-43af-abbd-69dce7e45ba4\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"D121 (\\u00b1 2 days)\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"ebd522de-164e-4ce1-aba8-1330285ff914\",\"datacell_roi_id\":\"70b9439f-0d97-4f0b-803d-8009cec8928c\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"D151 (\\u00b1 7 days)\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"1263d0d0-8c3b-4bb1-b777-8142e9a8f351\",\"datacell_roi_id\":\"2ba9e7e3-f80d-450b-a561-0cb9d51ee4e6\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"D361 (\\u00b1 7 days)\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"2321ce20-1a66-41d1-81f1-5045110529c7\",\"datacell_roi_id\":\"969a51b4-a02c-4fb6-ad82-601df38136cf\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"11.0\":{\"entities\":[],\"content\":\"D1-151 Q2W (\\u00b1 5 days)\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"fbff1cba-852f-43a9-bf52-4087d9e3ba1f\",\"datacell_roi_id\":\"24bb6af9-8991-49f1-a081-1b19418124b2\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"12.0\":{\"entities\":[],\"content\":\"D152-361 monthly (\\u00b1 5 days)\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"0d33bcad-18ea-47ef-8daa-29e7470d9396\",\"datacell_roi_id\":\"eebd9f2f-86b0-4f69-84e8-60a7c9b47cc9\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"13.0\":{\"entities\":[],\"content\":\"D1-361  as needed\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"4a91faa2-9685-41b8-a0c4-d021cc2b4368\",\"datacell_roi_id\":\"15ebde4b-4c43-44ae-a9a8-baa25d08a5a6\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"14.0\":{\"entities\":[],\"content\":\"D1-361  as needed\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"7e00d9c3-510e-43ae-a4d9-1651e8eeea81\",\"column_roi_id\":\"7d136e44-6710-4168-994c-643a449a672a\",\"datacell_roi_id\":\"7027f081-8019-4ab2-829f-ee2b7493a8a1\"},\"table_index\":15.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Medical history update\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"973fe14a-5f7b-45e5-812c-81d5273cd741\",\"column_roi_id\":\"5b083be6-bf97-4c4e-9d4e-b05210ebe315\",\"datacell_roi_id\":\"a3ce1478-a92f-4461-80e8-1b6d33192de8\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"973fe14a-5f7b-45e5-812c-81d5273cd741\",\"column_roi_id\":\"2f18e342-610e-41d6-992d-5cf4923b1f34\",\"datacell_roi_id\":\"443f4aad-b89b-4af7-b0b6-3478a1784b3b\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"973fe14a-5f7b-45e5-812c-81d5273cd741\",\"column_roi_id\":\"66a40947-04f5-48a8-98f9-1613d9571067\",\"datacell_roi_id\":\"7c903ca2-c48b-404b-a10f-e79cfc9974f7\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"973fe14a-5f7b-45e5-812c-81d5273cd741\",\"column_roi_id\":\"c10cd07a-9c6c-44f4-8d90-f46465131efe\",\"datacell_roi_id\":\"2ec8bf3d-01e9-44eb-b89e-08a53950077b\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"973fe14a-5f7b-45e5-812c-81d5273cd741\",\"column_roi_id\":\"f0686056-138c-4821-926e-83dd2ce99199\",\"datacell_roi_id\":\"c4cc93b8-3196-4845-b1a8-c320c231e85e\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"973fe14a-5f7b-45e5-812c-81d5273cd741\",\"column_roi_id\":\"03280c20-2e87-41af-a948-69fd4e02d5a4\",\"datacell_roi_id\":\"bc6100da-2374-4804-972d-7993f3a0648d\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"973fe14a-5f7b-45e5-812c-81d5273cd741\",\"column_roi_id\":\"5a7c9e71-ee01-4760-9c3e-8afe7007809d\",\"datacell_roi_id\":\"b70e5453-10cb-46e0-a2df-621db5777ac1\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"973fe14a-5f7b-45e5-812c-81d5273cd741\",\"column_roi_id\":\"c7f0ef92-a1b6-41e8-867e-fc24512df25f\",\"datacell_roi_id\":\"3ececcfd-5291-4443-b958-0ac913434467\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"973fe14a-5f7b-45e5-812c-81d5273cd741\",\"column_roi_id\":\"21bfe2a9-814e-4e07-9e3e-50cdea4fec92\",\"datacell_roi_id\":\"692c7dde-ab6b-4a43-a66f-22f9835ca82a\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Physical examination\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"546c495c-b204-4a1c-b1aa-428c4daea235\",\"column_roi_id\":\"529fd8e8-0959-4fd6-92b0-4b0da74baae9\",\"datacell_roi_id\":\"cb8de49a-e725-4223-9c6c-51690dee1139\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"546c495c-b204-4a1c-b1aa-428c4daea235\",\"column_roi_id\":\"453ab86a-5da1-4564-aaa4-eed7a074a482\",\"datacell_roi_id\":\"ce58cb5c-bd2a-47db-b658-3b29ec596698\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"546c495c-b204-4a1c-b1aa-428c4daea235\",\"column_roi_id\":\"1f7f34c5-1ced-4c19-867b-202f80a170a7\",\"datacell_roi_id\":\"d2b72fd0-1fae-4af0-b3c9-bd7834dedbfc\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"546c495c-b204-4a1c-b1aa-428c4daea235\",\"column_roi_id\":\"fa368dc0-0ff0-489f-b886-399b21463627\",\"datacell_roi_id\":\"8a35504f-9b00-458d-8e1d-160f59456fd2\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"546c495c-b204-4a1c-b1aa-428c4daea235\",\"column_roi_id\":\"7887a5b6-5b14-40a1-ae9f-6fc87c9bc191\",\"datacell_roi_id\":\"6f2ca8d5-176e-41af-b479-6b65d0669aa0\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"546c495c-b204-4a1c-b1aa-428c4daea235\",\"column_roi_id\":\"37a3f577-f8e1-487b-9409-e7d33f333917\",\"datacell_roi_id\":\"1889406e-1b90-4d5d-9254-61a73adf197d\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"546c495c-b204-4a1c-b1aa-428c4daea235\",\"column_roi_id\":\"2c60bb63-745f-4ab3-be66-0d873e4cb273\",\"datacell_roi_id\":\"e96f30e6-8a52-4843-a32f-b3c0d4b61335\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"546c495c-b204-4a1c-b1aa-428c4daea235\",\"column_roi_id\":\"2a541ae4-37fb-40b3-96f5-a577d414f553\",\"datacell_roi_id\":\"433c4104-aae6-4b65-976c-291f74c757d0\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"546c495c-b204-4a1c-b1aa-428c4daea235\",\"column_roi_id\":\"7756250d-3dd9-455c-8fb4-4e73700809a5\",\"datacell_roi_id\":\"4dd611a5-dab7-4952-896e-bc6568e9d050\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Weight\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"09b68ebd-eef0-4c4c-a78f-a150776d494a\",\"column_roi_id\":\"167babaa-1101-4dbc-aba0-0485c22af89f\",\"datacell_roi_id\":\"168246d5-573a-4832-b8b4-b02640609eda\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"09b68ebd-eef0-4c4c-a78f-a150776d494a\",\"column_roi_id\":\"e3ae9b76-2d16-4cd3-ad11-cc54923f8e4b\",\"datacell_roi_id\":\"5a168a48-de35-40b5-a80c-112184280555\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"09b68ebd-eef0-4c4c-a78f-a150776d494a\",\"column_roi_id\":\"976a9c84-bd29-42da-8474-c378a4b57c10\",\"datacell_roi_id\":\"2dc6e127-9829-4afe-b0cb-ac27de83c5b9\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"09b68ebd-eef0-4c4c-a78f-a150776d494a\",\"column_roi_id\":\"f29eb159-64ff-4320-a937-3971ef4341e9\",\"datacell_roi_id\":\"42458d18-ba71-45d2-98c8-e488ae29e2f3\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"09b68ebd-eef0-4c4c-a78f-a150776d494a\",\"column_roi_id\":\"932382ff-8e42-48fb-8451-8444afe9562a\",\"datacell_roi_id\":\"8d3af685-90cc-4657-a3e8-33f971e78d2a\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"09b68ebd-eef0-4c4c-a78f-a150776d494a\",\"column_roi_id\":\"e5046175-f0db-4739-b172-ab05b5161a39\",\"datacell_roi_id\":\"8e2b8442-5da9-4e6d-ab30-abaf8e67334f\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"09b68ebd-eef0-4c4c-a78f-a150776d494a\",\"column_roi_id\":\"4021af8e-e587-4885-a6d8-c6ced823e24d\",\"datacell_roi_id\":\"829fb2f5-2602-4b56-a987-3c136509212c\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"09b68ebd-eef0-4c4c-a78f-a150776d494a\",\"column_roi_id\":\"26449141-001d-42f8-a829-2892d5b7d5e1\",\"datacell_roi_id\":\"4bd4839d-af46-4d68-aaf0-5f85780baf8b\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"09b68ebd-eef0-4c4c-a78f-a150776d494a\",\"column_roi_id\":\"b2fae3d0-3fa6-42f8-a011-78f329d8ad8c\",\"datacell_roi_id\":\"93d2cdaf-50d3-4c99-b1b5-d8fa1fb759ab\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Vital signs\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"9d50b62d-cd04-4beb-a91b-8554c4c4df62\",\"column_roi_id\":\"187df32c-a615-4cb2-9912-8b1c661ce0ca\",\"datacell_roi_id\":\"c50a25dd-392a-4928-9a3d-b1352e2e1616\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X <sup>b<\\/sup> \",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"9d50b62d-cd04-4beb-a91b-8554c4c4df62\",\"column_roi_id\":\"a15535c8-924b-44c5-9133-884a17f86a56\",\"datacell_roi_id\":\"4e89ae30-449d-46dc-80f8-53856c2f0895\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"9d50b62d-cd04-4beb-a91b-8554c4c4df62\",\"column_roi_id\":\"a1580c49-720f-4cc2-ae83-77b451b8c812\",\"datacell_roi_id\":\"d5dd3192-8839-400c-aefe-d053b2562edb\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"9d50b62d-cd04-4beb-a91b-8554c4c4df62\",\"column_roi_id\":\"043dd37c-5c10-478c-9e36-0928024a34ca\",\"datacell_roi_id\":\"75f8cc2a-bd68-4533-8a3b-fa88aeccafea\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"X <sup><\\/sup> \",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"9d50b62d-cd04-4beb-a91b-8554c4c4df62\",\"column_roi_id\":\"4d740897-8e2f-4faf-8350-6c2af2a33428\",\"datacell_roi_id\":\"b7eecba1-7e1f-444c-96aa-d176476fedf2\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"9d50b62d-cd04-4beb-a91b-8554c4c4df62\",\"column_roi_id\":\"81c1884b-4244-47b3-8455-7a6e16bb0420\",\"datacell_roi_id\":\"fc252977-d96e-4f5f-9563-56fa1ff90df3\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"9d50b62d-cd04-4beb-a91b-8554c4c4df62\",\"column_roi_id\":\"f702c629-cda4-496b-b943-9b1f4ceb21c1\",\"datacell_roi_id\":\"a635cddd-231b-4fc5-b532-0cd453188c95\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"9d50b62d-cd04-4beb-a91b-8554c4c4df62\",\"column_roi_id\":\"20bd048c-cf03-4c55-ba5d-1aad9855bb13\",\"datacell_roi_id\":\"7b40c230-51c6-4750-9227-85fbc7ad730b\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"9d50b62d-cd04-4beb-a91b-8554c4c4df62\",\"column_roi_id\":\"c99f8604-b3a7-46bb-b630-05c4c552f76d\",\"datacell_roi_id\":\"917c5013-728a-4934-9c21-e01e5afaf87b\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Blood sample for PK, ADA\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"089274ac-c1cc-4fcf-89b7-0bceb8d32064\",\"column_roi_id\":\"58b0b703-126c-4311-a721-0cb7868d5acb\",\"datacell_roi_id\":\"728c2df2-34ec-44c2-bf6b-a35554ef92c8\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X <sup>c<\\/sup> \",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"089274ac-c1cc-4fcf-89b7-0bceb8d32064\",\"column_roi_id\":\"10724378-cd9f-4696-9bff-139c782ebf15\",\"datacell_roi_id\":\"0013229b-90ed-4088-9209-a22a4b4f39cf\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":{\"entities\":[],\"content\":\"X<sup> (PK only)<\\/sup>\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"089274ac-c1cc-4fcf-89b7-0bceb8d32064\",\"column_roi_id\":\"335f8537-2071-4f29-a641-ef00101f0b04\",\"datacell_roi_id\":\"8db14784-916f-4649-b19d-2cdc4560722b\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"089274ac-c1cc-4fcf-89b7-0bceb8d32064\",\"column_roi_id\":\"7e9a7960-5721-492a-9dbf-c4074a93d839\",\"datacell_roi_id\":\"edc4ce33-0496-48c6-a87e-ea918061315d\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"089274ac-c1cc-4fcf-89b7-0bceb8d32064\",\"column_roi_id\":\"79cba37f-a320-4389-bfd3-da81e599fe55\",\"datacell_roi_id\":\"439b2fe1-6310-4219-bf8e-0f1bbc682d2b\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"11.0\":\"\",\"12.0\":\"\",\"13.0\":{\"entities\":[],\"content\":\"X <sup>d<\\/sup> \",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"089274ac-c1cc-4fcf-89b7-0bceb8d32064\",\"column_roi_id\":\"102e976e-ada7-4f3d-bf18-f2998cf6dd42\",\"datacell_roi_id\":\"4346c7f5-40ea-4454-b4d1-7b6200386fe5\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Assessment of AEs\\/SAEs, AESIs, NOCDs\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"568b74ff-95c4-4a5c-be52-2e6577df8e15\",\"datacell_roi_id\":\"40fac7f1-a3e3-4ccd-bd41-daf37dd99396\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"6058df69-c2e1-43aa-a3e6-d02e3374bdc1\",\"datacell_roi_id\":\"3e7f73aa-41fd-4991-a8e2-a992913f2549\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"a69bd62e-71bf-4967-b230-a7b72eba226a\",\"datacell_roi_id\":\"8f6e8ae0-2cf9-4c53-8349-236a7a6ab237\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"4.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"1ee039d3-e8cd-4ada-9d09-5b69f96e134d\",\"datacell_roi_id\":\"c0598123-71bb-485b-bdb3-3becd9868c63\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"b6dc6fc3-faec-4ce4-a2d6-6f4f15eb73c6\",\"datacell_roi_id\":\"fdb28df7-3c8a-40af-a9db-faefb67cc422\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"24178d3c-1be5-4b51-8d02-61866c987c92\",\"datacell_roi_id\":\"26275cd6-5252-41b0-9290-179479ace83a\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"44c5ef45-acf1-4460-acaa-6e81be527d6d\",\"datacell_roi_id\":\"2eeb6913-a5c8-495b-a392-eef0b1b1e50b\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"7653dde4-56fe-4d6f-921f-49dc3316b69c\",\"datacell_roi_id\":\"77fc290d-4823-430f-bf30-99507a03dfdd\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"1d9b063b-094c-4b9e-a622-9b53c0ef4f5d\",\"datacell_roi_id\":\"313ece19-1047-435d-a676-92c585b34153\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"14c73e21-ced3-4619-a975-c044fbce9453\",\"datacell_roi_id\":\"994c9d7b-63a4-4598-9b6f-328802d1e981\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"11.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"219ff103-9a49-42dd-8191-aec0cb60096f\",\"datacell_roi_id\":\"f4ac03c7-e68d-421c-a487-d3115b6374dc\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"12.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"fb2eb3ea-c987-42ac-b69a-d8341fed32a9\",\"datacell_roi_id\":\"76fa783d-3cd3-4068-be23-4041f1aefb58\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"13.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"6d897dc8-46fa-4dfc-82b3-7aaaf301d5cb\",\"datacell_roi_id\":\"b6e17a5a-d23d-4bb2-b06b-10c9c0022c82\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"14.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"26e67423-b55c-4937-b4e3-2d7e313cc348\",\"column_roi_id\":\"ef839e81-b6ce-4f51-b199-066b6327eefa\",\"datacell_roi_id\":\"1b653d7c-6ecd-4010-bc40-ec516b951d9c\"},\"table_index\":15.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Concomitant medications\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"080462dc-0b08-446e-85dc-04bcc5c31588\",\"datacell_roi_id\":\"cdf08ae9-818c-4a89-9363-3d2420b4ff51\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"d686ceb2-833a-466e-a60a-d7c458ec11c7\",\"datacell_roi_id\":\"8b322a56-cf3e-46af-9c29-c3b05cbdc4c7\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"2d8aba04-1ee4-4a1f-9550-d6970ad6f768\",\"datacell_roi_id\":\"6f85e874-1dfb-4010-87e7-3dc177d19bb1\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"4.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"97383f61-6998-4641-9555-9893f17bbcb0\",\"datacell_roi_id\":\"b653017e-6d7d-412e-a133-332aa7d1dd99\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"9287ab33-b8ce-4db2-b288-bc3dc80581e6\",\"datacell_roi_id\":\"86da3fd8-68fe-43b6-88ff-3d7667af6665\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"b13770bc-d745-45d5-a8f0-e47a4e70cf5a\",\"datacell_roi_id\":\"cbd7141e-e93f-4024-a27d-851e2503d517\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"5cd73a17-e994-4f98-9123-1a29ea7e93f4\",\"datacell_roi_id\":\"f84dabc6-afcc-4303-a44e-29a4ba8da32d\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"759075ad-88a2-4679-91a4-a2e8c370873b\",\"datacell_roi_id\":\"920036e0-5e8d-4d84-ab99-f8e36f0c485f\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"c1c2acb1-b9ea-4c99-b605-76c329db9122\",\"datacell_roi_id\":\"197de18b-5d3b-42c2-8c56-c08dfed0057a\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"36ce3a63-0db2-4efd-980f-3baac850a269\",\"datacell_roi_id\":\"739f03d9-f5ad-4444-a265-9d6ed985b47f\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"11.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"f428b7d0-e1ae-4b43-94a1-bb928d95142d\",\"datacell_roi_id\":\"173b85a2-3f58-47ed-9bb0-c3cd2a066485\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"12.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"780e3d73-591e-4239-8503-1b1295b4ecad\",\"datacell_roi_id\":\"df75352f-d60f-48d6-b448-e417ffa981f8\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"13.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"385e0052-1038-45ea-82a1-4a5b077d2802\",\"datacell_roi_id\":\"b99cfade-6c77-421a-ad9a-57a48859d4be\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"14.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"aa7037db-4c4b-46df-b2ac-e5cc5c6cba3b\",\"column_roi_id\":\"97f29570-a5fc-4d87-b01e-7592e0e9d764\",\"datacell_roi_id\":\"a048d2e7-b5cf-4ad4-8c8f-b41b261a0a37\"},\"table_index\":15.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Verify eligibility criteria\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"79f1d21a-b5ae-434f-a6ba-a37e6908db06\",\"column_roi_id\":\"9c041026-5d70-4586-a78d-eddddb2615b3\",\"datacell_roi_id\":\"acee8bab-a78b-469a-b2e1-d83f0d97d1a0\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"79f1d21a-b5ae-434f-a6ba-a37e6908db06\",\"column_roi_id\":\"f3675670-e3b0-43cc-a48e-e381f282938d\",\"datacell_roi_id\":\"9d053d4f-fc49-41d6-ad19-801b9cf9ab79\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Randomization\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"79edb6ec-8cba-4899-8c5f-6bfb922ea889\",\"column_roi_id\":\"e8e9ce76-a9e6-43d8-8e38-f438e51035d2\",\"datacell_roi_id\":\"f2e7b4d0-b010-41b2-820c-9287d7b7f5ea\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"79edb6ec-8cba-4899-8c5f-6bfb922ea889\",\"column_roi_id\":\"8d1e331c-be64-4692-b789-426cf0a2523a\",\"datacell_roi_id\":\"669219f8-4612-4343-9c17-1f550f443677\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"IP administration\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"8198571f-5a32-4d4e-b412-31b8d15b60bd\",\"column_roi_id\":\"0f41fff9-a738-4413-80c4-9433ba2a32f0\",\"datacell_roi_id\":\"0c1284fc-b617-4d0c-8f10-14ee88e4304a\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"8198571f-5a32-4d4e-b412-31b8d15b60bd\",\"column_roi_id\":\"9e3b1637-2a39-4bef-869c-30835a06fcf4\",\"datacell_roi_id\":\"585cce4a-439f-485a-a35f-00227c4b7250\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Assessment of LRTI or any respiratory infection that requires hospitalization\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"1ce5eb7b-1914-45a1-afbc-cdfa9c660a71\",\"column_roi_id\":\"42ecebaa-928a-44eb-a71b-d250878a9c9d\",\"datacell_roi_id\":\"aceafded-3df3-4593-a62e-e6b3e16f3e3c\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":{\"entities\":[],\"content\":\"X <sup>d<\\/sup> \",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"1ce5eb7b-1914-45a1-afbc-cdfa9c660a71\",\"column_roi_id\":\"382aa41d-49d7-4c40-999c-a21c35614a2a\",\"datacell_roi_id\":\"697cb137-7eb3-4517-bda5-52ab41cd12f9\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Nasal swab collection\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"d8a624df-25fd-46bc-80ce-5baab5802b47\",\"column_roi_id\":\"51debc3b-8298-43cc-b3b2-60fcec6a8105\",\"datacell_roi_id\":\"f3e8887e-27cc-4333-97bd-dc6e8f1ab030\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":{\"entities\":[],\"content\":\"X <sup>d<\\/sup> \",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"d8a624df-25fd-46bc-80ce-5baab5802b47\",\"column_roi_id\":\"a9c9b539-da63-4ea8-a26a-a6ea66d75980\",\"datacell_roi_id\":\"7db7f933-7943-4352-85b8-38656ba24b4e\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Assessment of skin reaction\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"8eda33a1-dd3e-44aa-ad6c-7accb18b646a\",\"column_roi_id\":\"2d330624-f73b-4f75-9247-8d8e3a78f70e\",\"datacell_roi_id\":\"db218dfc-ec60-496a-ba24-7aee86b6d9df\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":{\"entities\":[],\"content\":\"X <sup>e<\\/sup> \",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"8eda33a1-dd3e-44aa-ad6c-7accb18b646a\",\"column_roi_id\":\"d19e00a0-bb56-43b8-bb31-29b40523b512\",\"datacell_roi_id\":\"a7094e7a-58e6-4a33-b1a4-aecf21c28c1f\"},\"table_index\":15.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Telephone  contact <sup>f<\\/sup> \",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"fa401b8b-b9e3-4c67-9a51-0f446d6f3107\",\"column_roi_id\":\"788eb5e1-65ed-417c-a7c6-147b0e9dc12a\",\"datacell_roi_id\":\"c22eebd6-4171-4deb-bbac-099369668e4b\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"fa401b8b-b9e3-4c67-9a51-0f446d6f3107\",\"column_roi_id\":\"47085961-f7b9-4063-ac7c-4993ce42a45d\",\"datacell_roi_id\":\"82f75600-e341-4f50-a6c7-19d33821b5ab\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"fa401b8b-b9e3-4c67-9a51-0f446d6f3107\",\"column_roi_id\":\"3bed7886-fe9b-4175-b5e3-e70c9e22cda3\",\"datacell_roi_id\":\"4bac7478-5801-4ef3-a0ff-368ab689cf31\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"12.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"fa401b8b-b9e3-4c67-9a51-0f446d6f3107\",\"column_roi_id\":\"cee6de61-8d15-4ad6-95bc-c731e2e2e41b\",\"datacell_roi_id\":\"d725b865-962f-4a42-91b0-f2b0162a612e\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"HRU <sup>g<\\/sup>\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"8b079036-ea43-4c92-8ab8-beebba959472\",\"column_roi_id\":\"5f9336e9-f9cd-43bf-96d8-e776d4f392c1\",\"datacell_roi_id\":\"242f0e30-90d8-4495-a278-844aaba2accf\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"f57d4859-df1f-401f-b6f2-9f7b25110dd0\",\"row_roi_id\":\"8b079036-ea43-4c92-8ab8-beebba959472\",\"column_roi_id\":\"44a4c7c5-b6ea-4fb0-93cf-d7cb21b0b1b7\",\"datacell_roi_id\":\"c63c15f1-df34-4002-ad43-a786e8222440\"},\"table_index\":15.0,\"qc_change_type\":\"\"},\"14.0\":\"\"}]",
              "SectionHeaderPrintPage": "31",
              "TableIndex": "16",
              "TableName": "4.2.2 Treatment and Follow-up Periods(Schedule of Assessment)",
              "Header": [0, 1, 2]
            },
            {
              "IsBold": true,
              "font_size": 18,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9ba6d309-cda2-44d5-82ed-6923a151ea77",
                "childbox": "f0777ccc-4ab5-4490-a051-fdca4186bdf0",
                "subtext": "ed4db13d-730c-4f19-b689-0179f4f1f775"
              },
              "Bold": true,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 18,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            633,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f4ef1a5e-42a7-4021-a5c3-8ee1aafa9034",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            634,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "dd20fe3b-4af2-4253-b757-16e9ec944b81",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            635,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2070c360-af8e-4b52-aeb6-437cc7756716",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            636,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a6fae623-0df9-4784-bf11-6d2197631f7e",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            637,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3fcd0fe0-e911-4d22-a284-388e67a4ba8f",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            638,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9b588932-f0da-474a-9685-5c6dd68fa870",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            639,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "814e6d2a-ca6f-4bee-9e03-1f6c0b74421d",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            640,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "95ca4874-8a54-40ce-a9f2-a21b13100983",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            641,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3ad64c7a-49c4-4fb6-9118-430e2f2b88d3",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            642,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e5aa9099-04c4-4776-b191-c8cb183f46ca",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            643,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "166a03dd-f06c-47b6-b258-6f811cbfb999",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            644,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "8d4412ea-1a97-4848-869e-9df602378c71",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            645,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "403b3ff3-294b-429d-8794-90941bfb8292",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            646,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "5dd1606f-a262-4066-bd1d-43ed8ad32619",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            647,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "b40f20ae-59ef-47d0-ae47-4c0e1a55106c",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            648,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "31e5a1fd-209e-42b7-a95a-b826e1bba541",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            649,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2d68d4b8-60f8-4f14-a705-68ff6dac6641",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            650,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "575f2704-f6e2-492e-ad19-7f788858e8d0",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            651,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "16540c1b-fbbc-4e49-b4ec-a9ff79425c1a",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            652,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "58dfc4c2-8f00-4dd4-8521-7d5cd4619170",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            653,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "38d12c7c-f4ee-46ac-9488-99d22e581687",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            654,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6e24b06f-bb30-4b7e-8286-2502b1855364",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            655,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "42abde15-fe6e-4c07-93d8-d636ab0888b5",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            656,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4d026a89-76d4-438d-92c1-a028d9701e1a",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            657,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ad6f5c29-d2bf-455c-be83-2d7067c34254",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            658,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f77967a5-7255-4152-b2f9-8c3355daaabe",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            659,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d7b4ef56-e9d3-4cf0-b06b-3764d92ad660",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            660,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d3815c28-dcf8-4a87-bd37-a06ab84cb925",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            661,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "bb5029df-01c4-4615-a962-678b97b78bf2",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            662,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "be488478-2eb5-4c84-82e4-b10277f8f438",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            663,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4d073cbe-f99a-4084-b56b-af244c1e96e4",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            664,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "82f36418-52f0-49f7-b428-595f5266c32a",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            665,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c2ad65c4-2695-4433-bb33-2232bb6f413b",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            666,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9951a8ae-e0c1-44b6-b876-d7cc20d33e7c",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            667,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "27f65b1e-82c2-4a90-b528-b2068979f939",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            668,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "05e7d2be-0fd0-440b-98ae-d6b235fcb774",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            669,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4f467982-b53c-4e3c-b30c-f0be693ac6f6",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            670,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c6ff4ac8-9f93-435c-86b7-c0a3623c6cab",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            671,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "7d29e17c-09d9-47fe-a9fc-f99eb06fd042",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            672,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6096fe13-b6f6-487d-8a31-de9feeb1cf8f",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            673,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "be140a9d-76c6-4095-bf21-daed1787e69a",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            674,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "cf1e3447-d965-4ef2-8c5a-123046458457",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            675,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e4ded0bb-e7c1-4ec9-9d8a-fb953f5fdd88",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            676,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a9e42bc6-6a9e-4659-b208-0819600ae5dc",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            677,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "cdaeaf02-fa0f-481b-ad7d-9f0fe8ceed92",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            678,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f7f2afbc-0d5f-499c-8849-0c09e78003e6",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            679,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f19eb60b-3998-419c-917e-855f2ba4eac4",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            680,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "37a9a1b4-1df0-4d69-8a98-8ee9bbad3d06",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            681,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "5e4c17cb-2242-4b9a-a0d3-1b146c2cff81",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            682,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "355fd9d1-0e92-4472-b17c-26443027a95c",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            683,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d13ac6f2-23b8-4be3-b7fb-9b36f939944d",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            684,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "80e34605-1b32-48fd-af26-8a38ec541e50",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            685,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f31c421b-05e2-47c6-af62-03b54b1d7087",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            686,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1c7859c3-6d12-46e3-88c5-9b1422c25cf8",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            687,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1d35f567-2e11-4bf0-8d51-a7a7ca315b4c",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            688,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "b28e6984-3eed-4c42-8639-3dd0dd238d74",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            689,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4ace68d9-b1ef-45c9-8a46-d222bd6e7f89",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            690,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "374b7d10-834b-4024-8d61-96a8f9cc9f21",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            691,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d2a1d248-d6ce-4068-8bbe-0f94e435f74a",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            692,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9b9e5e07-e8fb-4e95-ab3b-80f9894e2c2d",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            693,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "8eb0c5f8-93a5-453a-b61c-f8701df5d3e2",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            694,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "724ff1c1-16ed-4192-8ab4-80d9b447090d",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            695,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "da3eede9-7cd4-4741-bc93-bee8bf38a2fa",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            696,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d613f6b5-7c3b-486f-9392-0a94c6333169",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            697,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "fe7e25e6-5324-4e5f-bccf-39d29d62cf6f",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            698,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "72ff2e35-02e4-4af3-82e6-9eb16aa04c48",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            699,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "08c0c5ba-89d8-40f7-bf60-469c7eb4993d",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            700,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "cd64be83-ffb6-43ca-aac1-df732a7e01a8",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            701,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "bd48032d-4d68-4542-ba9b-efb5c0ffc4e8",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            702,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a136529a-5bab-4049-b3e3-486a61cb5b11",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            703,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "48a4d0c8-69db-43c8-8482-f5c4ce33d611",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            704,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "76ab429b-32a6-4f45-a783-3360cf4a943f",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            705,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6b4d85d0-80cd-44ec-9bc2-dc009e30ec07",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            706,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "b4f940e7-47fa-4ab6-9611-e90d5c6b5caf",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            707,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "86af2055-4684-4ab1-89b9-d066ec906654",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            708,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1610e9a3-f097-4e5f-82e9-746762c23432",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            709,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9012777b-f206-4e8a-af8d-9173c94d7c5b",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            710,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4357d50b-a408-4d68-9a1b-33f9c396ab8d",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            711,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "204c645d-79d8-4a04-8725-06fbc69958b1",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            712,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "aeb985cf-95fe-4e62-a17b-dc0612f6b54a",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            713,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a0262dc6-d0c2-4c9a-8c1a-a1ce610d87d0",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            714,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "cc4474fd-2444-4f29-ae85-d932f9ff0a45",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            715,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "13d10cc7-63b5-4d55-bf2b-0f25cb7adfda",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            716,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e1c4ef39-1773-4d91-b6a3-ff23f3a7d3a9",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            717,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "37022efc-e907-4ac4-8d9f-dd4eef8c940f",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            718,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "bb07c184-911a-4d63-a743-c86bfbda0464",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            719,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1bf31b68-1169-4672-a3c3-57ce13e9ed4c",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            720,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ad98a0d5-6fc8-4870-b48a-35d5d6ed927c",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            721,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "38f8b861-b0dd-4961-b077-40422397c109",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            722,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "5f9b7ecc-695f-4075-abc3-18b648380d99",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            723,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a7a1c03f-f08e-4076-94d0-63f0e472e268",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            724,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a83f7bc4-b678-428e-b8e5-50aa63e2b5d8",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            725,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ee8e77e3-08f3-430d-a2c5-198dd0aaccf4",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            726,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3df7114c-00bc-48cb-8bbb-6f44c1d9a7b5",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            727,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c3d8faf8-e524-415a-b9ff-bdc6acbcafb1",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            728,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4c57fc86-f4cf-4b0f-a9a9-3ae02edb8de1",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            729,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ef963944-fbf1-4972-a649-1838a4c603c1",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            730,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "662fba8e-501d-4d66-8885-eeb7ee0c303c",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            731,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c3022285-4c62-405b-887d-5a74660e7824",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            732,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2f8d939c-4b05-4b38-9801-6126b9531759",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            733,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3e6c95e0-f270-4dbf-8de6-3ca5aaaa803f",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            734,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3192fed1-6e8b-48ca-bb3a-b826382ad4ac",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            735,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e1a84561-5996-4608-8250-0ff22e2d5f27",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            736,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "23a82e4d-6d8c-4c70-9d86-d5c780d48805",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            737,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "40726fa7-b853-49d4-973b-bda43ed7d401",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            738,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "7ddcd966-5436-40e2-a657-84c81f179161",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            739,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4bbc9c7c-c8b0-4c2b-9610-8f5c0b148155",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            740,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "302c917d-0d6f-479e-80ad-85e5770ec749",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            741,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d044ee02-9e8b-4e1b-92e5-4e8315d7885c",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            742,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e9f001ae-21c1-4af8-9bf4-2eb49c5eb633",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            743,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "b2147f7d-e762-435a-8687-4f1fe447b5bb",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            744,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ecb0d78d-13fe-4517-a710-2a751cc4a970",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            745,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "cc5db2d8-093a-49a5-aa24-511ddc30aad0",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            746,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6814aa67-c83c-4f22-9e0b-ec5bdbed4b9e",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            747,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ac662e75-7ba3-4753-bfc7-5648df176fbc",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            748,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1c776355-37c1-46a4-9ee1-e48f59cd9060",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            749,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "b8ed0be4-d7d7-4b8e-b140-640aa101e131",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            750,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0d6ffcae-ed3b-45b0-90bf-05d3e00c4cf6",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            751,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "dc575af1-447f-4b73-82f8-4e1e4aecae5d",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            752,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "baef4e9b-23ef-450f-bd85-de2e719ba02f",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            753,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "140479af-1910-4a4c-a601-adf764d39dc5",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            754,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a7fd42f5-0d3d-4098-bf30-c4e3a54b5de8",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            755,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a216c23b-4a14-4a2a-b4d8-73203a89219d",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            756,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4bfa3b26-1868-40ca-a6c0-1076110f5ce0",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            757,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "45f814ec-2c13-4fc5-a4e6-ceaf2d7fe613",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            758,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "13726e74-d674-497d-accc-28441f056e53",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            759,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e01bb15a-552d-4cda-b5bf-487edfdfa9c4",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            760,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d630cd07-1b16-41b8-be89-4c9aa8bf504f",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            761,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "CONFIDENTIAL AND PROPRIETARY",
            {
              "IsBold": false,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9e02644a-6bc7-401e-9712-8a0d49b83330",
                "childbox": "9752b76a-f05d-4816-b6f2-6fc8846f1469",
                "subtext": "7ea29ce7-b99c-4991-8adc-df983ec19a91"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            762,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9e02644a-6bc7-401e-9712-8a0d49b83330",
                "childbox": "31365926-0d72-4315-bba7-fb8c4f81d838",
                "subtext": "a9667584-1d1b-4345-8035-47682e9eaa28"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            763,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "33 of 75",
            {
              "IsBold": false,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9e02644a-6bc7-401e-9712-8a0d49b83330",
                "childbox": "2a365b31-7ec1-4436-bf35-5a720088511e",
                "subtext": "a9667584-1d1b-4345-8035-47682e9eaa28"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            764,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9e02644a-6bc7-401e-9712-8a0d49b83330",
                "childbox": "0331f8d3-966c-488a-b3e8-06eedd664410",
                "subtext": "129e6504-ca58-4626-a349-4a72cb5326f5"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            765,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Template 18.0",
            {
              "IsBold": false,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9e02644a-6bc7-401e-9712-8a0d49b83330",
                "childbox": "0caf6b6c-856a-47fb-8ef5-18b73539251e",
                "subtext": "129e6504-ca58-4626-a349-4a72cb5326f5"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            766,
            ""
          ],
          [
            "",
            "Unmapped",
            "table",
            {
              "Table": "<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th>ColIndex</th>\n      <th>1.0</th>\n      <th>2.0</th>\n      <th>3.0</th>\n      <th>4.0</th>\n      <th>5.0</th>\n      <th>6.0</th>\n      <th>7.0</th>\n      <th>8.0</th>\n      <th>9.0</th>\n      <th>10.0</th>\n      <th>11.0</th>\n      <th>12.0</th>\n      <th>13.0</th>\n      <th>14.0</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>Visit Number</td>\n      <td>V2  <sup>a</sup></td>\n      <td>TC</td>\n      <td>V3</td>\n      <td>V4</td>\n      <td>V5</td>\n      <td>V6</td>\n      <td>V7</td>\n      <td>V8</td>\n      <td>V9</td>\n      <td></td>\n      <td></td>\n      <td>LRTI</td>\n      <td>Skin</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>Procedure /</td>\n      <td></td>\n      <td>D8</td>\n      <td>D15</td>\n      <td>D31</td>\n      <td>D61</td>\n      <td>D91</td>\n      <td>D121</td>\n      <td>D151</td>\n      <td>D361</td>\n      <td>D1-151</td>\n      <td>D152-361</td>\n      <td>D1-361</td>\n      <td>D1-361</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td></td>\n      <td>D1</td>\n      <td>( 2</td>\n      <td>( 2</td>\n      <td>( 2</td>\n      <td>( 2</td>\n      <td>( 2</td>\n      <td>( 2</td>\n      <td>( 7</td>\n      <td>( 7</td>\n      <td>Q2W</td>\n      <td>monthly</td>\n      <td>as</td>\n      <td>as</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>Study Day</td>\n      <td></td>\n      <td>days)</td>\n      <td>days)</td>\n      <td>days)</td>\n      <td>days)</td>\n      <td>days)</td>\n      <td>days)</td>\n      <td>days)</td>\n      <td>days)</td>\n      <td>( 5 days)</td>\n      <td>( 5 days)</td>\n      <td>needed</td>\n      <td>needed</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>Medical history update</td>\n      <td>X</td>\n      <td></td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>Physical examination</td>\n      <td>X</td>\n      <td></td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>Weight</td>\n      <td>X</td>\n      <td></td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>Vital signs</td>\n      <td><sup>b</sup> X</td>\n      <td></td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>Blood sample for PK,</td>\n      <td></td>\n      <td></td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>ADA</td>\n      <td><sup>c</sup> X</td>\n      <td></td>\n      <td>(PK</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td>X</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td><sup>d</sup> X</td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>Assessment of AEs/SAEs,  AESIs, NOCDs</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>Concomitant medications</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n      <td>X</td>\n    </tr>\n    <tr>\n      <th>12</th>\n      <td>Verify eligibility criteria</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>13</th>\n      <td>Randomization</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>14</th>\n      <td>IP administration</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>15</th>\n      <td>Assessment of LRTI or</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>16</th>\n      <td>any respiratory infection  that requires</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td><sup>d</sup> X</td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>17</th>\n      <td>hospitalization</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>18</th>\n      <td>Nasal swab collection</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td><sup>d</sup> X</td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>19</th>\n      <td>Assessment of skin  reaction</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td><sup>e</sup> X</td>\n    </tr>\n    <tr>\n      <th>20</th>\n      <td>Telephone   <sup>f</sup> contact</td>\n      <td></td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td>X</td>\n      <td>X</td>\n      <td></td>\n      <td></td>\n    </tr>\n    <tr>\n      <th>21</th>\n      <td><sup>g </sup> HRU</td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n      <td></td>\n    </tr>\n  </tbody>\n</table>",
              "TableProperties": "[{\"1.0\":{\"entities\":[],\"content\":\"Visit Number \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ea11e8ae-3f9d-4259-9f2b-6067d2fbc087\",\"column_roi_id\":\"f342f1b6-78db-4517-b223-b2f2f9a2fa4c\",\"datacell_roi_id\":\"b9e06027-7f37-11ec-be1d-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"V2  <sup>a<\\/sup>\",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ea11e8ae-3f9d-4259-9f2b-6067d2fbc087\",\"column_roi_id\":\"59abec00-e67f-4071-ab1c-c5e6d73e8d2a\",\"datacell_roi_id\":\"b9e06030-7f37-11ec-8ab0-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[],\"content\":\"TC \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ea11e8ae-3f9d-4259-9f2b-6067d2fbc087\",\"column_roi_id\":\"a4177612-3c07-48e8-8d03-1f1cf4a57eac\",\"datacell_roi_id\":\"b9e06036-7f37-11ec-adba-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"4.0\":{\"entities\":[],\"content\":\"V3 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ea11e8ae-3f9d-4259-9f2b-6067d2fbc087\",\"column_roi_id\":\"54c5b966-3afa-4c4a-932a-ce6e5164494f\",\"datacell_roi_id\":\"b9e0603c-7f37-11ec-ae77-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"V4 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ea11e8ae-3f9d-4259-9f2b-6067d2fbc087\",\"column_roi_id\":\"53a67aee-d910-4779-86f6-b2fb5a5d5f18\",\"datacell_roi_id\":\"b9e06042-7f37-11ec-a091-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"V5 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ea11e8ae-3f9d-4259-9f2b-6067d2fbc087\",\"column_roi_id\":\"d9a4df66-341d-41d5-b54d-a0b323cce32d\",\"datacell_roi_id\":\"b9e06048-7f37-11ec-ab8d-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"V6 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ea11e8ae-3f9d-4259-9f2b-6067d2fbc087\",\"column_roi_id\":\"8a0f8cb6-0835-40e3-8ae8-2921cf2a6a19\",\"datacell_roi_id\":\"b9e0604e-7f37-11ec-b999-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"V7 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ea11e8ae-3f9d-4259-9f2b-6067d2fbc087\",\"column_roi_id\":\"2c4c70ad-0439-4cf1-8b8a-7a2f7b64a9a4\",\"datacell_roi_id\":\"b9e06054-7f37-11ec-8134-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"V8 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ea11e8ae-3f9d-4259-9f2b-6067d2fbc087\",\"column_roi_id\":\"840d9931-b81c-47c6-90c8-9b8e015a4d7b\",\"datacell_roi_id\":\"b9e0605a-7f37-11ec-accf-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"V9  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ea11e8ae-3f9d-4259-9f2b-6067d2fbc087\",\"column_roi_id\":\"537fc529-b98f-452b-8cf4-520ae4ca643f\",\"datacell_roi_id\":\"b9e06060-7f37-11ec-aa8b-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"11.0\":\"\",\"12.0\":\"\",\"13.0\":{\"entities\":[],\"content\":\"LRTI \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ea11e8ae-3f9d-4259-9f2b-6067d2fbc087\",\"column_roi_id\":\"0047ee3e-24ce-4d2a-abee-e2598ba47e48\",\"datacell_roi_id\":\"b9e0606c-7f37-11ec-97f5-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"14.0\":{\"entities\":[],\"content\":\"Skin \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ea11e8ae-3f9d-4259-9f2b-6067d2fbc087\",\"column_roi_id\":\"57bddb5f-3821-4512-856a-dbb0de1d6712\",\"datacell_roi_id\":\"b9e06072-7f37-11ec-a913-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Procedure \\/  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"826f7cd5-7e14-47aa-ad44-e9c06bda74d2\",\"datacell_roi_id\":\"b9e06081-7f37-11ec-a0ee-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":{\"entities\":[],\"content\":\"D8  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"6ce1be42-292b-48d4-b5db-4e49094550bb\",\"datacell_roi_id\":\"b9e06096-7f37-11ec-a084-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"4.0\":{\"entities\":[],\"content\":\"D15  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"72e1502e-e2cc-4176-a602-726ebf0c1875\",\"datacell_roi_id\":\"b9e060ab-7f37-11ec-ae86-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"D31  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"d6aa514a-aa90-469d-ad01-415f7505afe8\",\"datacell_roi_id\":\"b9e060c0-7f37-11ec-af61-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"D61  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"65a062a9-cf96-4c0f-8269-d4b7230c39de\",\"datacell_roi_id\":\"b9e060d5-7f37-11ec-8056-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"D91  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"04dfc3dc-b7da-4dcb-8e30-ece1aa2ff3c4\",\"datacell_roi_id\":\"b9e060ea-7f37-11ec-b73a-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"D121  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"bd79aa3f-dde1-4af0-bc72-390a4c0a3b9e\",\"datacell_roi_id\":\"b9e12386-7f37-11ec-8219-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"D151  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"46888a5c-9a6d-466b-b931-4138b90fd73d\",\"datacell_roi_id\":\"b9e1239b-7f37-11ec-aa00-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"D361 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"7e36a390-dfad-4717-9f82-dd9e1a8e3f84\",\"datacell_roi_id\":\"b9e123b0-7f37-11ec-b258-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"11.0\":{\"entities\":[],\"content\":\"D1-151 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"902b3b19-782e-4bc5-85a0-16e8758f0c71\",\"datacell_roi_id\":\"b9eb41ad-7f37-11ec-a284-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"12.0\":{\"entities\":[],\"content\":\"D152-361 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"25b366e0-6dc1-4bd8-8ae2-2016d827a18f\",\"datacell_roi_id\":\"b9eb41c2-7f37-11ec-83f4-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"13.0\":{\"entities\":[],\"content\":\"D1-361  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"cf657bef-a85d-4948-9069-1f778d9a7196\",\"datacell_roi_id\":\"b9eb41d7-7f37-11ec-9ce1-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"14.0\":{\"entities\":[],\"content\":\"D1-361  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a17fdb64-0a88-428c-a998-329aec2d4f18\",\"column_roi_id\":\"c424bc26-36c7-4eb4-af20-d8014262a79b\",\"datacell_roi_id\":\"b9eb41ec-7f37-11ec-8088-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"}},{\"1.0\":\"\",\"2.0\":{\"entities\":[],\"content\":\"D1 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"4260c6e6-85c2-4d24-aefa-c09b2cc7eae5\",\"datacell_roi_id\":\"b9e0608d-7f37-11ec-82f5-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[],\"content\":\"( 2 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"eae4b559-ba90-4aa3-ac3d-bb435d44212a\",\"datacell_roi_id\":\"b9e0609c-7f37-11ec-9181-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"4.0\":{\"entities\":[],\"content\":\"( 2 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"cd845edf-7bed-4277-be17-f22313e5b219\",\"datacell_roi_id\":\"b9e060b1-7f37-11ec-ac10-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"( 2 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"802dd5b6-6184-43e7-a80b-d1be600263fa\",\"datacell_roi_id\":\"b9e060c6-7f37-11ec-880d-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"( 2 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"3eb4aa26-ace4-4efb-895f-1dd4366d6669\",\"datacell_roi_id\":\"b9e060db-7f37-11ec-83ac-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"( 2 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"4d1f87f3-3f8c-4baf-907f-7291638d7f96\",\"datacell_roi_id\":\"b9e12377-7f37-11ec-8db7-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"( 2 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"dff3ed8e-4386-469d-a08a-e04d30f4f7fc\",\"datacell_roi_id\":\"b9e1238c-7f37-11ec-a54f-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"( 7 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"77e6810d-ed31-4c2a-bbf2-b386d37201a0\",\"datacell_roi_id\":\"b9e123a1-7f37-11ec-b216-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"( 7 \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"37eab000-97ff-4820-83ed-d816ea52cff2\",\"datacell_roi_id\":\"b9e123b6-7f37-11ec-bba7-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"11.0\":{\"entities\":[],\"content\":\"Q2W  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"1758bfa4-aead-4ade-a718-692ab1971e6c\",\"datacell_roi_id\":\"b9eb41b3-7f37-11ec-bbec-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"12.0\":{\"entities\":[],\"content\":\"monthly \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"c6ec8a13-0ecd-48d0-88c3-b17c647ee29b\",\"datacell_roi_id\":\"b9eb41c8-7f37-11ec-9eb1-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"13.0\":{\"entities\":[],\"content\":\"as \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"3e5c57c0-61da-4b9f-8b21-7910a4728692\",\"datacell_roi_id\":\"b9eb41dd-7f37-11ec-959d-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"14.0\":{\"entities\":[],\"content\":\"as \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"49d7990d-08be-4393-aa94-12019c68169d\",\"column_roi_id\":\"a14aa4e3-6a34-42bc-bea3-926ce786398a\",\"datacell_roi_id\":\"b9eb41f2-7f37-11ec-a575-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Study Day \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"44ba7e7b-cc5a-4c50-89be-d72db4079b1a\",\"datacell_roi_id\":\"b9e06087-7f37-11ec-aeff-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":{\"entities\":[],\"content\":\"days) \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"94677b36-2fa5-49c1-b0ec-7de95d66cac0\",\"datacell_roi_id\":\"b9e060a2-7f37-11ec-8830-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"4.0\":{\"entities\":[],\"content\":\"days) \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"dc15b489-106a-444e-80aa-c09f928b5e71\",\"datacell_roi_id\":\"b9e060b7-7f37-11ec-a684-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"days) \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"5037ab13-99ad-4a85-ad11-a1e874ccbc0c\",\"datacell_roi_id\":\"b9e060cc-7f37-11ec-a109-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"days) \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"b6ead96e-eed1-4a57-8609-c05b40db37f3\",\"datacell_roi_id\":\"b9e060e1-7f37-11ec-ae99-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"days) \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"2158ff92-8757-412d-a2f3-ba3afa60272d\",\"datacell_roi_id\":\"b9e1237d-7f37-11ec-b8a0-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"days) \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"c2fe289f-89d5-4663-a0bb-fb5df70d0d18\",\"datacell_roi_id\":\"b9e12392-7f37-11ec-abb0-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"days) \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"2e7f6867-a469-44ad-9cb4-426654f63fd8\",\"datacell_roi_id\":\"b9e123a7-7f37-11ec-9e83-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"days) \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"0a7057f5-3d4d-47fd-a261-bb4ff3899408\",\"datacell_roi_id\":\"b9e123bc-7f37-11ec-a2f9-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"11.0\":{\"entities\":[],\"content\":\"( 5 days) \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"82c42c57-0304-426f-886a-29b777176527\",\"datacell_roi_id\":\"b9eb41b9-7f37-11ec-907e-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"12.0\":{\"entities\":[],\"content\":\"( 5 days) \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"7f26ea98-76a8-4049-ac81-754dcdaa9aaa\",\"datacell_roi_id\":\"b9eb41ce-7f37-11ec-af7f-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"13.0\":{\"entities\":[],\"content\":\"needed \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"0c8a14c9-a6ed-4d98-8f8d-2026b0405ebf\",\"datacell_roi_id\":\"b9eb41e3-7f37-11ec-a63b-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"14.0\":{\"entities\":[],\"content\":\"needed \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"95611972-ac24-4acf-a245-feaed4eea50f\",\"column_roi_id\":\"5e639367-07eb-49ce-8fb9-8ae750a9997f\",\"datacell_roi_id\":\"b9eb41f8-7f37-11ec-b063-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Medical history update \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d7bec9f7-71c3-4656-a204-431d3e471c0c\",\"column_roi_id\":\"8ad0f466-34d2-4dfa-bc2f-4818cc6b39ef\",\"datacell_roi_id\":\"b9eb4201-7f37-11ec-9d15-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d7bec9f7-71c3-4656-a204-431d3e471c0c\",\"column_roi_id\":\"cd3296e4-1b7c-4e21-8ab3-4917c6731ce1\",\"datacell_roi_id\":\"b9eb4207-7f37-11ec-af7f-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d7bec9f7-71c3-4656-a204-431d3e471c0c\",\"column_roi_id\":\"c7443489-ccb1-4fdd-9bad-0377225ccbd5\",\"datacell_roi_id\":\"b9eb4210-7f37-11ec-900f-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d7bec9f7-71c3-4656-a204-431d3e471c0c\",\"column_roi_id\":\"3b39dedf-b774-416f-bcd8-99d55ae8f2f9\",\"datacell_roi_id\":\"b9ec04e3-7f37-11ec-81f6-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d7bec9f7-71c3-4656-a204-431d3e471c0c\",\"column_roi_id\":\"caeb914a-f969-444c-8a1e-e2d2ef01cdde\",\"datacell_roi_id\":\"b9ec04e9-7f37-11ec-a138-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d7bec9f7-71c3-4656-a204-431d3e471c0c\",\"column_roi_id\":\"431ebb6a-1f4e-4030-a9b3-6003621acc9a\",\"datacell_roi_id\":\"b9ec04ef-7f37-11ec-b09b-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d7bec9f7-71c3-4656-a204-431d3e471c0c\",\"column_roi_id\":\"2e73a5fb-27ed-42ea-a454-a4317badd83d\",\"datacell_roi_id\":\"b9ec04f5-7f37-11ec-bf4b-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d7bec9f7-71c3-4656-a204-431d3e471c0c\",\"column_roi_id\":\"916cdf45-0771-4eda-b3b4-d8e62f4b8ace\",\"datacell_roi_id\":\"b9ec04fb-7f37-11ec-b044-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d7bec9f7-71c3-4656-a204-431d3e471c0c\",\"column_roi_id\":\"7475795b-62ca-4e65-8f85-7af5db8fbbf3\",\"datacell_roi_id\":\"b9ec0501-7f37-11ec-9ee2-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Physical examination \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a46faf53-b5fe-4e59-ae75-ebb49fe77bbc\",\"column_roi_id\":\"81b5e9ae-7394-43d0-9630-faf2e6501c67\",\"datacell_roi_id\":\"b9ec0516-7f37-11ec-90dc-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a46faf53-b5fe-4e59-ae75-ebb49fe77bbc\",\"column_roi_id\":\"6878c957-72c5-4a5a-801e-691f25e1f96c\",\"datacell_roi_id\":\"b9ec051c-7f37-11ec-b204-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a46faf53-b5fe-4e59-ae75-ebb49fe77bbc\",\"column_roi_id\":\"12a3a078-5c2e-4364-896a-23c55953dc04\",\"datacell_roi_id\":\"b9ec0525-7f37-11ec-8d98-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a46faf53-b5fe-4e59-ae75-ebb49fe77bbc\",\"column_roi_id\":\"05f733e2-e382-487a-86cf-e96a9ef0acb9\",\"datacell_roi_id\":\"b9ec052b-7f37-11ec-88c0-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a46faf53-b5fe-4e59-ae75-ebb49fe77bbc\",\"column_roi_id\":\"e9898782-6b4d-42c1-af50-92fba828973d\",\"datacell_roi_id\":\"b9ec0531-7f37-11ec-91bf-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a46faf53-b5fe-4e59-ae75-ebb49fe77bbc\",\"column_roi_id\":\"892f6d12-ea99-4c5c-ab60-6709181b8363\",\"datacell_roi_id\":\"b9ec0537-7f37-11ec-8848-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a46faf53-b5fe-4e59-ae75-ebb49fe77bbc\",\"column_roi_id\":\"c2b6302b-6994-4b80-bee8-1393e9e6f043\",\"datacell_roi_id\":\"b9ec053d-7f37-11ec-b093-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a46faf53-b5fe-4e59-ae75-ebb49fe77bbc\",\"column_roi_id\":\"1737b991-1935-49d0-86d7-132ccff65b99\",\"datacell_roi_id\":\"b9ec0543-7f37-11ec-ba73-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a46faf53-b5fe-4e59-ae75-ebb49fe77bbc\",\"column_roi_id\":\"63a8c086-ab20-47ba-863c-6619a55cfe10\",\"datacell_roi_id\":\"b9ec0549-7f37-11ec-bf7f-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Weight \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d011a9ad-0b62-47d8-ac93-419cb7365fb6\",\"column_roi_id\":\"73e6f9f4-7449-488e-a5a8-dbc2b31b4db3\",\"datacell_roi_id\":\"b9ec055e-7f37-11ec-9bab-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d011a9ad-0b62-47d8-ac93-419cb7365fb6\",\"column_roi_id\":\"96390c17-b487-454d-bc19-2295e6310841\",\"datacell_roi_id\":\"b9ec0564-7f37-11ec-851f-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d011a9ad-0b62-47d8-ac93-419cb7365fb6\",\"column_roi_id\":\"32b2b4f2-4922-4014-b899-9c80c2bcb05f\",\"datacell_roi_id\":\"b9ec056d-7f37-11ec-987d-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d011a9ad-0b62-47d8-ac93-419cb7365fb6\",\"column_roi_id\":\"e558a899-183f-4fb0-8abe-88db43e6d1d8\",\"datacell_roi_id\":\"b9ec0573-7f37-11ec-b906-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d011a9ad-0b62-47d8-ac93-419cb7365fb6\",\"column_roi_id\":\"019ff95f-0cfd-40fa-9496-67eae8ccd32b\",\"datacell_roi_id\":\"b9ec0579-7f37-11ec-b3bc-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d011a9ad-0b62-47d8-ac93-419cb7365fb6\",\"column_roi_id\":\"d87fbaac-ad22-4ce0-aa17-1953e3f54bdb\",\"datacell_roi_id\":\"b9ec057f-7f37-11ec-b28a-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d011a9ad-0b62-47d8-ac93-419cb7365fb6\",\"column_roi_id\":\"170398f3-acc9-488e-977a-ae2422d8df1e\",\"datacell_roi_id\":\"b9ec0585-7f37-11ec-823d-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d011a9ad-0b62-47d8-ac93-419cb7365fb6\",\"column_roi_id\":\"f22bbefb-f64c-4ca7-8554-2a13e57762c6\",\"datacell_roi_id\":\"b9ec058b-7f37-11ec-a912-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d011a9ad-0b62-47d8-ac93-419cb7365fb6\",\"column_roi_id\":\"eb277b1a-4d2b-4927-a4d3-10460ee7e6a4\",\"datacell_roi_id\":\"b9ec0591-7f37-11ec-8362-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Vital signs  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"11374fc0-eed0-4f79-b06f-343b6dd33331\",\"column_roi_id\":\"18f0f056-062c-4a3f-b815-65488eaf9d8e\",\"datacell_roi_id\":\"b9ecc84c-7f37-11ec-8ca2-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"<sup>b<\\/sup> X\",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"11374fc0-eed0-4f79-b06f-343b6dd33331\",\"column_roi_id\":\"353ca7a0-acdd-4167-add2-101b81aa2ea4\",\"datacell_roi_id\":\"b9ecc852-7f37-11ec-ae37-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"11374fc0-eed0-4f79-b06f-343b6dd33331\",\"column_roi_id\":\"bc833289-77fe-4bf7-a4aa-3952296b5d33\",\"datacell_roi_id\":\"b9ecc85e-7f37-11ec-9ad4-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"X  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"11374fc0-eed0-4f79-b06f-343b6dd33331\",\"column_roi_id\":\"5f48e3f2-31e4-489d-a986-e2e7db075442\",\"datacell_roi_id\":\"b9ecc864-7f37-11ec-8a93-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"X\",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"11374fc0-eed0-4f79-b06f-343b6dd33331\",\"column_roi_id\":\"ff0799b2-0a4e-4c0f-bb56-7c57656bc585\",\"datacell_roi_id\":\"b9ecc86a-7f37-11ec-ae1c-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"X  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"11374fc0-eed0-4f79-b06f-343b6dd33331\",\"column_roi_id\":\"031981ff-9a81-44b2-8cbc-8a2d771fd853\",\"datacell_roi_id\":\"b9ecc870-7f37-11ec-8d96-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"X  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"11374fc0-eed0-4f79-b06f-343b6dd33331\",\"column_roi_id\":\"b370fe1d-9b1d-484f-ab70-9c2e39a487e9\",\"datacell_roi_id\":\"b9ecc876-7f37-11ec-9afa-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"11374fc0-eed0-4f79-b06f-343b6dd33331\",\"column_roi_id\":\"eb7a5e9f-9bb4-483b-8c0d-fc55515d0217\",\"datacell_roi_id\":\"b9ecc87c-7f37-11ec-a140-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"11374fc0-eed0-4f79-b06f-343b6dd33331\",\"column_roi_id\":\"da6da91a-b8fb-49da-a136-162605fede24\",\"datacell_roi_id\":\"b9ecc882-7f37-11ec-b801-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Blood sample for PK, \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"40282908-bb15-488b-a425-50cbf48c26a3\",\"column_roi_id\":\"b9d3c9df-1153-4fa5-8e5b-a87fe028e93d\",\"datacell_roi_id\":\"b9ecc897-7f37-11ec-8f27-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":\"\",\"4.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"40282908-bb15-488b-a425-50cbf48c26a3\",\"column_roi_id\":\"bb5f7d69-eaed-4fe0-af44-92e2a0e89f8c\",\"datacell_roi_id\":\"b9ecc8b2-7f37-11ec-b303-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"ADA  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"e29b9b1c-de6b-4885-aa36-7b8e322bb21a\",\"column_roi_id\":\"c4f20906-c475-4436-8295-1f7c352ca2dd\",\"datacell_roi_id\":\"b9ecc89d-7f37-11ec-b516-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"<sup>c<\\/sup> X\",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"e29b9b1c-de6b-4885-aa36-7b8e322bb21a\",\"column_roi_id\":\"ed2d45e2-9e5c-425b-b07b-b083380400b5\",\"datacell_roi_id\":\"b9ecc8a3-7f37-11ec-8b71-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":{\"entities\":[],\"content\":\"(PK \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"e29b9b1c-de6b-4885-aa36-7b8e322bb21a\",\"column_roi_id\":\"11765bcb-74ad-4ce5-9233-df26600bae3d\",\"datacell_roi_id\":\"b9ecc8b8-7f37-11ec-a866-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"e29b9b1c-de6b-4885-aa36-7b8e322bb21a\",\"column_roi_id\":\"b08ad3dc-0c35-4eac-a109-3b1814ec0226\",\"datacell_roi_id\":\"b9ecc8d3-7f37-11ec-a253-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"e29b9b1c-de6b-4885-aa36-7b8e322bb21a\",\"column_roi_id\":\"5e12ede9-03c9-4903-8c83-08365a501021\",\"datacell_roi_id\":\"b9ecc8d9-7f37-11ec-a463-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"11.0\":\"\",\"12.0\":\"\",\"13.0\":{\"entities\":[],\"content\":\"<sup>d<\\/sup> X\",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"e29b9b1c-de6b-4885-aa36-7b8e322bb21a\",\"column_roi_id\":\"12c95c0e-e9a7-4d42-adf9-f5b839d71b0b\",\"datacell_roi_id\":\"b9ed8b18-7f37-11ec-86e6-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Assessment of AEs\\/SAEs,  AESIs, NOCDs \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"df975e34-ae03-4b16-926c-72ef81763bfb\",\"datacell_roi_id\":\"b9ed8b2d-7f37-11ec-9f80-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"a2a7fd33-45eb-47e5-a800-584d01a807ba\",\"datacell_roi_id\":\"b9ed8b33-7f37-11ec-9724-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"aaf9f2c2-efa6-42c3-ace4-6319bd247b3f\",\"datacell_roi_id\":\"b9ed8b39-7f37-11ec-a10c-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"4.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"deca6322-2623-440a-bc94-f6f2ddddbc1e\",\"datacell_roi_id\":\"b9ed8b3f-7f37-11ec-ac41-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"38af23c0-32c1-4421-8da2-b00e7a8752d9\",\"datacell_roi_id\":\"b9ed8b45-7f37-11ec-9d50-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"948de0c4-2104-4a81-a15e-efd2531843d5\",\"datacell_roi_id\":\"b9ed8b4b-7f37-11ec-9e30-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"635dafea-8b27-4be9-a358-2f6f76ceb9de\",\"datacell_roi_id\":\"b9ed8b51-7f37-11ec-917a-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"65f35b28-5677-41b6-b98f-6e4d1e0ace79\",\"datacell_roi_id\":\"b9ed8b57-7f37-11ec-a90d-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"d8ceba68-b957-4fc7-b4bc-096fd720ce28\",\"datacell_roi_id\":\"b9ed8b5d-7f37-11ec-bdad-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"3ee82249-146a-4cd1-8832-15b4295b1455\",\"datacell_roi_id\":\"b9ed8b63-7f37-11ec-994c-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"11.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"487e6787-6aee-4c78-b70f-1e828c1c2ea2\",\"datacell_roi_id\":\"b9ed8b69-7f37-11ec-92bb-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"12.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"fb1b4b2b-7434-41c6-a35f-3109856a1389\",\"datacell_roi_id\":\"b9ed8b6f-7f37-11ec-a6c2-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"13.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"40492b20-95c8-44d9-9591-3436a3b57ba9\",\"datacell_roi_id\":\"b9ed8b75-7f37-11ec-8692-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"14.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"d890263d-a672-45ec-93bd-1e0e4b5896f7\",\"column_roi_id\":\"3cdc08fa-4e7d-49cf-abeb-2b10fb055a63\",\"datacell_roi_id\":\"b9ed8b7b-7f37-11ec-a4dd-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Concomitant medications \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"20509c78-5fb2-46d4-b69b-95c454bad40c\",\"datacell_roi_id\":\"b9ed8b84-7f37-11ec-a2f8-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"3944f525-5f6f-426c-a4ec-2313e28ce866\",\"datacell_roi_id\":\"b9ed8b8a-7f37-11ec-9f06-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"419a9e68-b133-46a8-8699-da0b31859823\",\"datacell_roi_id\":\"b9ed8b90-7f37-11ec-9bbe-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"4.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"a3dab5b3-df2d-4330-b568-be1b38343b85\",\"datacell_roi_id\":\"b9ed8b96-7f37-11ec-a96c-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"5.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"1e544d2e-91fc-4d61-b606-e1d38ab06829\",\"datacell_roi_id\":\"b9ed8b9c-7f37-11ec-bbb0-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"6.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"2ecd89eb-dd91-4ffc-a872-6d8ee2b82352\",\"datacell_roi_id\":\"b9ed8ba2-7f37-11ec-9544-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"7.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"e782ee0b-ec60-48f7-ac78-aaf07a90170e\",\"datacell_roi_id\":\"b9ed8ba8-7f37-11ec-a17e-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"8.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"f4502f03-3233-4826-a58e-8ff834edb5e3\",\"datacell_roi_id\":\"b9ed8bae-7f37-11ec-913c-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"9.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"140116b1-8812-422a-88cd-2f454efb20ab\",\"datacell_roi_id\":\"b9ed8bb4-7f37-11ec-8616-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"10.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"8d147d9f-a8c1-4a88-ae78-a5db63aa2827\",\"datacell_roi_id\":\"b9ed8bba-7f37-11ec-90e1-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"11.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"f3015925-0e64-4fae-93fc-3538e0ac63aa\",\"datacell_roi_id\":\"b9ed8bc0-7f37-11ec-96f2-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"12.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"8638b4df-8e3f-4a6c-95b1-b079ec0e3355\",\"datacell_roi_id\":\"b9ed8bc6-7f37-11ec-81d4-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"13.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"8ca4fb95-d10b-4a9d-8263-eeb0fda243e4\",\"datacell_roi_id\":\"b9ed8bcc-7f37-11ec-a3c2-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"14.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fe1ec4f1-c96b-47ef-94a6-09bab0a30179\",\"column_roi_id\":\"fe3c05f4-c6bf-456e-9303-a3d0377bfc03\",\"datacell_roi_id\":\"b9ed8bd2-7f37-11ec-b2b7-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Verify eligibility criteria \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fd1a0998-1e8c-4d8d-be22-326441b7f34f\",\"column_roi_id\":\"2bb0631e-af02-463b-9bed-71daea54123c\",\"datacell_roi_id\":\"b9ed8bdb-7f37-11ec-9a71-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fd1a0998-1e8c-4d8d-be22-326441b7f34f\",\"column_roi_id\":\"7f7c4e20-9f7a-48fd-b2e7-fca0d99fd187\",\"datacell_roi_id\":\"b9ee4ea0-7f37-11ec-b83b-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Randomization  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a9ce0f0b-5e29-4e3f-ac81-45ef2697c730\",\"column_roi_id\":\"603a8c3d-30c9-42b0-a46b-a262e37109f2\",\"datacell_roi_id\":\"b9ee4ecd-7f37-11ec-b252-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a9ce0f0b-5e29-4e3f-ac81-45ef2697c730\",\"column_roi_id\":\"1a738fa2-6e47-4ab4-b35b-c963d0a2a23c\",\"datacell_roi_id\":\"b9ee4ed3-7f37-11ec-8797-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"IP administration  \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"589cbc61-9097-4b1c-a193-b23510cfec70\",\"column_roi_id\":\"ba46386b-2892-4931-9716-818a9d8f03e8\",\"datacell_roi_id\":\"b9ee4f00-7f37-11ec-bf40-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"589cbc61-9097-4b1c-a193-b23510cfec70\",\"column_roi_id\":\"de545484-01da-405c-af66-3507eb2b5ce7\",\"datacell_roi_id\":\"b9ee4f06-7f37-11ec-8dab-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Assessment of LRTI or \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"ef872f36-2e0d-4042-92e8-84bff7359fae\",\"column_roi_id\":\"fa995cfb-5328-4cc0-9a86-7ace0361aed2\",\"datacell_roi_id\":\"b9ee4f33-7f37-11ec-9746-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"any respiratory infection  that requires \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a751d2b5-9e60-4dce-b1b3-c872c7bfad3a\",\"column_roi_id\":\"f32d9761-b557-4d9a-87e9-7f2156ab0210\",\"datacell_roi_id\":\"b9ee4f3f-7f37-11ec-8d83-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":{\"entities\":[],\"content\":\"<sup>d<\\/sup> X\",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"a751d2b5-9e60-4dce-b1b3-c872c7bfad3a\",\"column_roi_id\":\"3e573167-442d-4d5b-a829-c7c4c9451a52\",\"datacell_roi_id\":\"b9ef1240-7f37-11ec-8d42-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"hospitalization \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"0816e679-3bf9-4908-a7bd-940d58b897d3\",\"column_roi_id\":\"fc717d14-cd54-4ffe-9cc0-0611e05e70ad\",\"datacell_roi_id\":\"b9ee4f45-7f37-11ec-817b-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Nasal swab collection \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fd930b41-3fa0-4b97-a279-b5a927ebb25b\",\"column_roi_id\":\"88bc5678-ed7c-414a-a7d8-ed2c4d167d5b\",\"datacell_roi_id\":\"b9ef124f-7f37-11ec-bfc3-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":{\"entities\":[],\"content\":\"<sup>d<\\/sup> X\",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"fd930b41-3fa0-4b97-a279-b5a927ebb25b\",\"column_roi_id\":\"0c9aea4e-87d1-434f-a9e8-b247f8e2fd76\",\"datacell_roi_id\":\"b9ef1276-7f37-11ec-80a7-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"Assessment of skin  reaction \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"45d014d4-8498-4219-9015-2cd66a42a6a5\",\"column_roi_id\":\"81e16072-797b-4e78-a73e-98dda2622a69\",\"datacell_roi_id\":\"b9ef128b-7f37-11ec-9b65-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":{\"entities\":[],\"content\":\"<sup>e<\\/sup> X\",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"45d014d4-8498-4219-9015-2cd66a42a6a5\",\"column_roi_id\":\"0a22c150-0e52-4e04-8a01-e8b8d603c7c6\",\"datacell_roi_id\":\"b9ef12b5-7f37-11ec-a54d-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Telephone   <sup>f<\\/sup> contact\",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"75a348c7-38bd-4950-b758-9f79a7177122\",\"column_roi_id\":\"4712aae9-0acd-4f6e-bd32-46449f827de0\",\"datacell_roi_id\":\"b9ef12c7-7f37-11ec-b445-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"75a348c7-38bd-4950-b758-9f79a7177122\",\"column_roi_id\":\"3601313a-986c-4eaa-890e-49828fc446bc\",\"datacell_roi_id\":\"b9ef12d3-7f37-11ec-ac1f-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"75a348c7-38bd-4950-b758-9f79a7177122\",\"column_roi_id\":\"633ee0d0-23a4-41ea-b330-7ed2a0fae3aa\",\"datacell_roi_id\":\"b9ef12ee-7f37-11ec-8caa-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"12.0\":{\"entities\":[],\"content\":\"X \",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"75a348c7-38bd-4950-b758-9f79a7177122\",\"column_roi_id\":\"db01ab8a-7a1c-4241-a3df-7a740f647653\",\"datacell_roi_id\":\"b9ef12f4-7f37-11ec-9c44-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"13.0\":\"\",\"14.0\":\"\"},{\"1.0\":{\"entities\":[],\"content\":\"<sup>g <\\/sup> HRU\",\"roi_id\":{\"table_roi_id\":\"6eae2f91-191c-4352-8d66-6f7a6fef3a87\",\"row_roi_id\":\"906a8d6c-843f-45bf-89fd-a766166e6970\",\"column_roi_id\":\"d8c679b1-7136-4b69-bc07-698941ae0054\",\"datacell_roi_id\":\"b9efd5d7-7f37-11ec-b1a6-00505697f439\"},\"table_index\":21.0,\"qc_change_type\":\"\"},\"2.0\":\"\",\"3.0\":\"\",\"4.0\":\"\",\"5.0\":\"\",\"6.0\":\"\",\"7.0\":\"\",\"8.0\":\"\",\"9.0\":\"\",\"10.0\":\"\",\"11.0\":\"\",\"12.0\":\"\",\"13.0\":\"\",\"14.0\":\"\"}]",
              "SectionHeaderPrintPage": "32",
              "TableIndex": "22",
              "TableName": "Table 5 Schedule of Treatment Period and Follow-up Period Study Procedures(Schedule of Assessment)",
              "AttachmentListProperties": [
                {
                  "TableId": "6eae2f91-191c-4352-8d66-6f7a6fef3a87",
                  "AttachmentIndex": 0,
                  "AttachmentId": "b9f2215b-7f37-11ec-86de-00505697f439",
                  "Key": "a",
                  "Text": "ADA = anti-drug antibody; AE = adverse event; AESIs = adverse events of special interest; D = study day; ER = emergency room; HRU = healthcare resource utilization; ICU = intensive care unit; IP = investigational product; LRTI = lower respiratory tract infection; NOCDs = new onset chronic diseases; OTC = over-the-counter; PK = pharmacokinetic; Q2W = once every 2 weeks; SAE = serious adverse event; TC = telephone call; V = visit.",
                  "qc_change_type": "",
                  "entities": []
                },
                {
                  "TableId": "6eae2f91-191c-4352-8d66-6f7a6fef3a87",
                  "AttachmentIndex": 1,
                  "AttachmentId": "b9f2216d-7f37-11ec-99c0-00505697f439",
                  "Key": "a",
                  "Text": "a Visit 2/Day 1 and Visit 1/Screening can occur on the same day.",
                  "qc_change_type": "",
                  "entities": [
                    {
                      "start_idx": 10,
                      "end_idx": 12,
                      "standard_entity_name": "OTHER: Person Name",
                      "subcategory": "OTHER: Person Name",
                      "confidence": 100,
                      "text": "Day"
                    },
                    {
                      "start_idx": 60,
                      "end_idx": 62,
                      "standard_entity_name": "OTHER: Person Name",
                      "subcategory": "OTHER: Person Name",
                      "confidence": 100,
                      "text": "Day"
                    }
                  ]
                },
                {
                  "TableId": "6eae2f91-191c-4352-8d66-6f7a6fef3a87",
                  "AttachmentIndex": 2,
                  "AttachmentId": "b9f22179-7f37-11ec-b8f9-00505697f439",
                  "Key": "b",
                  "Text": "b All vital signs (temperature, blood pressure, heart rate, and respiratory rate) should be obtained within 60 minutes prior to dosing, and at 30 minutes ( 5 minutes) and 60 minutes ( 5 minutes) post dose.",
                  "qc_change_type": "",
                  "entities": []
                },
                {
                  "TableId": "6eae2f91-191c-4352-8d66-6f7a6fef3a87",
                  "AttachmentIndex": 3,
                  "AttachmentId": "b9f2218b-7f37-11ec-9190-00505697f439",
                  "Key": "c",
                  "Text": "c PK and ADA samples will only be collected predose in randomized subjects .",
                  "qc_change_type": "",
                  "entities": []
                },
                {
                  "TableId": "6eae2f91-191c-4352-8d66-6f7a6fef3a87",
                  "AttachmentIndex": 4,
                  "AttachmentId": "b9f2219a-7f37-11ec-b324-00505697f439",
                  "Key": "d",
                  "Text": "d Nasal samples will be collected from all subjects with LRTIs (inpatient or outpatient) and from all hospitalized subjects with any new respiratory infection (upper or lower) within approximately 2 days after the initial healthcare provider assessment and diagnosis. Blood samples will be collected from all subjects hospitalized with LRTI or any respiratory infection within approximately 2 days following hospital admission.",
                  "qc_change_type": "",
                  "entities": []
                },
                {
                  "TableId": "6eae2f91-191c-4352-8d66-6f7a6fef3a87",
                  "AttachmentIndex": 5,
                  "AttachmentId": "b9f221b8-7f37-11ec-97fa-00505697f439",
                  "Key": "e",
                  "Text": "e Skin reaction assessment will be done for any post-dosing skin or skin-related reaction regardless of severity, duration, time of onset post dosing, or relationship to IP.",
                  "qc_change_type": "",
                  "entities": []
                },
                {
                  "TableId": "6eae2f91-191c-4352-8d66-6f7a6fef3a87",
                  "AttachmentIndex": 6,
                  "AttachmentId": "b9f221ca-7f37-11ec-9699-00505697f439",
                  "Key": "f",
                  "Text": "f Telephone contact must be verbal communication and documented. Written communication via text, email, or other written form is not acceptable.",
                  "qc_change_type": "",
                  "entities": []
                },
                {
                  "TableId": "6eae2f91-191c-4352-8d66-6f7a6fef3a87",
                  "AttachmentIndex": 7,
                  "AttachmentId": "b9f2e357-7f37-11ec-aea1-00505697f439",
                  "Key": "g",
                  "Text": "g HRU includes admission and duration of hospital and ICU stay, number of subjects who require respiratory support and supplemental oxygen use, duration of respiratory support and supplemental oxygen use, number and type of outpatient visits (eg, ER, outpatient clinic), and number and days of prescription and OTC medication.",
                  "qc_change_type": "",
                  "entities": []
                }
              ],
              "FootnoteText_0": "a ADA = anti-drug antibody; AE = adverse event; AESIs = adverse events of special interest; D = study day; ER = emergency room; HRU = healthcare resource utilization; ICU = intensive care unit; IP = investigational product; LRTI = lower respiratory tract infection; NOCDs = new onset chronic diseases; OTC = over-the-counter; PK = pharmacokinetic; Q2W = once every 2 weeks; SAE = serious adverse event; TC = telephone call; V = visit.",
              "FootnoteText_1": "a a Visit 2/Day 1 and Visit 1/Screening can occur on the same day.",
              "FootnoteText_2": "b b All vital signs (temperature, blood pressure, heart rate, and respiratory rate) should be obtained within 60 minutes prior to dosing, and at 30 minutes ( 5 minutes) and 60 minutes ( 5 minutes) post dose.",
              "FootnoteText_3": "c c PK and ADA samples will only be collected predose in randomized subjects .",
              "FootnoteText_4": "d d Nasal samples will be collected from all subjects with LRTIs (inpatient or outpatient) and from all hospitalized subjects with any new respiratory infection (upper or lower) within approximately 2 days after the initial healthcare provider assessment and diagnosis. Blood samples will be collected from all subjects hospitalized with LRTI or any respiratory infection within approximately 2 days following hospital admission.",
              "FootnoteText_5": "e e Skin reaction assessment will be done for any post-dosing skin or skin-related reaction regardless of severity, duration, time of onset post dosing, or relationship to IP.",
              "FootnoteText_6": "f f Telephone contact must be verbal communication and documented. Written communication via text, email, or other written form is not acceptable.",
              "FootnoteText_7": "g g HRU includes admission and duration of hospital and ICU stay, number of subjects who require respiratory support and supplemental oxygen use, duration of respiratory support and supplemental oxygen use, number and type of outpatient visits (eg, ER, outpatient clinic), and number and days of prescription and OTC medication.",
              "Header": [0, 1, 2, 3]
            },
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "b9e06027-7f37-11ec-be1d-00505697f439",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Treatment and Follow-up Periods",
            "4.2.2",
            "3",
            767,
            ""
          ],
          [
            "",
            "Unmapped",
            "table",
            "",
            {
              "IsBold": true,
              "font_size": 18,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "659bbe87-39f8-4fa6-87c4-503304d76c50",
                "childbox": "bf66d04f-6684-48aa-9f01-1fd1b4eb146c",
                "subtext": "e6f7e561-36b5-44d1-b02a-2dc6e1eeb5b3"
              },
              "Bold": true,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 18,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Schedule of Treatment Period and Follow-up Period Study Procedures",
            "Table 5",
            "1",
            769,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3151a710-9c4b-4136-8624-d2c44df13ae1",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Schedule of Treatment Period and Follow-up Period Study Procedures",
            "Table 5",
            "1",
            770,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "983227fc-54d2-4c30-969a-3c1451988624",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Schedule of Treatment Period and Follow-up Period Study Procedures",
            "Table 5",
            "1",
            771,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4ea6fe7b-ff8b-473a-8b1e-1fa274f95827",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Schedule of Treatment Period and Follow-up Period Study Procedures",
            "Table 5",
            "1",
            772,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "7375c3b0-a382-4cbe-83f8-07ea4d857896",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Schedule of Treatment Period and Follow-up Period Study Procedures",
            "Table 5",
            "1",
            773,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1ebde479-093b-4a81-9ffc-7eee42514d92",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Schedule of Treatment Period and Follow-up Period Study Procedures",
            "Table 5",
            "1",
            774,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c25f3236-f5ea-4465-9b81-5ded17540682",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Schedule of Treatment Period and Follow-up Period Study Procedures",
            "Table 5",
            "1",
            775,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9703fdaf-93f1-4fd5-b5c6-a420ba5f4e88",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Schedule of Treatment Period and Follow-up Period Study Procedures",
            "Table 5",
            "1",
            776,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f87551a7-8cbb-4a97-bba9-679ef7ff0181",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Schedule of Treatment Period and Follow-up Period Study Procedures",
            "Table 5",
            "1",
            777,
            ""
          ],
          [
            "",
            "Unmapped",
            "table",
            {
              "Table": "<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th>ColIndex</th>\n      <th>1.0</th>\n      <th>2.0</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>AstraZeneca</td>\n      <td>Protocol D5290C00006</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>Nirsevimab (MEDI8897)</td>\n      <td>07Jun2020; Final</td>\n    </tr>\n  </tbody>\n</table>",
              "TableProperties": "[{\"1.0\":{\"entities\":[{\"start_idx\":0,\"end_idx\":10,\"standard_entity_name\":\"ANY: Organization\",\"subcategory\":\"ANY: Organization\",\"confidence\":75.0,\"text\":\"AstraZeneca\"},{\"start_idx\":0,\"end_idx\":10,\"standard_entity_name\":\"Sponsor Name\",\"subcategory\":\"Sponsor Name\",\"confidence\":100.0,\"text\":\"AstraZeneca\"}],\"content\":\"AstraZeneca\",\"roi_id\":{\"table_roi_id\":\"ae7aad1d-48fb-4382-b6bf-ba33ded71f67\",\"row_roi_id\":\"fd8a56c5-4f74-4bbf-aa48-98df429e7f64\",\"column_roi_id\":\"f6eba2ad-e1c6-4ff5-9736-b7aa6f06c67f\",\"datacell_roi_id\":\"f2535059-df89-4cf6-b9fa-430d1c7c35fe\"},\"table_index\":17.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"Protocol D5290C00006\",\"roi_id\":{\"table_roi_id\":\"ae7aad1d-48fb-4382-b6bf-ba33ded71f67\",\"row_roi_id\":\"fd8a56c5-4f74-4bbf-aa48-98df429e7f64\",\"column_roi_id\":\"210c3547-2572-4256-999d-46f9de55cf71\",\"datacell_roi_id\":\"d12561e4-4a2a-427d-b76f-35276f9d06ce\"},\"table_index\":17.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[{\"start_idx\":0,\"end_idx\":9,\"standard_entity_name\":\"Molecule\",\"subcategory\":\"Molecule\",\"confidence\":75.0,\"text\":\"Nirsevimab\"},{\"start_idx\":12,\"end_idx\":19,\"standard_entity_name\":\"Molecule\",\"subcategory\":\"Molecule\",\"confidence\":87.0,\"text\":\"MEDI8897\"}],\"content\":\"Nirsevimab (MEDI8897)\",\"roi_id\":{\"table_roi_id\":\"ae7aad1d-48fb-4382-b6bf-ba33ded71f67\",\"row_roi_id\":\"c9f7f0ed-e945-448d-968f-f402e0fee44d\",\"column_roi_id\":\"a7c44e71-1ce9-4916-a400-1c468f9a2c26\",\"datacell_roi_id\":\"ad0a2373-5f7f-403a-bac9-195be6ed18f8\"},\"table_index\":17.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"07Jun2020; Final\",\"roi_id\":{\"table_roi_id\":\"ae7aad1d-48fb-4382-b6bf-ba33ded71f67\",\"row_roi_id\":\"c9f7f0ed-e945-448d-968f-f402e0fee44d\",\"column_roi_id\":\"6ff5453a-2b7f-4290-81c7-8e9467881e6f\",\"datacell_roi_id\":\"c56dc655-dbf6-43cd-bfab-0d9c057a4c91\"},\"table_index\":17.0,\"qc_change_type\":\"\"}}]",
              "SectionHeaderPrintPage": "32",
              "TableIndex": "18",
              "TableName": "Table 5 Schedule of Treatment Period and Follow-up Period Study Procedures",
              "Header": []
            },
            {
              "IsBold": false,
              "font_size": 20,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 0,
                  "end_idx": 10,
                  "standard_entity_name": "ANY: Organization",
                  "subcategory": "ANY: Organization",
                  "confidence": 75,
                  "text": "AstraZeneca"
                },
                {
                  "start_idx": 0,
                  "end_idx": 10,
                  "standard_entity_name": "Sponsor Name",
                  "subcategory": "Sponsor Name",
                  "confidence": 100,
                  "text": "AstraZeneca"
                }
              ],
              "roi_id": {
                "para": "f2535059-df89-4cf6-b9fa-430d1c7c35fe",
                "childbox": "e420ae38-facc-408c-9579-d71d1d70e803",
                "subtext": "d4aef15a-a63a-46f4-af6e-0c55a2919d43"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Schedule of Treatment Period and Follow-up Period Study Procedures",
            "Table 5",
            "1",
            778,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "5b9ab590-0b11-45ce-8ed2-77c093bb2b8c",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Schedule of Treatment Period and Follow-up Period Study Procedures",
            "Table 5",
            "1",
            779,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1af12ca6-91e2-4fbc-862e-c3bf4b9e7653",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Schedule of Treatment Period and Follow-up Period Study Procedures",
            "Table 5",
            "1",
            780,
            ""
          ]
        ]
      },
      {
        "id": "4.3-Description-of-Study-Procedures",
        "header": "4.3 Description of Study Procedures",
        "data": [
          [
            "",
            "Unmapped",
            "header",
            "Efficacy.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "f071bd61-bede-4ede-a58f-fbd65925e0ec",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Efficacy.",
            "4.3.1",
            "3",
            782,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.3.1.1 Lower Respiratory Tract Infection",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "3211a82a-7f92-42a6-9e54-c11d70fe5d78",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            783,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subjects will be monitored throughout the study for LRTI (see Table 5).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "49b0fd3e-87bd-4f72-9b29-67ec3174d9de",
                "childbox": "ae4d1a97-eef9-4053-9b5a-da7397f01131",
                "subtext": "c5c0f83d-6732-4700-b344-78ae68a5ce7e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            784,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "All subjects seeking medical attention for a respiratory illness (in either the inpatient or outpatient setting) will be evaluated for the occurrence of LRTI (Table 6).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "49b0fd3e-87bd-4f72-9b29-67ec3174d9de",
                "childbox": "1e48ec81-e8eb-4d87-81c3-28aaa81bd39b",
                "subtext": "c5c0f83d-6732-4700-b344-78ae68a5ce7e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            785,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "All subjects found to have an LRTI and all subjects who require hospitalization for a respiratory infection, even if there is not a diagnosis of LRTI, should have respiratory samples obtained and respiratory assessment forms completed.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "49b0fd3e-87bd-4f72-9b29-67ec3174d9de",
                "childbox": "79f236d7-bd2b-464c-8f24-cf883f630eb7",
                "subtext": "c5c0f83d-6732-4700-b344-78ae68a5ce7e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            786,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Samples should be collected for all of these respiratory events even those not meeting the protocol definition of LRTI.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "49b0fd3e-87bd-4f72-9b29-67ec3174d9de",
                "childbox": "8d653c0b-c58a-4772-926e-397b01823925",
                "subtext": "a1f1d9db-c85f-431f-8bb4-90bfda3a1f0c"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            787,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subjects who have a primary hospitalization for a respiratory infection (ie, upper or lower tract) or a respiratory deterioration during a hospitalization, or who seek outpatient medical attention (including ER visits) for a lower respiratory illness, will be assessed clinically for the presence of LRTI and for RSV by central laboratory diagnostic testing of respiratory secretions.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "49b0fd3e-87bd-4f72-9b29-67ec3174d9de",
                "childbox": "b0d2181e-dd82-4ed9-b9f3-e1196f54037e",
                "subtext": "78b4954d-2566-40e9-b054-e47d6a8d620a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            788,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "A diagnosis of RSV LRTI requires having a respiratory sample positive for RSV.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "49b0fd3e-87bd-4f72-9b29-67ec3174d9de",
                "childbox": "0c4de32b-dfc6-470e-b4a7-03be29c428d4",
                "subtext": "dd7de9a0-692e-4154-8108-7e08ce51e5a1"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            789,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Testing for RSV will be performed centrally in China using an RT-PCR assay.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "49b0fd3e-87bd-4f72-9b29-67ec3174d9de",
                "childbox": "19c985bc-07a3-400c-bd46-4b205ccab82b",
                "subtext": "a2b0a03e-9bc8-4a7a-b26c-1af8132f8b2d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            790,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "In addition to the clinical assessment of LRTI, there is a protocol definition using objective criteria for the determination of protocol-defined medically attended LRTI.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "cbf7cb9a-4d55-435d-80fb-065ea2ca7bda",
                "childbox": "bc097e95-c7f1-4f55-824a-e3f5bd4f7903",
                "subtext": "e4bb0337-d280-4665-b4c6-461f3171b5fc"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            791,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "To meet the protocol-defined endpoint of medically attended LRTI, subjects with signs of LRTI must have documented at least one physical examination finding of rhonchi, rales, crackles, or wheeze AND at least one of the following clinical signs:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "cbf7cb9a-4d55-435d-80fb-065ea2ca7bda",
                "childbox": "9b9afe04-0149-4688-9e01-2fec5abcf7e1",
                "subtext": "e106fc23-ee8e-4c79-9b91-ab98456836be"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            792,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Increased respiratory rate at rest (age: < 2 months, ≥ 60 breaths/min; 2 to 6 months,",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "99d982ab-c1df-4401-83c6-2658c5c83f53",
                "childbox": "12f886a5-af3c-4d97-9708-7eef7bb85588",
                "subtext": "fe2ea912-1444-4ed7-9f0f-a6aa192924a7"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            793,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "≥ 50 breaths/min; > 6 months, ≥ 40 breaths/min), OR",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "82cc5829-bb9a-4091-9fcb-699ff16a68dd",
                "childbox": "df4babb6-8d90-4c7f-8c27-eb96e682ae44",
                "subtext": "42c08c36-9d29-41c5-b1d7-7be485c542a3"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            794,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Hypoxemia (in room air: oxygen saturation < 95% at altitudes ≤ 1,800 meters or < 92% at altitudes > 1,800 meters), OR",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "177cb14b-2697-4e47-82a9-a66fafa5c53d",
                "childbox": "4f29d808-e311-4ab9-99ec-b0f6303a6b99",
                "subtext": "465368da-be9e-4f92-a17e-63c2111d1d8f"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            795,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Clinical signs of severe respiratory disease (eg, acute hypoxic or ventilatory failure, new onset apnea, nasal flaring, intercostal, subcostal or supraclavicular retractions, grunting) or dehydration secondary to inadequate oral intake due to respiratory distress (need for IV fluid).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "10224ad3-0f2b-413b-85d6-bb95ceac2db0",
                "childbox": "93cac50d-d4ed-4477-9630-ca14b2201d5a",
                "subtext": "579ea429-538c-4ec6-804f-ac2bab4c2bed"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            796,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "79cbca2d-d3c9-43f2-8077-30f226e5c271",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Lower Respiratory Tract Infection",
            "4.3.1.1",
            "4",
            797,
            ""
          ],
          [
            "",
            "Unmapped",
            "table",
            {
              "Table": "<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th>ColIndex</th>\n      <th>1.0</th>\n      <th>2.0</th>\n      <th>3.0</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>RSV</td>\n      <td>Lower Respiratory Tract</td>\n      <td>Medical Significance</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>RSV Confirmed : •  Positive by central laboratory RT-PCR assay</td>\n      <td>Documented PE findings localizing to lower respiratory tract : Rhonchi Rales Crackles Wheeze</td>\n      <td>Objective measures of clinical severity : Increased respiratory rate Hypoxemia Acute hypoxic or ventilatory failure New onset apnea Nasal flaring Retractions Grunting Dehydration due to respiratory distress</td>\n    </tr>\n  </tbody>\n</table>",
              "TableProperties": "[{\"1.0\":{\"entities\":[],\"content\":\"RSV\",\"roi_id\":{\"table_roi_id\":\"36ab6253-393a-4ea9-bb9f-f059d211660b\",\"row_roi_id\":\"b0c675d4-a154-4668-85f6-ef4eacec88c7\",\"column_roi_id\":\"896e06ed-0c4c-46f2-a7ee-f4aff02fe3da\",\"datacell_roi_id\":\"f7c75fdf-253f-46a4-99b4-3e051cb9083d\"},\"table_index\":18.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"Lower Respiratory Tract\",\"roi_id\":{\"table_roi_id\":\"36ab6253-393a-4ea9-bb9f-f059d211660b\",\"row_roi_id\":\"b0c675d4-a154-4668-85f6-ef4eacec88c7\",\"column_roi_id\":\"23fbf9fe-380f-46d3-bfb1-b9bfbbd6b140\",\"datacell_roi_id\":\"2a14d84b-d07a-4f0e-9ec2-3193d4f2f91a\"},\"table_index\":18.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[],\"content\":\"Medical Significance\",\"roi_id\":{\"table_roi_id\":\"36ab6253-393a-4ea9-bb9f-f059d211660b\",\"row_roi_id\":\"b0c675d4-a154-4668-85f6-ef4eacec88c7\",\"column_roi_id\":\"141aad50-f346-4253-af29-af76766568b0\",\"datacell_roi_id\":\"7ba79d69-f966-4ce6-bd9f-ef3b9e85a4d6\"},\"table_index\":18.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"RSV Confirmed : \\u2022  Positive by central laboratory RT-PCR assay\",\"roi_id\":{\"table_roi_id\":\"36ab6253-393a-4ea9-bb9f-f059d211660b\",\"row_roi_id\":\"531946ed-65e7-49aa-b710-cb53f9f64dfa\",\"column_roi_id\":\"351f37e7-31e3-47bf-8d2c-5f66bc604add\",\"datacell_roi_id\":\"c5da7996-a6b4-4c56-b071-f3287d606bc0\"},\"table_index\":18.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"Documented PE findings localizing to lower respiratory tract : Rhonchi Rales Crackles Wheeze\",\"roi_id\":{\"table_roi_id\":\"36ab6253-393a-4ea9-bb9f-f059d211660b\",\"row_roi_id\":\"531946ed-65e7-49aa-b710-cb53f9f64dfa\",\"column_roi_id\":\"9f61f264-3b7c-4b52-9702-30e24ecbef22\",\"datacell_roi_id\":\"4d0f2c0b-e19f-4f6e-9aa9-1a5b83928a94\"},\"table_index\":18.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[],\"content\":\"Objective measures of clinical severity : Increased respiratory rate Hypoxemia Acute hypoxic or ventilatory failure New onset apnea Nasal flaring Retractions Grunting Dehydration due to respiratory distress\",\"roi_id\":{\"table_roi_id\":\"36ab6253-393a-4ea9-bb9f-f059d211660b\",\"row_roi_id\":\"531946ed-65e7-49aa-b710-cb53f9f64dfa\",\"column_roi_id\":\"7be0c226-578e-4a6d-bcc0-08fd5efe4b5e\",\"datacell_roi_id\":\"05f88c1c-76f1-475a-8206-f594e8c1006e\"},\"table_index\":18.0,\"qc_change_type\":\"\"}}]",
              "SectionHeaderPrintPage": "35",
              "TableIndex": "19",
              "TableName": "Table 6 Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
              "Header": [0]
            },
            {
              "IsBold": true,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f7c75fdf-253f-46a4-99b4-3e051cb9083d",
                "childbox": "ce80fe2f-8b41-43d3-8d51-078ff2931490",
                "subtext": "da6dd140-5d52-4927-8a55-23028cfa9284"
              },
              "Bold": true,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            799,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "LRTI = lower respiratory tract infection; PE = physical examination; RSV = respiratory syncytial virus; RT-PCR = reverse transcriptase-polymerase chain reaction.",
            {
              "IsBold": false,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d41f5100-3cac-49aa-9037-57ed09f5c6cf",
                "childbox": "78396d54-4eb2-49d1-a2a3-93eb585f0312",
                "subtext": "dcec9c0b-f661-44bb-8c93-7d14e606f9a3"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            800,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Note: One item from each column is required to meet the protocol-defined endpoint of RSV LRTI.",
            {
              "IsBold": false,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "806b7ed5-9a2c-43e9-b878-ecd03a7528f4",
                "childbox": "9084abb0-09ab-489f-bac5-f1b37c3d4ebf",
                "subtext": "7fbf47cc-e948-4e1b-b044-514e6997ead8"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            801,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1cb6712a-4d82-4bc3-b98a-c9ff799cbecd",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            802,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "RSV Hospitalization",
            {
              "IsBold": false,
              "font_size": 24,
              "font_style": "Heading6",
              "entity": [],
              "roi_id": {
                "para": "84d0d124-3e17-4b13-9f3c-4824e9740c7b",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 24,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "single",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            803,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "An RSV hospitalization is defined as either (1) a respiratory hospitalization with a positive RSV test within approximately 2 days of hospital admission (primary) or (2) a new onset of respiratory symptoms in an already hospitalized subject, with an objective measure of worsening respiratory status and positive RSV test (nosocomial).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "09bf048e-2cb0-4864-89f6-54a829500c82",
                "childbox": "2142f111-d594-498c-912d-55f98b919fa8",
                "subtext": "d7aa81b1-a932-4e56-a460-de7ac87f89fd"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            804,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Primary and nosocomial RSV hospitalization are further defined below.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "09bf048e-2cb0-4864-89f6-54a829500c82",
                "childbox": "2ad5e79a-add1-42a5-866c-4eaae48bb42f",
                "subtext": "353559a9-73f4-4b5d-a07f-95743b4e8613"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            805,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Primary RSV Hospitalization",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading7",
              "entity": [],
              "roi_id": {
                "para": "852fbbf3-17ed-4c86-b18c-fad3616e03ed",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            806,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "RSV diagnostic testing will be performed on respiratory secretions obtained within approximately 2 days before or after admission for subjects hospitalized for respiratory infection (upper or lower respiratory tract).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3a9a6fd2-1ada-4286-8e73-b94f1e1855be",
                "childbox": "9ff190f0-2652-4901-97e5-9a7e69a4daf6",
                "subtext": "3cd4706d-1fd7-4467-a5b2-903d56e2299c"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            807,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If the RSV diagnostic test (performed centrally via RT-PCR) is positive, the hospitalization will be classified as a primary RSV hospitalization.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3a9a6fd2-1ada-4286-8e73-b94f1e1855be",
                "childbox": "c57f37dc-6996-4923-b718-4393757bf60f",
                "subtext": "9ab9b25f-52c2-4d02-af2d-b44dc8762cfa"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            808,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Deaths that can be demonstrated as caused by RSV (by autopsy or clinical history and virologic evidence) will also be considered as primary RSV hospitalization endpoints.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3a9a6fd2-1ada-4286-8e73-b94f1e1855be",
                "childbox": "f4863673-0f6a-42b1-be7a-0b32e7053037",
                "subtext": "7edfa68b-eefa-4a07-b6be-faea3e9acd1b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            809,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Nosocomial RSV Hospitalization",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading7",
              "entity": [],
              "roi_id": {
                "para": "6965adee-1242-4a63-a6ac-f47aafa99f38",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            810,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subjects hospitalized for a respiratory illness or non-respiratory illness whose RSV diagnostic test is negative may develop nosocomial RSV illness during the study.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2cf19b4d-1a34-4450-8d0a-f8a214d530cc",
                "childbox": "242e9219-fc52-4e62-af72-a705db90f0de",
                "subtext": "8307dc05-e837-4234-9ea5-c39b0a122ca1"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            811,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If signs (such as retractions, rhonchi, wheezing, crackles or rales) of a new lower respiratory illness occur during a hospitalization, whatever the reason for hospitalization, and there is an objective measure of worsening respiratory status (that is, new requirement for supplemental oxygen, increase in supplemental oxygen requirement from prior to the onset of symptoms, or need for new or additional mechanical ventilation), a specimen will be collected within approximately 2 days from worsening of respiratory status for RSV diagnostic testing by the central laboratory.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "93490005-3e8e-48db-a29e-bf2269d1a0a2",
                "childbox": "774f581f-a1ca-49a3-81ab-e8d72a08c980",
                "subtext": "b07c1a6f-e91d-4263-a060-13e18b987827"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            812,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "For any subject who is hospitalized for a respiratory infection (upper or lower respiratory tract), the subject must return to his/her baseline respiratory status or be clearly resolving the preceding respiratory illness before a subsequent respiratory deterioration for a nosocomial RSV hospitalization event can be determined.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "93490005-3e8e-48db-a29e-bf2269d1a0a2",
                "childbox": "90560303-28c8-4c1f-877a-f49aae797725",
                "subtext": "2045e1a3-f352-4510-bf01-8ca582179e26"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            813,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If the RSV diagnostic test (performed centrally via RT-PCR) is positive, the subsequent hospital days will count as a nosocomial RSV hospitalization.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "00d866b8-e23c-42c3-b4a9-9f89a168a4d5",
                "childbox": "a79c3634-b686-44d3-8aae-b2314b43514c",
                "subtext": "94a3909f-a8bd-4de9-8c91-d12c312cd2e3"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            814,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The days of RSV hospitalization will be counted beginning with the start of the respiratory deterioration that resulted in the RSV diagnostic test.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "00d866b8-e23c-42c3-b4a9-9f89a168a4d5",
                "childbox": "42c6872f-7696-4cd5-ac7c-41a2fb60f64d",
                "subtext": "94a3909f-a8bd-4de9-8c91-d12c312cd2e3"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            815,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "RSV LRTI Outpatient Events",
            {
              "IsBold": false,
              "font_size": 24,
              "font_style": "Heading6",
              "entity": [],
              "roi_id": {
                "para": "e534e501-4ed2-4c02-a3f8-e2ff6e3edf70",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 24,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "single",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            816,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subjects who seek outpatient medical attention, including ER visits, for an LRTI should have respiratory secretions obtained within approximately 2 days after the initial healthcare provider assessment.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "88e0238c-eab1-4acf-9e16-dee4e1c7f16d",
                "childbox": "0704b831-4fd5-4789-a33d-94346d8df1b6",
                "subtext": "29d0e401-e763-4346-85c7-104eebfab1d3"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            817,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Respiratory Secretions for RSV Detection",
            {
              "IsBold": false,
              "font_size": 24,
              "font_style": "Heading6",
              "entity": [],
              "roi_id": {
                "para": "25568bca-8a28-467e-8b35-1b856c6eae27",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 24,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "single",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            818,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Respiratory secretions for RSV testing must be collected from all subjects with LRTIs",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "baf0ee33-8f5b-49ab-b506-7c826d40a234",
                "childbox": "f73045eb-40d7-40e4-a78a-f49156bb4185",
                "subtext": "e56163d0-62a7-4f36-9eda-7ee64cd2abe6"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            819,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "(inpatient or outpatient) and from all hospitalized subjects with any new respiratory infection (upper or lower) within approximately 2 days after the initial healthcare provider assessment and diagnosis.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "fd89a530-dd8c-4308-9a50-cc173d7acedc",
                "childbox": "0ddd418f-c183-4f7d-b68e-da00d9497207",
                "subtext": "61e2bfea-c321-4f3f-b8e6-83ca4cabfa3d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            820,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Nasal secretions will be obtained unless the subject is intubated, and then tracheal secretions may be obtained.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "fd89a530-dd8c-4308-9a50-cc173d7acedc",
                "childbox": "c687966e-3849-479e-b91b-93d9d23c27c6",
                "subtext": "74988329-703a-4485-87a0-990e815ab10c"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            821,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Respiratory secretions will be tested in a central laboratory in China for RSV using an RT-PCR assay.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "35639b39-f77a-495e-b6fe-c44606884829",
                "childbox": "1f68e93d-12ba-456a-bc43-b92555064cc6",
                "subtext": "6164adc0-6089-4920-92c4-5cddecd44175"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            822,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Testing may include other respiratory pathogens.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "35639b39-f77a-495e-b6fe-c44606884829",
                "childbox": "b9823004-3fbd-4eac-90b6-3b707f4a46d8",
                "subtext": "6164adc0-6089-4920-92c4-5cddecd44175"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            823,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Monitoring for RSV Resistance",
            {
              "IsBold": false,
              "font_size": 24,
              "font_style": "Heading6",
              "entity": [],
              "roi_id": {
                "para": "e45ce7fc-3dab-4422-a9bf-672cb592cf40",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 24,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "single",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            824,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "As an exploratory endpoint, novel RSV F variants identified in RSV positive nasal specimens collected from study subjects will be evaluated by genotypic and phenotypic methods to monitor potential susceptibility changes to nirsevimab neutralization.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 223,
                  "end_idx": 232,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 100,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "c109cf9a-6420-40c1-8ddc-20d314072b60",
                "childbox": "b669495f-b4eb-4395-8a2a-811b327697fb",
                "subtext": "96cac75a-22ea-46f1-a262-936f92c27483"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            825,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The subtype and genotypic determination of RSV will be performed directly on the nasal specimens that are collected from all subjects who are confirmed RSV-positive using an RT-PCR assay.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c109cf9a-6420-40c1-8ddc-20d314072b60",
                "childbox": "2d4b8a05-0091-4dea-afbb-18a7b7b7a9de",
                "subtext": "96cac75a-22ea-46f1-a262-936f92c27483"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            826,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The full-length F gene will be amplified using a standard, single-tube population-based RT-PCR method and sequenced by Sanger and Next-Generation sequencing methodology to detect polymorphisms and minor variants, respectively.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c109cf9a-6420-40c1-8ddc-20d314072b60",
                "childbox": "7a158466-4a8b-4298-bf21-0e3660c01437",
                "subtext": "dcb9f2ff-b3da-4362-a65b-b2a3da2f8d32"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            827,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Amino acid (aa) substitution(s) within the nirsevimab binding site (aa 62-69 and aa 196-212) and outside the binding site in the extracellular regions of mature F protein (aa 24-109 and aa 137-524) will be reported and compared to F protein sequences of contemporary reference RSV A or RSV B strains.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 43,
                  "end_idx": 52,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "c109cf9a-6420-40c1-8ddc-20d314072b60",
                "childbox": "b1e0eb66-da73-47ad-9f80-a3578788b457",
                "subtext": "23543146-c455-4bb9-87de-bd270217d0e1"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            828,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "In vitro phenotypic analysis (susceptibility to nirsevimab neutralization) will be attempted using an RSV neutralization assay (performed at Viroclinics Biosciences, Rotterdam, The Netherlands) with recombinant RSV viruses constructed through site-directed mutagenesis of the F gene and reverse genetics into laboratory-adapted RSV A2 or B9320 strains.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 48,
                  "end_idx": 57,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 100,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "c109cf9a-6420-40c1-8ddc-20d314072b60",
                "childbox": "06b2ce72-4ac8-4f6d-9afe-06e5fbf26a19",
                "subtext": "923e6529-3052-4beb-8a6b-d28777a1c3bb"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Criteria for Meeting the Protocol-defined Endpoint of Medically Attended RSV LRTI",
            "Table 6",
            "1",
            829,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.3.2 Medical History and Physical Examination, Weight, and Vital Signs",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "56d97262-80c3-4a7f-9cb1-144452fc3e19",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Medical History and Physical Examination, Weight, and Vital Signs",
            "4.3.2",
            "3",
            830,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "A complete medical history will be obtained at screening and a medical history update will be obtained on the day of dosing and during the follow-up period as defined in Section 4.2.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c6e0a9df-a568-4b66-acd3-73d392068e9f",
                "childbox": "3a25352b-e63c-4335-a0d8-4a4776f65c73",
                "subtext": "e9fac9b4-a8b3-4079-93aa-c829553405cd"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Medical History and Physical Examination, Weight, and Vital Signs",
            "4.3.2",
            "3",
            831,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Assessment will include history and current medical conditions, past or present cardiovascular disorders, respiratory, gastrointestinal, renal, hepatic, neurological, endocrine, lymphatic, hematologic, immunologic, dermatological, psychiatric, genitourinary, drug and surgical history, or any other diseases or disorders.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c6e0a9df-a568-4b66-acd3-73d392068e9f",
                "childbox": "145fa007-44ae-46ae-85e4-72d18d74cbb6",
                "subtext": "dfb2b14b-a9b4-48f7-a170-0cbad00b62ef"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Medical History and Physical Examination, Weight, and Vital Signs",
            "4.3.2",
            "3",
            832,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "A physical examination will be performed at screening, on the day of dosing, and during the follow-up period as defined in Section 4.2.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "18326a8e-7d3d-4edd-94a2-2a62404af825",
                "childbox": "d6a9c33c-218e-4611-a067-1a075eed9083",
                "subtext": "eeab786f-78c5-42c5-9b32-2af23dcd2e42"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Medical History and Physical Examination, Weight, and Vital Signs",
            "4.3.2",
            "3",
            833,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The physical examination will include assessment of weight at screening and at each study visit mentioned above.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "18326a8e-7d3d-4edd-94a2-2a62404af825",
                "childbox": "0b30dd1b-97ef-4e1a-be88-e6e15d72903d",
                "subtext": "eeab786f-78c5-42c5-9b32-2af23dcd2e42"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Medical History and Physical Examination, Weight, and Vital Signs",
            "4.3.2",
            "3",
            834,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Vital signs (temperature, blood pressure, respiratory rate, and heart rate measurements) will be collected at screening, on the day of dosing, and during the follow-up period as defined in Section 4.2.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "7215e18a-a6ce-4fa0-bdff-2d448b900e1f",
                "childbox": "ff4ac0d3-29f5-43d1-9273-07ae2296e114",
                "subtext": "57251484-8370-45a6-87b7-4c975fa6ce6d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Medical History and Physical Examination, Weight, and Vital Signs",
            "4.3.2",
            "3",
            835,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "On Day 1, vital signs will be monitored before and after administration of investigational product.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 3,
                  "end_idx": 5,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                }
              ],
              "roi_id": {
                "para": "7215e18a-a6ce-4fa0-bdff-2d448b900e1f",
                "childbox": "b216d826-a4ab-466d-bdc5-75a46c0de9d9",
                "subtext": "cb6b0387-e649-4dcf-ac30-9c5f05e9ec5c"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Medical History and Physical Examination, Weight, and Vital Signs",
            "4.3.2",
            "3",
            836,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Baseline information will be collected on breastfeeding, smoking in the household, and if the infant attends day care.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "03f33943-b7e5-478a-a094-067ec21269ae",
                "childbox": "c6a47105-d6bb-4435-96d6-d657b81c9ca6",
                "subtext": "bbb5d11f-924d-46ed-bd2f-e87f1d3f4fcd"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Medical History and Physical Examination, Weight, and Vital Signs",
            "4.3.2",
            "3",
            837,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.3.3 Pharmacokinetics and Antidrug Antibody",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "91f872fc-076d-42df-9ef6-7c4314f9cef5",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Pharmacokinetics and Antidrug Antibody",
            "4.3.3",
            "3",
            838,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "A blood sample for assessment of PK and ADA will be collected through Day 361 according to the schedule defined in Section 4.2.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 70,
                  "end_idx": 72,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                }
              ],
              "roi_id": {
                "para": "6a0bc9d7-4f4e-4c7a-9ffe-520d4f142237",
                "childbox": "af72a5e0-bf54-475c-bb91-9535d084de56",
                "subtext": "f407bf9b-3678-40cb-960c-fa4d5e099c33"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Pharmacokinetics and Antidrug Antibody",
            "4.3.3",
            "3",
            839,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "A Laboratory Manual will be provided to the sites that specifies the procedures for collection, processing, storage, and shipment of samples, as well as laboratory contact information, specific to this clinical research study.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 202,
                  "end_idx": 218,
                  "standard_entity_name": "ANY: Organization",
                  "subcategory": "ANY: Organization",
                  "confidence": 75,
                  "text": "clinical research"
                }
              ],
              "roi_id": {
                "para": "6a0bc9d7-4f4e-4c7a-9ffe-520d4f142237",
                "childbox": "1892e779-7e52-46b5-84ae-faece1863166",
                "subtext": "f407bf9b-3678-40cb-960c-fa4d5e099c33"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Pharmacokinetics and Antidrug Antibody",
            "4.3.3",
            "3",
            840,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.3.3.1 Pharmacokinetic Evaluation",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "6ce4da03-d315-42e3-a170-1d8147e230d1",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Pharmacokinetic Evaluation",
            "4.3.3.1",
            "4",
            841,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Blood samples to evaluate the PK of nirsevimab in serum will be collected according to scheduled time points.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 36,
                  "end_idx": 45,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "7dfad7d0-e57e-4ca9-ac38-2952eaceb5f3",
                "childbox": "fdd31145-ce8c-4986-ac2f-64fe56b927b6",
                "subtext": "8ab81e86-ce1b-434e-94b5-cde4087df2c5"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Pharmacokinetic Evaluation",
            "4.3.3.1",
            "4",
            842,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Blood samples for PK evaluation will also be collected from subjects hospitalized with LRTI or any respiratory infection within approximately 2 days following hospitalization.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "7dfad7d0-e57e-4ca9-ac38-2952eaceb5f3",
                "childbox": "d31bc951-8be9-4021-b95d-be85590bc114",
                "subtext": "59c3934b-c938-4598-894b-7242cb0d8631"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Pharmacokinetic Evaluation",
            "4.3.3.1",
            "4",
            843,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "See the collection schedule in Section 4.2.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "7dfad7d0-e57e-4ca9-ac38-2952eaceb5f3",
                "childbox": "fb0f0461-160d-4791-a640-558a59a9849e",
                "subtext": "59c3934b-c938-4598-894b-7242cb0d8631"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Pharmacokinetic Evaluation",
            "4.3.3.1",
            "4",
            844,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The concentration of nirsevimab in serum will be measured using validated assays.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 21,
                  "end_idx": 30,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "7dfad7d0-e57e-4ca9-ac38-2952eaceb5f3",
                "childbox": "ed7e57f7-52dd-4d93-a52f-0b6a1e17fd3d",
                "subtext": "59c3934b-c938-4598-894b-7242cb0d8631"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Pharmacokinetic Evaluation",
            "4.3.3.1",
            "4",
            845,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.3.3.2 Antidrug Antibody Evaluation",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "9f48df3e-859d-4897-ba5a-0f7bc741efa3",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Antidrug Antibody Evaluation",
            "4.3.3.2",
            "4",
            846,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Blood samples to evaluate ADA responses to nirsevimab in serum will be collected according to scheduled time points.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 43,
                  "end_idx": 52,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 100,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "0c2a5379-41c2-4316-8e0e-366cb9ae52c9",
                "childbox": "7fd053f1-58f6-4c0b-8710-4442ca3e25c3",
                "subtext": "364a2820-3183-473a-a190-7dbcce4f602f"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Antidrug Antibody Evaluation",
            "4.3.3.2",
            "4",
            847,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Blood samples will also be collected for ADA response from subjects hospitalized with LRTI or any respiratory infection within approximately 2 days following hospitalization.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0c2a5379-41c2-4316-8e0e-366cb9ae52c9",
                "childbox": "f70d7c3e-da18-44c5-bd67-98da1652f85b",
                "subtext": "364a2820-3183-473a-a190-7dbcce4f602f"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Antidrug Antibody Evaluation",
            "4.3.3.2",
            "4",
            848,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "ADA samples may also be further tested for characterization of the ADA response.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0c2a5379-41c2-4316-8e0e-366cb9ae52c9",
                "childbox": "0c71a1c0-c0cd-4570-a7e5-147f7ee8264f",
                "subtext": "361612af-eb1a-4d6c-9b66-46f914f8ce30"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Antidrug Antibody Evaluation",
            "4.3.3.2",
            "4",
            849,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "See the collection schedule in Section 4.2.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0c2a5379-41c2-4316-8e0e-366cb9ae52c9",
                "childbox": "b41c0119-3d76-4996-ad7c-c7e456472127",
                "subtext": "361612af-eb1a-4d6c-9b66-46f914f8ce30"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Antidrug Antibody Evaluation",
            "4.3.3.2",
            "4",
            850,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Evaluations will be performed using validated immunoassays.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0c2a5379-41c2-4316-8e0e-366cb9ae52c9",
                "childbox": "5580e0ac-c282-4e50-8831-5404a9e045f2",
                "subtext": "361612af-eb1a-4d6c-9b66-46f914f8ce30"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Antidrug Antibody Evaluation",
            "4.3.3.2",
            "4",
            851,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.3.4 Healthcare Resource Utilization",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "e248c9f6-0bd2-4bf0-a387-f3cb3992f7d9",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Healthcare Resource Utilization",
            "4.3.4",
            "3",
            852,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Information on HRU will be collected for all events of medically attended LRTI through Day 361 (see Section 4.2).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 87,
                  "end_idx": 89,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                }
              ],
              "roi_id": {
                "para": "8a43759c-a53d-4da5-ad72-9bd00ea81f74",
                "childbox": "db3943d5-c88c-4c51-a733-f39e9ecd9ffe",
                "subtext": "4c3692d6-2967-43c7-b2a3-756c3b71488e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Healthcare Resource Utilization",
            "4.3.4",
            "3",
            853,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "This will include admission to and duration of hospital and intensive care unit stay, number of subjects who require respiratory support and supplemental oxygen use, duration of respiratory support and supplemental oxygen use, number and type of outpatient visits (eg, ER, outpatient clinic), and the number of prescription and OTC medications and their duration of use.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "8a43759c-a53d-4da5-ad72-9bd00ea81f74",
                "childbox": "bf38c07a-98c1-4e18-9de0-41990aa0e0c5",
                "subtext": "4c3692d6-2967-43c7-b2a3-756c3b71488e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Healthcare Resource Utilization",
            "4.3.4",
            "3",
            854,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.3.5 Skin Reactions",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "b9972e0a-1922-4a75-a475-84ae74e450ea",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Skin Reactions",
            "4.3.5",
            "3",
            855,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Skin reaction assessment will be done for any post-dosing skin or skin-related reaction through Day 361 to assist in determination of the etiology of the reaction (see Section 4.2).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 96,
                  "end_idx": 98,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                }
              ],
              "roi_id": {
                "para": "4e7dbc2a-f849-4477-8065-5595c325dbf8",
                "childbox": "cf5462cb-c226-4bd7-be7f-d01f7fa89684",
                "subtext": "ce7701e1-b454-4800-bf49-e75ef721ef10"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Skin Reactions",
            "4.3.5",
            "3",
            856,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Information will be collected regardless of event severity, duration, time of onset post dosing, or relationship to investigational product.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4e7dbc2a-f849-4477-8065-5595c325dbf8",
                "childbox": "ee68b187-c805-4fc6-9dbe-1c63df274ea0",
                "subtext": "5a987d4d-efb1-4968-8363-9a337f47a314"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Skin Reactions",
            "4.3.5",
            "3",
            857,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Parents/legal representatives of study subjects will be given a hypersensitivity card and instructed to call the study site immediately for signs of hypersensitivity or allergic reaction.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4e7dbc2a-f849-4477-8065-5595c325dbf8",
                "childbox": "5aea95c2-9830-475c-ae2a-4366e0548014",
                "subtext": "41628715-76a0-4ef2-b7b5-c5f605d2dddc"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Skin Reactions",
            "4.3.5",
            "3",
            858,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Sites must notify the Sponsor within 24 hours of knowledge of such events.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4e7dbc2a-f849-4477-8065-5595c325dbf8",
                "childbox": "5b83f919-f8f5-48d1-b71b-6b9883127eee",
                "subtext": "41628715-76a0-4ef2-b7b5-c5f605d2dddc"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Skin Reactions",
            "4.3.5",
            "3",
            859,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "For any skin or skin-related reactions, including all rashes that occur within 7 days after dosing, the infant will be brought to the study site as soon as possible for evaluation.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4e7dbc2a-f849-4477-8065-5595c325dbf8",
                "childbox": "b565dbc1-5a02-4650-81ee-d26c97b8beaf",
                "subtext": "82991aac-658a-47c4-b277-6f2d0b2690ad"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Skin Reactions",
            "4.3.5",
            "3",
            860,
            ""
          ]
        ]
      },
      {
        "id": "4.4-Study-Suspension-or-Termination",
        "header": "4.4 Study Suspension or Termination",
        "data": [
          [
            "",
            "Unmapped",
            "text",
            "The Sponsor reserves the right to temporarily suspend or permanently terminate this study at any time.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f95f22a6-8a8a-4e02-bbcb-4d97c844510e",
                "childbox": "6c3f7ab9-4321-4c65-9930-ba5588239e15",
                "subtext": "87c2e425-7274-4e58-8908-737014cd18a7"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            862,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The reasons for temporarily suspending or permanently terminating the study may include but are not limited to the following:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f95f22a6-8a8a-4e02-bbcb-4d97c844510e",
                "childbox": "55739dac-0540-4167-a525-558ee092a4d2",
                "subtext": "87c2e425-7274-4e58-8908-737014cd18a7"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            863,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "1 Death in any subject in which the cause of death is assessed as related to investigational product (in this case the study will be paused for the Sponsor safety review committee to evaluate the events)",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6db5ad4f-9375-4e90-aebd-36e7e4be65da",
                "childbox": "b6cb0de6-ca4e-4c48-9ae5-a51a190fe0c3",
                "subtext": "3f6bf0b3-84f8-4b9b-bf47-0e2b22f4525c"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            864,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "2 Anaphylactic reaction that is related to investigational product (see Appendix B for a definition of anaphylaxis; in this case the study will be paused for the Sponsor safety review committee to evaluate the events)",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "eac5f640-effd-4552-8eb3-4bdac764ecb9",
                "childbox": "351f0722-e8fd-4a42-837e-d0247e30bd3b",
                "subtext": "179d76e3-9fb0-4cc9-aec0-9405a85beb96"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            865,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "3 Grade 3 and/or 4 hypersensitivity AEs based on the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) grading scale that are assessed as related to nirsevimab in 2 or more subjects",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 53,
                  "end_idx": 77,
                  "standard_entity_name": "ANY: Organization",
                  "subcategory": "ANY: Organization",
                  "confidence": 87,
                  "text": "National Cancer Institute"
                },
                {
                  "start_idx": 127,
                  "end_idx": 129,
                  "standard_entity_name": "ANY: Organization",
                  "subcategory": "ANY: Organization",
                  "confidence": 37,
                  "text": "NCI"
                },
                {
                  "start_idx": 184,
                  "end_idx": 193,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 100,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "5e7745ea-f56d-411c-a652-b378f0faf998",
                "childbox": "38d82f5a-b572-4e3e-a52a-a7661ff340fe",
                "subtext": "62debac7-52b7-45ce-869b-923c45b406c9"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            866,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "4 Two serious adverse events (SAEs) of the same type that are assessed as related to nirsevimab",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 85,
                  "end_idx": 94,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 100,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "3bead420-5503-4d30-a083-3c2b553d6c15",
                "childbox": "9a0707a6-f05c-406b-8767-f1c874a64518",
                "subtext": "a14b1eda-89e4-4616-b856-0ae5537c70e9"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            867,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "5 Other events that, in the judgment of the Sponsor or site Investigator, are deemed serious enough to warrant immediate review by the Sponsor safety review committee",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f7103180-a46e-4ff4-be70-db96e11398d9",
                "childbox": "19d4403b-5359-46d2-89c8-af1ff1181359",
                "subtext": "e6ff395c-fa5b-4391-8014-30a8124789ca"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            868,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subject enrollment is unsatisfactory",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "b3e37859-9752-4d1f-b94d-08d9afde4555",
                "childbox": "2f25f734-fe0c-427c-903e-551f147e3ef3",
                "subtext": "6d36f71b-89e6-4c7c-9e2a-e2dd2e7230e6"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            869,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "7 Sponsor decision to terminate development",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "fcc0b5c0-15c8-4fd0-befb-4800b4dcde99",
                "childbox": "253c2294-4f3e-45bd-9398-7232941eda27",
                "subtext": "8f250a86-728f-447d-8f5f-bd01469444e1"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            870,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4e764d62-b7da-4e95-a6e6-e161c8817f7a",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            871,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If the Sponsor determines that temporary suspension or termination of the study is required, the Sponsor will discuss the reasons for taking such action with all participating Investigators (or head of the medical institution, where applicable).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "65525443-f4bf-4c51-88d3-88c447cf9d73",
                "childbox": "bead22fe-4768-4be3-8278-704365d61d4c",
                "subtext": "e8ea861f-c186-4f2e-8e0c-e8df4574978b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            872,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "When feasible, the Sponsor will provide advance notice to all participating Investigators (or head of the medical institution, where applicable) of the impending action.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "65525443-f4bf-4c51-88d3-88c447cf9d73",
                "childbox": "ba632cd4-7b9a-40eb-9be0-ebcf95b6eaaf",
                "subtext": "e8ea861f-c186-4f2e-8e0c-e8df4574978b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            873,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If the study is suspended or terminated for safety reasons, the Sponsor will promptly inform all Investigators, heads of the medical institutions (where applicable), and/or institutions conducting the study.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9f557286-4047-4bcc-a122-dba4ac48c808",
                "childbox": "6a3c0362-1c71-422a-bd61-077d41267eca",
                "subtext": "752864b1-09c7-4b72-9e45-edbd123e7c4b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            874,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The Sponsor will also promptly inform the relevant regulatory authorities of the suspension/termination along with the reasons for such action.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9f557286-4047-4bcc-a122-dba4ac48c808",
                "childbox": "6a196bed-c6cf-4365-846c-7b89ad2fe55f",
                "subtext": "57bfee51-5f39-4978-ab01-90cf728497b5"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            875,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Where required by applicable regulations, the Investigator or head of the medical institution must inform the Institutional Review Board (IRB)/Independent Ethics Committee (IEC) promptly and provide the reason(s) for the suspension/termination.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9f557286-4047-4bcc-a122-dba4ac48c808",
                "childbox": "599fec94-4974-4d58-b59b-634017013ba1",
                "subtext": "7aca4253-01e9-413b-8bb0-86bc2aefc1ad"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            876,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If the study is suspended for safety reasons and it is deemed appropriate by the Sponsor to resume the study, approval from the relevant regulatory authorities (and IRBs/IECs when applicable) will be obtained prior to resuming the study.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9f557286-4047-4bcc-a122-dba4ac48c808",
                "childbox": "a1b41f19-9c2b-4c5c-b236-fd5b9aded213",
                "subtext": "7aca4253-01e9-413b-8bb0-86bc2aefc1ad"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Study Suspension or Termination",
            "4.4",
            "2",
            877,
            ""
          ]
        ]
      },
      {
        "id": "4.5-Investigational-Products",
        "header": "4.5 Investigational Products",
        "data": [
          [
            "",
            "Unmapped",
            "header",
            "4.5.1 Identity of Investigational Products",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "cb1876eb-633a-49a0-bf2f-2a957717d377",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Identity of Investigational Products",
            "4.5.1",
            "3",
            879,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The Sponsor will provide the Investigator(s) with investigational product (Table 7) using designated distribution centers.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "33b93633-1cf2-41d0-a6be-24788ae15cf1",
                "childbox": "55207716-5784-49bb-8150-d33b02c57308",
                "subtext": "54db6bb6-bd95-4321-a05b-dc5be221dff9"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Identity of Investigational Products",
            "4.5.1",
            "3",
            880,
            ""
          ],
          [
            "",
            "Unmapped",
            "table",
            {
              "Table": "<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th>ColIndex</th>\n      <th>1.0</th>\n      <th>2.0</th>\n      <th>3.0</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>Investigational Product</td>\n      <td>Manufacturer</td>\n      <td>Concentration and Formulation as Supplied</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>Nirsevimab</td>\n      <td>MedImmune</td>\n      <td>Supplied as 50 mg (nominal) per vial solution. The solution contains 100 mg/mL nirsevimab, 30 mM histidine/histidine-HCl, 80 mM arginine-HCl, 120 mM sucrose, 0.02% (w/v) polysorbate 80, pH 6.0. The nominal fill volume is 0.5 mL.</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>Placebo</td>\n      <td>To be provided by study sites</td>\n      <td>Commercially available 0.9% (w/v) saline (sterile for human use)</td>\n    </tr>\n  </tbody>\n</table>",
              "TableProperties": "[{\"1.0\":{\"entities\":[],\"content\":\"Investigational Product\",\"roi_id\":{\"table_roi_id\":\"382f2abf-0ee8-4753-abee-62c4426017af\",\"row_roi_id\":\"1892d70a-612c-40d3-bbb8-2e8f65b5d78c\",\"column_roi_id\":\"b8be1906-822e-4335-9e19-ad534126d1bb\",\"datacell_roi_id\":\"fe0d1eb7-295f-4c1f-b99b-ca7d4a4c6c4e\"},\"table_index\":19.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"Manufacturer\",\"roi_id\":{\"table_roi_id\":\"382f2abf-0ee8-4753-abee-62c4426017af\",\"row_roi_id\":\"1892d70a-612c-40d3-bbb8-2e8f65b5d78c\",\"column_roi_id\":\"0892c56f-9f9f-46b5-8e25-9bf93a12a8c6\",\"datacell_roi_id\":\"423c5665-d033-44c2-8f06-861c24323c23\"},\"table_index\":19.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[],\"content\":\"Concentration and Formulation as Supplied\",\"roi_id\":{\"table_roi_id\":\"382f2abf-0ee8-4753-abee-62c4426017af\",\"row_roi_id\":\"1892d70a-612c-40d3-bbb8-2e8f65b5d78c\",\"column_roi_id\":\"c06d7987-eefe-4aa0-b988-eee35c085310\",\"datacell_roi_id\":\"fb847ffa-77ae-40c9-ba4c-222081d9c11c\"},\"table_index\":19.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[{\"start_idx\":0,\"end_idx\":9,\"standard_entity_name\":\"Molecule\",\"subcategory\":\"Molecule\",\"confidence\":75.0,\"text\":\"Nirsevimab\"}],\"content\":\"Nirsevimab\",\"roi_id\":{\"table_roi_id\":\"382f2abf-0ee8-4753-abee-62c4426017af\",\"row_roi_id\":\"cc0341d1-ed8a-43bb-b576-c97939976239\",\"column_roi_id\":\"3897b3e1-0cc4-4d62-9279-d82fd4898ddf\",\"datacell_roi_id\":\"db3e9b0e-ff70-4c87-b0cd-4a0397d63231\"},\"table_index\":19.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[{\"start_idx\":0,\"end_idx\":8,\"standard_entity_name\":\"ANY: Organization\",\"subcategory\":\"ANY: Organization\",\"confidence\":75.0,\"text\":\"MedImmune\"}],\"content\":\"MedImmune\",\"roi_id\":{\"table_roi_id\":\"382f2abf-0ee8-4753-abee-62c4426017af\",\"row_roi_id\":\"cc0341d1-ed8a-43bb-b576-c97939976239\",\"column_roi_id\":\"b57402e0-a745-496a-80f9-aa3e7dae30dd\",\"datacell_roi_id\":\"6b3023cf-c99c-42ae-bc76-ba5e41ac401b\"},\"table_index\":19.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[{\"start_idx\":79,\"end_idx\":88,\"standard_entity_name\":\"Molecule\",\"subcategory\":\"Molecule\",\"confidence\":25.0,\"text\":\"nirsevimab\"}],\"content\":\"Supplied as 50 mg (nominal) per vial solution. The solution contains 100 mg\\/mL nirsevimab, 30 mM histidine\\/histidine-HCl, 80 mM arginine-HCl, 120 mM sucrose, 0.02% (w\\/v) polysorbate 80, pH 6.0. The nominal fill volume is 0.5 mL.\",\"roi_id\":{\"table_roi_id\":\"382f2abf-0ee8-4753-abee-62c4426017af\",\"row_roi_id\":\"cc0341d1-ed8a-43bb-b576-c97939976239\",\"column_roi_id\":\"475d7883-b846-42bc-93df-cde5b3e224cc\",\"datacell_roi_id\":\"ff2cf9ad-d28e-4bcc-a759-dec4d75d42fa\"},\"table_index\":19.0,\"qc_change_type\":\"\"}},{\"1.0\":{\"entities\":[],\"content\":\"Placebo\",\"roi_id\":{\"table_roi_id\":\"382f2abf-0ee8-4753-abee-62c4426017af\",\"row_roi_id\":\"cf306d5f-9fde-4e96-b2cd-92f309251df5\",\"column_roi_id\":\"b2f75880-1f8b-4680-b6ef-e87b08142ba6\",\"datacell_roi_id\":\"9e47a538-d9a3-4060-8c4d-6458e17c0cfe\"},\"table_index\":19.0,\"qc_change_type\":\"\"},\"2.0\":{\"entities\":[],\"content\":\"To be provided by study sites\",\"roi_id\":{\"table_roi_id\":\"382f2abf-0ee8-4753-abee-62c4426017af\",\"row_roi_id\":\"cf306d5f-9fde-4e96-b2cd-92f309251df5\",\"column_roi_id\":\"094dd9da-64f3-4d6c-a6b3-98f906362973\",\"datacell_roi_id\":\"a6b2e259-92c6-4412-8c5c-681c3d30a505\"},\"table_index\":19.0,\"qc_change_type\":\"\"},\"3.0\":{\"entities\":[],\"content\":\"Commercially available 0.9% (w\\/v) saline (sterile for human use)\",\"roi_id\":{\"table_roi_id\":\"382f2abf-0ee8-4753-abee-62c4426017af\",\"row_roi_id\":\"cf306d5f-9fde-4e96-b2cd-92f309251df5\",\"column_roi_id\":\"f31dc68f-77a9-42b6-bd2f-7a4059c8410f\",\"datacell_roi_id\":\"6cb33d85-d6e0-4e77-8cf0-2f78c53ea6c0\"},\"table_index\":19.0,\"qc_change_type\":\"\"}}]",
              "SectionHeaderPrintPage": "39",
              "TableIndex": "20",
              "TableName": "Table 7 Identification of Investigational Products",
              "Header": [0]
            },
            {
              "IsBold": true,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "fe0d1eb7-295f-4c1f-b99b-ca7d4a4c6c4e",
                "childbox": "2e850379-f20c-4e5e-a960-c794ec4089e7",
                "subtext": "021fd9b3-5888-4640-a3c7-84d9b21bccd5"
              },
              "Bold": true,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Identification of Investigational Products",
            "Table 7",
            "1",
            882,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "HCl = hydrochloride; w/v = weight/volume.",
            {
              "IsBold": false,
              "font_size": 20,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2b0e054a-7337-40f3-9591-f1d009592886",
                "childbox": "fac27a1e-7559-47f4-a7bb-0e830157c6d2",
                "subtext": "07010d93-2a09-41de-a0f2-e02e1b44baef"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": 20,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Identification of Investigational Products",
            "Table 7",
            "1",
            883,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2ffe6568-e1e5-4e3b-9672-5208e1fda801",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Identification of Investigational Products",
            "Table 7",
            "1",
            884,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Investigational product should be stored at 2°C to 8°C.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e06c113f-1135-4432-b4c7-cf85ad822653",
                "childbox": "753fcabd-647c-475f-afe4-312e9d860288",
                "subtext": "c31c614b-ac33-4c80-ae6c-bdb0e392e172"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Identification of Investigational Products",
            "Table 7",
            "1",
            885,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Labels will be prepared in accordance with Good Manufacturing Practice and local regulatory guidelines.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2d0d0f71-634b-467d-bd6c-c2d379a1378a",
                "childbox": "fc8e0b12-8193-46df-9080-911089ed5e24",
                "subtext": "9f243d9a-b6eb-4ba4-874f-4d4b125b2fc1"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Identification of Investigational Products",
            "Table 7",
            "1",
            886,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Investigational product will be supplied to the site in open-labeled kits.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "b68272c8-0352-4ba8-8c9d-b48a2dd982be",
                "childbox": "87d1fd28-c785-49aa-aa7d-1381faebdd0f",
                "subtext": "1f0889e4-ef4b-42db-b05f-7136f35da3ac"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Identification of Investigational Products",
            "Table 7",
            "1",
            887,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Each kit has a unique number printed on all labels within the kit (ie, the outer carton label and the label of each vial).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "b68272c8-0352-4ba8-8c9d-b48a2dd982be",
                "childbox": "a64e0649-93da-4818-9496-470f40fec9c8",
                "subtext": "1f0889e4-ef4b-42db-b05f-7136f35da3ac"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Identification of Investigational Products",
            "Table 7",
            "1",
            888,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Refer to Section 4.6.2 for information on coding of the container for blinding purposes.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "23517948-1034-4df9-9db2-7851df470981",
                "childbox": "66ca4bc8-7626-4681-8e4c-1103a71dd2ef",
                "subtext": "0ebb4875-dbfa-4ad6-a10a-9f9ecf751478"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Identification of Investigational Products",
            "Table 7",
            "1",
            889,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.5.1.1 Investigational Product Inspection",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "987dc8d7-1b39-4acb-8013-dffc05d910d7",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Investigational Product Inspection",
            "4.5.1.1",
            "4",
            890,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Each vial selected for dose administration should be inspected.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "7ccf3c64-15eb-41c2-88fe-4bee701a981b",
                "childbox": "21156da2-a65b-44af-b513-24111823ced4",
                "subtext": "92012bc0-ad00-4a14-8a99-31d7f3a3b30e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Investigational Product Inspection",
            "4.5.1.1",
            "4",
            891,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Refer to Table 7 for identification of investigational product.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "7ccf3c64-15eb-41c2-88fe-4bee701a981b",
                "childbox": "2d711c15-5333-4621-b772-095e7d0286b1",
                "subtext": "92012bc0-ad00-4a14-8a99-31d7f3a3b30e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Investigational Product Inspection",
            "4.5.1.1",
            "4",
            892,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If there are any defects noted with the investigational product, the Investigator and Site Monitor should be notified immediately.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f26bbcd7-0ef0-4b51-b6df-78c5789e5a9d",
                "childbox": "5122cb57-5ca3-4b5d-bb89-619c627fd61b",
                "subtext": "b220fda8-bc20-411d-8a98-7a2f6e6b2d55"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Investigational Product Inspection",
            "4.5.1.1",
            "4",
            893,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Refer to the Product Complaint section (Section 4.5.1.5) for further instructions.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f26bbcd7-0ef0-4b51-b6df-78c5789e5a9d",
                "childbox": "d4f61656-4b87-4dd5-9252-1ff915dbd930",
                "subtext": "b220fda8-bc20-411d-8a98-7a2f6e6b2d55"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Investigational Product Inspection",
            "4.5.1.1",
            "4",
            894,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.5.1.2 Dose Administration Steps",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "97980ec8-bbab-4747-80c7-575d9dbaafeb",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            895,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "No incompatibilities between nirsevimab and polycarbonate or polypropylene syringes have been observed.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 29,
                  "end_idx": 38,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "0a51e05f-62c2-4fa7-ab26-3f3a010a059e",
                "childbox": "b8734980-1b76-431e-a68a-52dea733a0da",
                "subtext": "419aefa6-4543-438f-9c51-e6bb2f4c92d0"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            896,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Nirsevimab does not contain preservatives and any unused portion must be discarded.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 0,
                  "end_idx": 9,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "Nirsevimab"
                }
              ],
              "roi_id": {
                "para": "881c75fd-5fa4-4b07-be16-a40f768c6865",
                "childbox": "5ec84b60-350c-4e1e-88f5-82b6ea4a98f4",
                "subtext": "2ea79220-0197-4975-ba9b-b2189f44528a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            897,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Total in-use storage time from needle puncture of the investigational product vial to administration should not exceed 4 hours at room temperature.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "881c75fd-5fa4-4b07-be16-a40f768c6865",
                "childbox": "378ecb6a-8e77-4fc4-ad9a-8846803176b2",
                "subtext": "2ea79220-0197-4975-ba9b-b2189f44528a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            898,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If storage time exceeds these limits, a new vial should be used.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "881c75fd-5fa4-4b07-be16-a40f768c6865",
                "childbox": "113e6954-d056-4863-bdb3-653e7d6904c5",
                "subtext": "2ea79220-0197-4975-ba9b-b2189f44528a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            899,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The dose administration steps are as follows:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "594854e6-0e20-4a04-850b-23964c2b0fc5",
                "childbox": "1b33e0e7-edb0-49d2-be44-16c678b9a90c",
                "subtext": "b6435f01-5c03-4aeb-b733-0c3bae6f91b1"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            900,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "1 A dose of 50 mg (ie, 0.5 mL) of nirsevimab will be obtained by withdrawing the entire contents of 1 investigational vial with an appropriately sized syringe.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 34,
                  "end_idx": 43,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "bf4b369a-9087-4f8a-a009-32fe8a883434",
                "childbox": "9a8ba8b2-86d7-4409-adfe-809f5cd7a6ec",
                "subtext": "ba64d0ef-6710-4b08-8fc4-df71b4ef57bc"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            901,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "2 A dose of 100 mg (ie, 1.0 mL) of nirsevimab will be obtained by withdrawing the entire contents of 2 investigational vials with an appropriately sized syringe.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 35,
                  "end_idx": 44,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "46229a2e-e680-49a8-a24b-417c461510b5",
                "childbox": "c32eafe1-f539-4875-aa36-a8306c14a947",
                "subtext": "a15bf5d5-0af1-433e-a85a-c7cc30fd827a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            902,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "3",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "46229a2e-e680-49a8-a24b-417c461510b5",
                "childbox": "95e01e12-9b13-4002-be91-3586b8260a0f",
                "subtext": "e1d32d32-84c2-4f73-86f3-59c3abe3168c"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            903,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "46229a2e-e680-49a8-a24b-417c461510b5",
                "childbox": "95e01e12-9b13-4002-be91-3586b8260a0f",
                "subtext": "d7827046-80e2-4314-878a-372a06b311e8"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "Arial",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            904,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "46229a2e-e680-49a8-a24b-417c461510b5",
                "childbox": "bbed24fd-a0d7-4f79-a16b-9798e341297e",
                "subtext": "161bfe38-3a1c-454f-8715-a827467507b1"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "Arial",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            905,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "For subjects randomized to placebo, a corresponding volume of placebo (0.5 mL for infants < 5 kg or 1.0 mL for infants ≥ 5 kg) should be administered.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "46229a2e-e680-49a8-a24b-417c461510b5",
                "childbox": "1fdf3946-5f1b-4f1d-a70a-1726e7ae5866",
                "subtext": "21d167cc-2942-454f-8c3e-5d9570bfb9c3"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            906,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "1 Switch the needle prior to administration.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e2ac965e-86a4-436a-b3fe-7fd72f76da5c",
                "childbox": "ed20f539-5b43-425a-88b3-26adec25ff60",
                "subtext": "2eab5f72-d5f2-4ad9-b488-995fbc92d0a2"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            907,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "2 Administer investigational product using the appropriate size needle ranging from 22 to 25 gauge and 5/8 to 1.0 inches based on muscle size and weight of the subject.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e21e702b-3a61-4946-8d72-79d140b5934f",
                "childbox": "72dc7c1c-573d-4ff6-ac78-25bd5cd6d2bd",
                "subtext": "647f8f59-1954-4962-b453-c35ad40c9550"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            908,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f51ca6df-961a-4717-a0a7-02c02650811b",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Dose Administration Steps",
            "4.5.1.2",
            "4",
            909,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.5.1.3 Treatment Administration",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "860339cb-2e18-47c0-ba3d-d5f021cb63f9",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment Administration",
            "4.5.1.3",
            "4",
            910,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The first day of dosing is considered Day 1.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 10,
                  "end_idx": 12,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                },
                {
                  "start_idx": 38,
                  "end_idx": 40,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                }
              ],
              "roi_id": {
                "para": "b140e586-af9a-4575-8b54-0eabb6cdbfb7",
                "childbox": "680add5c-d07e-4f14-a367-540a28e371c6",
                "subtext": "cf7d7d2f-0d20-4826-9367-f43266325f3a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment Administration",
            "4.5.1.3",
            "4",
            911,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Investigational product (nirsevimab or placebo) will be supplied by an unblinded investigational product manager.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 25,
                  "end_idx": 34,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "7dead301-5c5d-4cb3-b214-f60c37d655f8",
                "childbox": "6d72b01e-5006-43a6-a188-71df3c25fa65",
                "subtext": "ecbcb6d8-fa21-47ae-9ab2-eb166426354f"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment Administration",
            "4.5.1.3",
            "4",
            912,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Blinding will be performed at the site level to ensure that nirsevimab and placebo are indistinguishable in appearance and are not labeled to reveal treatment identity.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 60,
                  "end_idx": 69,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "7dead301-5c5d-4cb3-b214-f60c37d655f8",
                "childbox": "5f141c46-9711-487c-a838-66c3511a3185",
                "subtext": "ecbcb6d8-fa21-47ae-9ab2-eb166426354f"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment Administration",
            "4.5.1.3",
            "4",
            913,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Investigational product (nirsevimab or placebo) should be administered in the anterolateral aspect of the thigh according to standard practice procedures for IM injections.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 25,
                  "end_idx": 34,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "423896ca-6f95-4c12-9517-48466c447379",
                "childbox": "182d8b51-9c9f-43a0-80d2-a8c76575c0fb",
                "subtext": "b7309fbe-d75b-4dfc-a296-13f95de8d063"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment Administration",
            "4.5.1.3",
            "4",
            914,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.5.1.4 Monitoring of Dose Administration",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "20dea216-0494-4ee5-a768-72038eb48f86",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Monitoring of Dose Administration",
            "4.5.1.4",
            "4",
            915,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subjects will be monitored before and after investigational product administration through assessment of vital signs (temperature, blood pressure, heart rate, and respiratory rate).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9a8155b3-d6bb-4ca6-934b-5b721e98ca90",
                "childbox": "1f2b421d-81b6-40b8-ac53-e39ecc025e6a",
                "subtext": "dda7f6d4-04ea-4a30-b96d-626d48afdb86"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Monitoring of Dose Administration",
            "4.5.1.4",
            "4",
            916,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "All vital signs should be obtained within 60 minutes prior to dosing, and at 30 minutes (± 5 minutes) and at 60 minutes (± 5 minutes) post dose.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9a8155b3-d6bb-4ca6-934b-5b721e98ca90",
                "childbox": "759de4eb-569b-4b12-ab6c-2b554b65d5ff",
                "subtext": "dda7f6d4-04ea-4a30-b96d-626d48afdb86"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Monitoring of Dose Administration",
            "4.5.1.4",
            "4",
            917,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "As with any antibody, allergic reactions to dose administration are possible.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2276dd89-5d6a-4554-b09e-ee719b201e1a",
                "childbox": "68c3906d-f228-4b38-a9ea-70a14344d148",
                "subtext": "c68b3c5b-f10a-4273-b2fc-8ff7b281a087"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Monitoring of Dose Administration",
            "4.5.1.4",
            "4",
            918,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Therefore, appropriate drugs and medical equipment to treat acute anaphylactic reactions must be immediately available, and study personnel must be trained to recognize and treat anaphylaxis.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2276dd89-5d6a-4554-b09e-ee719b201e1a",
                "childbox": "83e47a0c-8dd3-42b1-ad81-37dc126897b8",
                "subtext": "c68b3c5b-f10a-4273-b2fc-8ff7b281a087"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Monitoring of Dose Administration",
            "4.5.1.4",
            "4",
            919,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.5.1.5 Reporting Product Complaints",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "204b5f58-0d7c-4ad6-958a-6e44b6b5164e",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            920,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Any defects with the investigational product must be reported",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e870ebb5-d949-4c97-b92b-7c443eb91bf1",
                "childbox": "b0645ad4-2f7a-43d2-b904-00eadcb1bf0c",
                "subtext": "f1c8cc1f-620f-4982-a762-0165e8e49972"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            921,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "immediately",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e870ebb5-d949-4c97-b92b-7c443eb91bf1",
                "childbox": "b0645ad4-2f7a-43d2-b904-00eadcb1bf0c",
                "subtext": "ad901a2e-0091-4305-a64f-9802d9a47214"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": true,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            922,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "to the Sponsor Product Complaint Department by the site with further notification to the site monitor.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e870ebb5-d949-4c97-b92b-7c443eb91bf1",
                "childbox": "b0645ad4-2f7a-43d2-b904-00eadcb1bf0c",
                "subtext": "18cfa9bf-e1da-4e9c-a029-f71703ccd8f3"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            923,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "All defects will be communicated to the Sponsor and investigated further with the Product Complaint Department.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 82,
                  "end_idx": 109,
                  "standard_entity_name": "ANY: Organization",
                  "subcategory": "ANY: Organization",
                  "confidence": 87,
                  "text": "Product Complaint Department"
                }
              ],
              "roi_id": {
                "para": "e870ebb5-d949-4c97-b92b-7c443eb91bf1",
                "childbox": "cc79a273-e406-4657-b71f-c3209ccfe875",
                "subtext": "6abb2708-3277-46d9-9c24-c1083e45e8d2"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            924,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "During the investigation of the product complaint, all investigational product must be stored at labeled conditions unless otherwise instructed.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e870ebb5-d949-4c97-b92b-7c443eb91bf1",
                "childbox": "051138fb-e9cb-48ab-8f3e-1f3bb4d3ba27",
                "subtext": "6abb2708-3277-46d9-9c24-c1083e45e8d2"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            925,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Sponsor’s contact information for reporting product complaints:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "33cf4ef2-1dcc-434e-94be-5beb7388b75d",
                "childbox": "7e64f929-ebc1-42db-8ac0-44164c25e1eb",
                "subtext": "d06dc2e9-b89d-4c26-b04f-3574e4be2679"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            926,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": 22,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "04e65050-cd14-4c9a-bcdb-f6f1358e26cb",
                "childbox": "6d099c5f-4459-4f89-95e4-33296746c6a4",
                "subtext": "3175dd3c-f123-4888-a259-282e951b5258"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "Calibri",
              "rStyle": "",
              "Shadow": false,
              "Size": 22,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            927,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Email:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "04e65050-cd14-4c9a-bcdb-f6f1358e26cb",
                "childbox": "bcc12d2f-7342-4446-b0eb-787107b09215",
                "subtext": "9177bb88-0fcb-4abf-b21e-0df716ee6b75"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            928,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "04e65050-cd14-4c9a-bcdb-f6f1358e26cb",
                "childbox": "d2b8ffcb-fbe9-4e66-8c53-8bd94c11c9f4",
                "subtext": "b42fec24-4b41-455b-b636-553955e57165"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            929,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "productcomplaints3@astrazeneca.com",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 0,
                  "end_idx": 33,
                  "standard_entity_name": "ANY: Email",
                  "subcategory": "ANY: Email",
                  "confidence": 87,
                  "text": "productcomplaints3@astrazeneca.com"
                },
                {
                  "start_idx": 0,
                  "end_idx": 33,
                  "standard_entity_name": "ANY: Email",
                  "subcategory": "ANY: Email",
                  "confidence": 100,
                  "text": "productcomplaints3@astrazeneca.com"
                },
                {
                  "start_idx": 0,
                  "end_idx": 33,
                  "standard_entity_name": "Sponsor Name",
                  "subcategory": "Sponsor Name",
                  "confidence": 100,
                  "text": "productcomplaints3@astrazeneca.com"
                }
              ],
              "roi_id": {
                "para": "04e65050-cd14-4c9a-bcdb-f6f1358e26cb",
                "childbox": "f07e1664-26ee-4623-9089-f30e75f46a5e",
                "subtext": "b42fec24-4b41-455b-b636-553955e57165"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            930,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9d1acf6e-55f0-44df-8fdb-513599d9c295",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            931,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": 22,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "8d817a30-bc17-4df3-ac6b-77c44f500fe9",
                "childbox": "c131cac1-a40a-44a6-986d-7b0a84c44c62",
                "subtext": "dcd00736-01cf-43c1-8251-0ebef06da88e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "Calibri",
              "rStyle": "",
              "Shadow": false,
              "Size": 22,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            932,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Phone:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "8d817a30-bc17-4df3-ac6b-77c44f500fe9",
                "childbox": "41907381-4b0a-402c-afe0-27aec3e45778",
                "subtext": "5e00b804-f04e-4f2f-bd10-f08f5e7ba3a6"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            933,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "8d817a30-bc17-4df3-ac6b-77c44f500fe9",
                "childbox": "81e6fcbc-7253-436f-bf84-bc5d55092e38",
                "subtext": "0c669995-b2ce-4f7e-90bc-35e6370eec13"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            934,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "+1-301-398-2105",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 0,
                  "end_idx": 14,
                  "standard_entity_name": "ANY: Telephone/Fax",
                  "subcategory": "ANY: Telephone/Fax",
                  "confidence": 100,
                  "text": "+1-301-398-2105"
                }
              ],
              "roi_id": {
                "para": "8d817a30-bc17-4df3-ac6b-77c44f500fe9",
                "childbox": "a65235b5-6c27-4436-94d6-9657957bc032",
                "subtext": "0c669995-b2ce-4f7e-90bc-35e6370eec13"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            935,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "79c4f527-8b26-4336-b275-802ede12ff7b",
                "childbox": "ed05c975-36f8-4cf1-add3-d9b54d910207",
                "subtext": "67ee936a-ac68-4678-8604-91dede3d8778"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            936,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": 22,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "538ad73f-ed68-4433-be23-2621d42fd7b7",
                "childbox": "b72f0845-80d1-4976-9e2b-5504975a2756",
                "subtext": "f4d2932f-13eb-4666-97d1-d2742d787d22"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "Calibri",
              "rStyle": "",
              "Shadow": false,
              "Size": 22,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            937,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Mail:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "538ad73f-ed68-4433-be23-2621d42fd7b7",
                "childbox": "24ef167e-f061-43c3-b352-1340bc34c9dd",
                "subtext": "b226892f-0cce-4300-8510-83bf6d0657bf"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            938,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "538ad73f-ed68-4433-be23-2621d42fd7b7",
                "childbox": "c1101c9c-cd2f-4352-8421-8d7904d51cdc",
                "subtext": "decde8d0-861f-43cc-af37-6a2a9781bf14"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            939,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "MedImmune",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 0,
                  "end_idx": 8,
                  "standard_entity_name": "ANY: Organization",
                  "subcategory": "ANY: Organization",
                  "confidence": 75,
                  "text": "MedImmune"
                }
              ],
              "roi_id": {
                "para": "538ad73f-ed68-4433-be23-2621d42fd7b7",
                "childbox": "46653bcc-86ab-470b-9624-80bf7ccf9cf5",
                "subtext": "decde8d0-861f-43cc-af37-6a2a9781bf14"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            940,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": 22,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e13efbed-3b0a-47a3-b2f4-c4a950070ba3",
                "childbox": "9f01a55f-019b-41bd-a989-6929ebf75e6f",
                "subtext": "60dd9011-8620-430e-9b37-d7edbb4fd08f"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "Calibri",
              "rStyle": "",
              "Shadow": false,
              "Size": 22,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            941,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e13efbed-3b0a-47a3-b2f4-c4a950070ba3",
                "childbox": "ad0b06ab-5360-4865-8d34-3070005ed7a0",
                "subtext": "cf386bfb-cb22-4652-bdc5-e8582373eef6"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            942,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Attn: Product Complaint Department",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 6,
                  "end_idx": 33,
                  "standard_entity_name": "ANY: Organization",
                  "subcategory": "ANY: Organization",
                  "confidence": 87,
                  "text": "Product Complaint Department"
                }
              ],
              "roi_id": {
                "para": "e13efbed-3b0a-47a3-b2f4-c4a950070ba3",
                "childbox": "222e3230-593b-4011-8eea-5e3d85c68dfb",
                "subtext": "cf386bfb-cb22-4652-bdc5-e8582373eef6"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            943,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": 22,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "5d083ed4-5c0c-43d7-85b7-73c9c76587ff",
                "childbox": "caa3f5dd-4fb9-4ba6-baff-0e23a971cc99",
                "subtext": "c7bdc959-6e7e-4278-a9f9-6937fa28942d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "Calibri",
              "rStyle": "",
              "Shadow": false,
              "Size": 22,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            944,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "5d083ed4-5c0c-43d7-85b7-73c9c76587ff",
                "childbox": "c15954bb-b886-400f-9fd2-b386a3c77307",
                "subtext": "fa8b80b1-6e70-471c-922f-8051d20f7c94"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            945,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "One MedImmune Way,",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 0,
                  "end_idx": 17,
                  "standard_entity_name": "ANY: Address",
                  "subcategory": "ANY: Address",
                  "confidence": 100,
                  "text": "One MedImmune Way,"
                },
                {
                  "start_idx": 4,
                  "end_idx": 12,
                  "standard_entity_name": "ANY: Organization",
                  "subcategory": "ANY: Organization",
                  "confidence": 75,
                  "text": "MedImmune"
                }
              ],
              "roi_id": {
                "para": "5d083ed4-5c0c-43d7-85b7-73c9c76587ff",
                "childbox": "371326e6-ccd9-43a7-ad49-634ba8a2001b",
                "subtext": "fa8b80b1-6e70-471c-922f-8051d20f7c94"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            946,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": 22,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "868ea7dd-9b66-42f4-b09a-be34e2dff55a",
                "childbox": "0d79c093-9d3e-43a5-a210-a8b2bf9d85d8",
                "subtext": "09102994-285a-439e-848b-49ce5fe5844d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "Calibri",
              "rStyle": "",
              "Shadow": false,
              "Size": 22,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            947,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "868ea7dd-9b66-42f4-b09a-be34e2dff55a",
                "childbox": "28b29a75-9be8-478e-8fc8-dc1826dbfae1",
                "subtext": "9ff99994-b493-432b-a231-636517082da8"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            948,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Gaithersburg, MD USA 20878",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "868ea7dd-9b66-42f4-b09a-be34e2dff55a",
                "childbox": "72aaa47a-b692-495e-8351-e8dfbad3b4b9",
                "subtext": "9ff99994-b493-432b-a231-636517082da8"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            949,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3b9162ea-34a9-4a4a-800b-8a5339684162",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Reporting Product Complaints",
            "4.5.1.5",
            "4",
            950,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.5.2 Additional Study Medications",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "11e0858d-330e-4bce-8500-316b375347ec",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Additional Study Medications",
            "4.5.2",
            "3",
            951,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "No other study medications are specified for use in this clinical protocol.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a525673a-bf68-472a-b55d-71f3d18275a4",
                "childbox": "9b142702-ed4c-4d4d-acc4-eac2c4986e98",
                "subtext": "d3b6a26e-2920-4c78-95e1-b001a8300702"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Additional Study Medications",
            "4.5.2",
            "3",
            952,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Labeling",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "ee46fbd7-f4ef-4f15-a487-32b452e24c93",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Labeling",
            "4.5.3",
            "3",
            953,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Labels for the investigational product will be prepared in accordance with Good",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a06d2c8b-8a66-426b-8168-fdecffd68a72",
                "childbox": "f0f2e65b-8a4d-4ddd-9aa5-ba401ad64ecf",
                "subtext": "6a65ad74-38ca-458e-bee4-0334535cb6ba"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Labeling",
            "4.5.3",
            "3",
            954,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Manufacturing Practice and local regulatory guidelines.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "fb838e4d-ef40-40c0-aa38-edfc88538d37",
                "childbox": "5d2cbcbc-6c1c-4403-b69e-45a9c48462cf",
                "subtext": "641a7d87-5a61-404b-b10e-34dbe3f12022"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Labeling",
            "4.5.3",
            "3",
            955,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Label text will be translated into local languages, as required.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "fb838e4d-ef40-40c0-aa38-edfc88538d37",
                "childbox": "b264c1f3-239a-4d60-a329-b29252b0e2e7",
                "subtext": "641a7d87-5a61-404b-b10e-34dbe3f12022"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Labeling",
            "4.5.3",
            "3",
            956,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Storage",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "c87e8e81-42b8-4a93-b5d3-8edef7b47d19",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Storage",
            "4.5.4",
            "3",
            957,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Store investigational product at 2°C to 8°C.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f3b0f871-95cc-44a5-b0f4-9790821fae22",
                "childbox": "fa9af92c-e382-45d5-bd1a-426e4a5d5a8f",
                "subtext": "750af3d6-7741-441e-a650-ba5a5fdf2ce2"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Storage",
            "4.5.4",
            "3",
            958,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.5.5 Treatment Compliance",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "fdc08bc4-eb62-4d7e-9041-c3543e9709df",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment Compliance",
            "4.5.5",
            "3",
            959,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Investigational product is administered by study site personnel, who will monitor compliance.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e402e467-9a7e-46ca-9636-459f3a20154d",
                "childbox": "a2e072a8-b2db-48af-93ce-1058475e2665",
                "subtext": "49f71d02-4af9-4eba-adf8-eb1b45dc7f47"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Treatment Compliance",
            "4.5.5",
            "3",
            960,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.5.6 Accountability",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "82595251-b6b3-49dd-9785-0daec4bd365f",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Accountability",
            "4.5.6",
            "3",
            961,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The Investigator’s or site’s designated investigational product manager is required to maintain accurate investigational product accountability records.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9c4c40f4-4a1e-4030-b08d-351078148aac",
                "childbox": "da8c2aa0-cd1f-4a06-9762-1ababe0d09d9",
                "subtext": "8a8d1043-924c-4902-a3bc-b27d4c628417"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Accountability",
            "4.5.6",
            "3",
            962,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Upon completion of the study, copies of investigational product accountability records will be returned to the Sponsor.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9c4c40f4-4a1e-4030-b08d-351078148aac",
                "childbox": "8add6e49-b57d-42e0-847a-a07d0584c17b",
                "subtext": "6aefc233-84d5-48aa-a78c-d9ed85d7fb52"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Accountability",
            "4.5.6",
            "3",
            963,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "All unused investigational product will be returned to a Sponsor-authorized depot or disposed of upon authorization by the Sponsor.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9c4c40f4-4a1e-4030-b08d-351078148aac",
                "childbox": "6710714d-d518-498e-a707-c82c42c25f4a",
                "subtext": "ba086b4b-5f0e-4dc3-bd8e-26c80c186577"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Accountability",
            "4.5.6",
            "3",
            964,
            ""
          ]
        ]
      },
      {
        "id": "4.6-Treatment-Assignment-and-Blinding",
        "header": "4.6 Treatment Assignment and Blinding",
        "data": [
          [
            "",
            "Unmapped",
            "header",
            "4.6.1 Methods for Assigning Treatment Groups",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "83575c17-1da4-4252-8b31-54c78cdfada8",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            966,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "An IWRS will be used for randomization to a treatment group and assignment of blinded investigational product kit numbers.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "bbac8b35-4b49-4523-9565-374f5c1da678",
                "childbox": "7ba3c874-aa6a-41fb-b11e-a94355c65320",
                "subtext": "7c50825f-1180-4fa2-9d45-ca921f95a76e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            967,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "A subject is considered randomized into the study when the Investigator notifies the IWRS that the subject meets eligibility criteria and the IWRS provides the assignment of blinded investigational product kit numbers to the subject.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "bbac8b35-4b49-4523-9565-374f5c1da678",
                "childbox": "728aed1c-388e-4dfa-a430-803a25908a9b",
                "subtext": "8a9f8e80-bad2-4f44-9eb1-7fd09e7ac9e2"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            968,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subjects will be randomized at a 2:1 ratio to receive nirsevimab (N = 530) or placebo",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 54,
                  "end_idx": 63,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "4f8f814d-d47f-489b-bfbb-823db7bc8e1e",
                "childbox": "771220a2-0378-4443-b578-c29cf50c8994",
                "subtext": "92739077-8d17-4b92-a14b-668c62aa335d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            969,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "(N = 270). Randomization will be stratified by subject age at the time of randomization (≤ 3 months, > 3 to ≤ 6 months, > 6 months), and by GA (< 35 wGA, ≥ 35 wGA).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "51b00fa9-c628-4b6e-9df6-c0fdc3f6bdfd",
                "childbox": "d31fb9bb-33bb-4773-a57c-51712f7cdad3",
                "subtext": "3d56ff31-804e-4c6f-8f0d-df739bdad634"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            970,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The number of randomized infants > 6 months of age will be limited to approximately 100.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "51b00fa9-c628-4b6e-9df6-c0fdc3f6bdfd",
                "childbox": "a251cf7c-a778-4bd1-994e-70b44ab8b04f",
                "subtext": "08068d83-518b-4082-b1b9-925281512053"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            971,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The procedure for using IWRS is as follows:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e4630789-4ab9-4c7f-8cdd-ed88de20edb2",
                "childbox": "41e8cfb3-bd56-4b84-8709-dd693593af84",
                "subtext": "9dda0760-2c60-4d9c-8a3a-f4ab05786bb6"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            972,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• The Investigator or designee contacts the IWRS and provides the SID number and subject’s baseline characteristic(s) used to verify that it is the same subject.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "fcd4b7a0-8a30-41e2-85f2-85d0ad199f91",
                "childbox": "0a61cf24-5d0c-460b-b14b-291ccd4f59a0",
                "subtext": "bb418965-5b21-45ee-a825-0c97191842a2"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            973,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Placebo (provided by site) or a vial from a nirsevimab kit will be assigned to the subject.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 46,
                  "end_idx": 55,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "6a886ac8-1c25-4099-b114-8ec8f327dfc7",
                "childbox": "2af57381-1cd6-433d-b9d1-4f35c0a69f1a",
                "subtext": "dbc28193-e796-4565-93b3-0cedea42b511"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            974,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Confirmation of this information is sent to the unblinded investigational product manager who prepares the investigational product to be dispensed to the subject per the response system and records the appropriate information in the investigational product accountability log.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "8c967c51-1853-4d89-a3bb-1ff28513e5cd",
                "childbox": "c80455c7-11ca-4566-a1d3-0d7b05b501e5",
                "subtext": "4d65f053-bd6c-4ea9-b136-f53eae98a9d5"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            975,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c06c8525-ede2-483d-9419-f2d375d5f29f",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            976,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Investigational product (nirsevimab or placebo) must be administered the same day the investigational product is assigned.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 25,
                  "end_idx": 34,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "947bf9f0-19a9-4ae6-b875-1176fa23cbc0",
                "childbox": "b1e00c24-5b4a-4fe4-807d-fbb0334b3ab8",
                "subtext": "e1cc0a7f-dda5-4dd6-9e5c-da614db859b8"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            977,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Total in-use storage time from needle puncture of the investigational product vial to administration should not exceed 4 hours at room temperature.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "947bf9f0-19a9-4ae6-b875-1176fa23cbc0",
                "childbox": "b33b6659-1e1a-4299-86ba-7b36b224be25",
                "subtext": "d5cad387-ef29-4228-a9a2-69f26011a1de"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            978,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If storage time exceeds these limits, a new vial should be used.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "947bf9f0-19a9-4ae6-b875-1176fa23cbc0",
                "childbox": "398ffcdb-d9e7-41f2-9b24-d25a3b8c039f",
                "subtext": "d5cad387-ef29-4228-a9a2-69f26011a1de"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            979,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If there is a delay in the administration of investigational product such that it will not be administered within the specified timeframe, the unblinded investigational product manager must be notified immediately.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "947bf9f0-19a9-4ae6-b875-1176fa23cbc0",
                "childbox": "51114af6-b3c9-47fe-99b1-1365a5c3fb9a",
                "subtext": "de55d976-22ef-4e11-96ea-2a607707b481"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Assigning Treatment Groups",
            "4.6.1",
            "3",
            980,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.6.2 Methods to Ensure Blinding",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "c86b42c6-336a-4d86-a249-7fa23480f4a8",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods to Ensure Blinding",
            "4.6.2",
            "3",
            981,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "This is a double-blind study in which sites are using commercially available saline as the placebo.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c610c479-2a04-44ea-9103-c2b10b55ed91",
                "childbox": "f925a67f-50b9-44c9-a397-782d14c6797e",
                "subtext": "f7c9f80d-4a99-499d-bf0d-1224bf5b2c4b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods to Ensure Blinding",
            "4.6.2",
            "3",
            982,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Nirsevimab and placebo are visually indistinguishable once in syringes.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 0,
                  "end_idx": 9,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "Nirsevimab"
                }
              ],
              "roi_id": {
                "para": "c610c479-2a04-44ea-9103-c2b10b55ed91",
                "childbox": "1e213d8c-23ec-43aa-9fcb-adc0f22be512",
                "subtext": "f7c9f80d-4a99-499d-bf0d-1224bf5b2c4b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods to Ensure Blinding",
            "4.6.2",
            "3",
            983,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Neither the subjects’ parent(s)/legal representatives nor the Investigator or any of the site staff who are involved in the treatment or clinical evaluation of the subjects will be aware of the treatment received (ICH E9).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c610c479-2a04-44ea-9103-c2b10b55ed91",
                "childbox": "71c38e7b-164f-4b66-bad9-35d960924684",
                "subtext": "f7c9f80d-4a99-499d-bf0d-1224bf5b2c4b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods to Ensure Blinding",
            "4.6.2",
            "3",
            984,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "In the event that treatment allocation for a subject becomes known to the Investigator or other blinded study staff involved in the management of study subjects, the Sponsor must be notified",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c610c479-2a04-44ea-9103-c2b10b55ed91",
                "childbox": "2e5417f4-5e12-412a-b90b-17840545f016",
                "subtext": "d76a59e5-7a67-4e35-86bc-282bab1b80e1"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods to Ensure Blinding",
            "4.6.2",
            "3",
            985,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "immediately",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c610c479-2a04-44ea-9103-c2b10b55ed91",
                "childbox": "2e5417f4-5e12-412a-b90b-17840545f016",
                "subtext": "a04a84ad-1509-43aa-88d7-967af7146842"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": true,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods to Ensure Blinding",
            "4.6.2",
            "3",
            986,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            ".",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c610c479-2a04-44ea-9103-c2b10b55ed91",
                "childbox": "2e5417f4-5e12-412a-b90b-17840545f016",
                "subtext": "581ab34a-385a-4bdf-888c-e449fa56176e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods to Ensure Blinding",
            "4.6.2",
            "3",
            987,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If the treatment allocation for a subject needs to be known to treat an individual subject for an AE, the Investigator must notify the Sponsor",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c610c479-2a04-44ea-9103-c2b10b55ed91",
                "childbox": "d5ff4dc4-1f4e-451b-8c04-e451817355c1",
                "subtext": "581ab34a-385a-4bdf-888c-e449fa56176e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods to Ensure Blinding",
            "4.6.2",
            "3",
            988,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "immediately",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c610c479-2a04-44ea-9103-c2b10b55ed91",
                "childbox": "d5ff4dc4-1f4e-451b-8c04-e451817355c1",
                "subtext": "8a46aa39-cc7e-4f15-9f31-c0929887d5ce"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": true,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods to Ensure Blinding",
            "4.6.2",
            "3",
            989,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            ".",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c610c479-2a04-44ea-9103-c2b10b55ed91",
                "childbox": "d5ff4dc4-1f4e-451b-8c04-e451817355c1",
                "subtext": "16c955a4-4848-458c-b31c-6bac29cd4d4a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods to Ensure Blinding",
            "4.6.2",
            "3",
            990,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The site will maintain a written plan detailing which staff members are blinded/unblinded and the process of investigational product administration used to maintain the blind.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c610c479-2a04-44ea-9103-c2b10b55ed91",
                "childbox": "bbf42052-bf7b-4135-985c-2c7d8403389e",
                "subtext": "16c955a4-4848-458c-b31c-6bac29cd4d4a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods to Ensure Blinding",
            "4.6.2",
            "3",
            991,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Methods for Unblinding",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "3f820eed-dfd6-4ad5-b1b6-f9e090e22810",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Methods for Unblinding",
            "4.6.3",
            "3",
            992,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.6.3.1 Unblinding in the Event of a Medical Emergency",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "0a4a04a3-11ca-4515-985f-e85500ce8b60",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Unblinding in the Event of a Medical Emergency",
            "4.6.3.1",
            "4",
            993,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "In the event of a medical emergency, the Investigator may unblind an individual subject’s investigational product allocation.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f1b057c9-2d3d-442b-b1a7-461636bacf8b",
                "childbox": "76d6879b-9afa-4695-a1f4-41af76578502",
                "subtext": "c796e07b-9880-4b0e-a27c-c271a8d3104d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Unblinding in the Event of a Medical Emergency",
            "4.6.3.1",
            "4",
            994,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Instructions for unblinding an individual subject’s investigational product allocation are contained in the IWRS manual.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f1b057c9-2d3d-442b-b1a7-461636bacf8b",
                "childbox": "7b97447d-8f1e-498c-a5e1-b15ce4a70492",
                "subtext": "40abedda-c65e-4730-bfb2-b0f28a60ff60"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Unblinding in the Event of a Medical Emergency",
            "4.6.3.1",
            "4",
            995,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "In general, unblinding should only occur if management of the medical emergency would be different based on the subject having received investigational product.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f1b057c9-2d3d-442b-b1a7-461636bacf8b",
                "childbox": "2f5d7092-6ffb-477a-b302-e3962f5c2d90",
                "subtext": "8268ef5e-f678-41b6-b622-e01cc19cd3af"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Unblinding in the Event of a Medical Emergency",
            "4.6.3.1",
            "4",
            996,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "In the majority of cases, the management of a medical emergency would be the same whether or not investigational product was received by the subject.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f1b057c9-2d3d-442b-b1a7-461636bacf8b",
                "childbox": "61f7274a-ab88-46fe-ae1f-f0d70d81f49b",
                "subtext": "46f30715-b030-460b-b75c-aae9da6043d2"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Unblinding in the Event of a Medical Emergency",
            "4.6.3.1",
            "4",
            997,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If this was the case, the investigational product allocation should not be unblinded.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "f1b057c9-2d3d-442b-b1a7-461636bacf8b",
                "childbox": "bf9d6096-d8c6-43f7-a376-99e470e5b57d",
                "subtext": "e284dc20-33b1-46ff-8854-b96fbaaf8a33"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Unblinding in the Event of a Medical Emergency",
            "4.6.3.1",
            "4",
            998,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The Sponsor retains the right to unblind the treatment allocation for SAEs that are unexpected and are suspected to be causally related to an investigational product and that potentially require expedited reporting to regulatory authorities.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "44a1d7e2-780a-45d7-b8d6-cb7e5ff96aa5",
                "childbox": "e007ab85-f6b0-435b-b6b0-4b10bccc7b62",
                "subtext": "77077f63-aeaf-4bbc-8adb-678bc113b1fc"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Unblinding in the Event of a Medical Emergency",
            "4.6.3.1",
            "4",
            999,
            ""
          ]
        ]
      },
      {
        "id": "4.7-Restrictions-During-the-Study-and-Concomitant-Treatment(s)",
        "header": "4.7 Restrictions During the Study and Concomitant Treatment(s)",
        "data": [
          [
            "",
            "Unmapped",
            "text",
            "The Investigator must be informed as soon as possible about any medication taken from the time of screening until the end of the clinical phase of the study (final study visit).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4d1c2899-a67a-4d7e-be90-2baac8f50227",
                "childbox": "6d575854-97fa-4f99-9d0f-19befed64a73",
                "subtext": "a0cd2c95-b877-4ad4-a442-ea9a5d476ba0"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Restrictions During the Study and Concomitant Treatment(s)",
            "4.7",
            "2",
            1001,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Any concomitant medication(s), including herbal preparations, taken during the study will be recorded in the eCRF.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4d1c2899-a67a-4d7e-be90-2baac8f50227",
                "childbox": "c7551448-8c63-42d2-b04d-f1b704e6576c",
                "subtext": "03f60c89-1c9f-415a-ad55-c23922223e62"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Restrictions During the Study and Concomitant Treatment(s)",
            "4.7",
            "2",
            1002,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.7.1 Permitted Concomitant Medications",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "5a831fb4-5cf2-472c-93b2-6f95e4da36e4",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Permitted Concomitant Medications",
            "4.7.1",
            "3",
            1003,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Investigators may prescribe concomitant medications or treatments deemed necessary to provide adequate supportive care including routine vitamins and iron.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "7cadfe75-19ca-4da9-8e33-757598fd75f8",
                "childbox": "47c442ec-9eab-4976-85ee-7c4ee58b21c9",
                "subtext": "99fbf93e-8c39-4bf8-9d8b-5652c7af7af0"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Permitted Concomitant Medications",
            "4.7.1",
            "3",
            1004,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Prohibited Concomitant Medications",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "2008ab64-382b-41af-a8dd-e0d7d97052a3",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Prohibited Concomitant Medications",
            "4.7.2",
            "3",
            1005,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Use of concomitant medications including OTC medications (except for routine vitamins and iron), herbal supplements, etc from Day 1 through Day 15 post dose is discouraged.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 126,
                  "end_idx": 128,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                },
                {
                  "start_idx": 140,
                  "end_idx": 142,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                }
              ],
              "roi_id": {
                "para": "a1f5df66-fbe3-4b43-a36a-e2690c176b1d",
                "childbox": "b73f9f01-7ff9-41a5-9323-fef6e5de0aa4",
                "subtext": "a4cf5a36-e36f-4705-bb63-f525cc7caae8"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Prohibited Concomitant Medications",
            "4.7.2",
            "3",
            1006,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subjects’ parent(s)/legal representatives should be instructed not to administer any medications, including OTC products, without first consulting with the Investigator.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a1f5df66-fbe3-4b43-a36a-e2690c176b1d",
                "childbox": "3e88d9a7-53fe-4df5-9b01-878815ee111d",
                "subtext": "f713a9a5-c58f-434c-9362-7a8a7e73104c"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Prohibited Concomitant Medications",
            "4.7.2",
            "3",
            1007,
            ""
          ]
        ]
      },
      {
        "id": "4.8-Statistical-Evaluation",
        "header": "4.8 Statistical Evaluation",
        "data": [
          [
            "3",
            "General Considerations",
            "header",
            "4.8.1 General Considerations",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "849abbca-fbc1-4bc7-bb89-5be86c616615",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1009,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "There are 2 planned analyses for this study: the primary analysis and the final analysis.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ef96caa2-cfea-41cb-aeb5-7d70d1d28463",
                "childbox": "0a8e8ad3-a776-4cd2-a373-422855d97249",
                "subtext": "1331f7eb-e5fe-4a1f-a659-e0cd2cecfb7e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1010,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "The primary analysis will be conducted after all randomized subjects have completed the Day 151 visit, and the final analysis will be conducted when all subjects have completed the last visit of the study (Day 361).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 88,
                  "end_idx": 90,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                },
                {
                  "start_idx": 206,
                  "end_idx": 208,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                }
              ],
              "roi_id": {
                "para": "ef96caa2-cfea-41cb-aeb5-7d70d1d28463",
                "childbox": "b8c45449-5505-4542-8746-b63297a38656",
                "subtext": "1331f7eb-e5fe-4a1f-a659-e0cd2cecfb7e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1011,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "Tabular summaries will be presented by treatment group.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "00a28c2e-efca-422f-84b7-00944644375b",
                "childbox": "53c08e8a-e5fb-421c-a7ac-b028afc8a68b",
                "subtext": "7e849031-e72c-4820-b764-632b9f6161ed"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1012,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "Categorical data will be summarized by the number and percentage of subjects in each category.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "00a28c2e-efca-422f-84b7-00944644375b",
                "childbox": "958a62e1-21b4-49a7-a544-3128c43f9ac3",
                "subtext": "7e849031-e72c-4820-b764-632b9f6161ed"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1013,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "Continuous variables will be summarized by descriptive statistics.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "00a28c2e-efca-422f-84b7-00944644375b",
                "childbox": "5a420488-7db9-43b8-97a7-157045561e2b",
                "subtext": "7e849031-e72c-4820-b764-632b9f6161ed"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1014,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "Additional details of statistical analyses will be described in the statistical analysis plan.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "00a28c2e-efca-422f-84b7-00944644375b",
                "childbox": "510645be-00da-45d3-8b96-f26e3ad9d13b",
                "subtext": "5f51ad1d-483b-4fee-97d8-a4fc53d51f5b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1015,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "The ITT Population will include all subjects who are randomized.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6f163ec0-ecef-4df3-823d-9f8725972de4",
                "childbox": "724eac2d-9ffa-46c6-a409-fad0907baffa",
                "subtext": "3216b8c6-c1c7-4ce6-9aa9-5b806d7f3343"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1016,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "In this population, data will be analyzed according to the randomized treatment.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6f163ec0-ecef-4df3-823d-9f8725972de4",
                "childbox": "7b89de0b-7c00-4d7b-85d1-fb0de0de5398",
                "subtext": "3216b8c6-c1c7-4ce6-9aa9-5b806d7f3343"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1017,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "All efficacy and HRU analyses will be performed on the ITT Population unless otherwise specified.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6f163ec0-ecef-4df3-823d-9f8725972de4",
                "childbox": "db89bed2-a00d-4edd-b078-fbb513813657",
                "subtext": "ea93717a-bafe-4a66-a485-26614faa956b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1018,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "The As-treated Population will include all subjects who are randomized and who receive any amount of investigational product.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "993bb190-741d-43ad-a2db-1bc8540aee06",
                "childbox": "c873ed09-d45e-40a0-9a9d-44ea97f859ad",
                "subtext": "55683e17-c0e9-40b5-a106-53c7663c9519"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1019,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "In this population, data will be analyzed according to the treatment actually received.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "993bb190-741d-43ad-a2db-1bc8540aee06",
                "childbox": "909660d9-e996-46d4-9037-5c1a33b20199",
                "subtext": "55683e17-c0e9-40b5-a106-53c7663c9519"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1020,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "All safety and ADA analyses will be performed on the As-treated Population.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "993bb190-741d-43ad-a2db-1bc8540aee06",
                "childbox": "4b7da75b-557e-4bd0-9e6e-39b76133968f",
                "subtext": "e74e2802-fb6c-4ab3-8760-f02f406d1026"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1021,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "The Per-protocol Population will include subjects in the ITT Population who receive the correct dose of randomized treatment and who do not have a serious protocol violation.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "126bdb9b-f780-43c5-be4b-7786533d8b45",
                "childbox": "909370ed-348d-4088-8474-fbc7f5b838a8",
                "subtext": "e36765a1-f62c-44d0-b56e-cc0447117953"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1022,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "Detailed criteria defining this population will be determined and documented prior to performing the primary analysis.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "126bdb9b-f780-43c5-be4b-7786533d8b45",
                "childbox": "4c12c928-6116-4e98-9ed4-91ae4fe2cd3e",
                "subtext": "4204555c-bb5c-42fc-be56-4b0d1d6c2f0d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1023,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "The PK Population will include all subjects who have received any dose of investigational product, and have at least one measurable post-dose serum PK observation and for whom PK blood samples are assumed not to be affected by factors such as important protocol deviations (to be determined prior to unblinding).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ff6fd4f5-16aa-40b9-b4dc-12bec17ba4ba",
                "childbox": "74e69bb5-87a4-4fbf-b982-8e27f7f819b3",
                "subtext": "b36db638-fa83-4dda-a4f3-28676a3de832"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1024,
            ""
          ],
          [
            "3",
            "General Considerations",
            "text",
            "PK analyses will be performed on the PK Population.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ff6fd4f5-16aa-40b9-b4dc-12bec17ba4ba",
                "childbox": "8fe996c9-877d-4f30-8e12-23a6de8e1497",
                "subtext": "6a85117a-14f2-4dae-8980-2ab697be6956"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "General Considerations",
            "4.8.1",
            "3",
            1025,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.8.2 Sample Size",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "1b750124-2639-4d7a-89ad-49554a66ace6",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Sample Size",
            "4.8.2",
            "3",
            1026,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "This study will randomize approximately 800 subjects of whom approximately 530 subjects will receive nirsevimab and approximately 270 subjects will receive placebo.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 101,
                  "end_idx": 110,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "19b60d64-34fa-4b8d-b4aa-82b6e84663fb",
                "childbox": "94f9efa6-ed72-4069-8ea3-a842cbc13d48",
                "subtext": "ec269169-0157-4ae3-9d90-eb1034953370"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Sample Size",
            "4.8.2",
            "3",
            1027,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Considering 10% attrition, this sample size has at least 90% power to detect 70% RRR, assuming a placebo medically attended RSV LRTI incidence of 8%, with a 2-sided α = 0.05 based on a Poisson regression model with robust variance (Zou 2004).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 232,
                  "end_idx": 234,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Zou"
                }
              ],
              "roi_id": {
                "para": "19b60d64-34fa-4b8d-b4aa-82b6e84663fb",
                "childbox": "5c229d9c-f2b6-496b-a784-bbb870fc9f8d",
                "subtext": "ec269169-0157-4ae3-9d90-eb1034953370"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Sample Size",
            "4.8.2",
            "3",
            1028,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The assumption of 8% incidence is supported both by the literature (Paramore et al 2010, Yan et al 2017) and the observed placebo incidence rate (9.5%) in the Phase 2b Study (D5290C00003).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 68,
                  "end_idx": 75,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Paramore"
                },
                {
                  "start_idx": 89,
                  "end_idx": 91,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Yan"
                }
              ],
              "roi_id": {
                "para": "19b60d64-34fa-4b8d-b4aa-82b6e84663fb",
                "childbox": "c7d5fc6d-ff7f-46ee-a519-0dd1cd6492ee",
                "subtext": "8f84e863-745f-4491-b7f0-e2c269ef03b3"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Sample Size",
            "4.8.2",
            "3",
            1029,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The 70% RRR assumption is based on the Phase 2b Study D5290C00003 in which nirsevimab prophylaxis resulted in 70.1% RRR in the incidence of medically attended RSV LRTI (9.5% placebo, 2.6% nirsevimab; p < 0.0001) and 78.4% RRR in the incidence of RSV hospitalization (4.1% placebo, 0.8% nirsevimab; p = 0.0002).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 75,
                  "end_idx": 84,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                },
                {
                  "start_idx": 188,
                  "end_idx": 197,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                },
                {
                  "start_idx": 286,
                  "end_idx": 295,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "19b60d64-34fa-4b8d-b4aa-82b6e84663fb",
                "childbox": "98baa580-3d3f-49a3-b0ea-b5c36aab1668",
                "subtext": "7f2ea906-0eba-4242-aea0-49401b3570c9"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Sample Size",
            "4.8.2",
            "3",
            1030,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "To evaluate risk, a sample size of 530 subjects exposed to nirsevimab will provide a > 95% probability of observing at least one AE if the true event rate is 0.6%; if no AEs are observed, this study provides 95% confidence that the true event rate is < 0.6%.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 59,
                  "end_idx": 68,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 100,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "237d9c21-c100-43af-8530-cdf11a52dbc1",
                "childbox": "8f56e1b7-61c5-4424-bc9a-ec1c28d22978",
                "subtext": "cc7e7288-f904-4c30-87e5-f92f63cd3ebd"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Sample Size",
            "4.8.2",
            "3",
            1031,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The sample size necessary to achieve the power for the incidence of medically-attended RSV LRTI is calculated based on the assumed placebo event rate and the RRR of nirsevimab over placebo using Poisson regression model with robust variance.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 165,
                  "end_idx": 174,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "3929adad-91b3-424d-ab30-7bf76a566f04",
                "childbox": "2c878686-f912-43b5-a664-d52645bf6c7c",
                "subtext": "3e8b022d-76f1-42f1-81e3-3674b93d9b58"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Sample Size",
            "4.8.2",
            "3",
            1032,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "To mitigate the uncertainty around these assumptions, a blinded sample size re-estimation will be conducted prior to the last subject being randomized into the study.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3929adad-91b3-424d-ab30-7bf76a566f04",
                "childbox": "61f368ab-e306-4f03-9442-7d5b0a937997",
                "subtext": "887b9556-3988-4242-988e-428fb13497be"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Sample Size",
            "4.8.2",
            "3",
            1033,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The overall event rate, as well as the data from external sources (eg, RRR of nirsevimab over placebo in the global Phase 3 study D5290C00004), will be used in the sample size re-estimation and strictly no treatment information from this study will be used in the review.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 78,
                  "end_idx": 87,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "4c5c0822-c5b8-477a-8384-ba50918ccef1",
                "childbox": "c2be1447-dba4-4eda-b208-29bd4e6c639e",
                "subtext": "9fd8573e-01df-4eed-a82e-f5ec80edf252"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Sample Size",
            "4.8.2",
            "3",
            1034,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The summaries will not contain any information that would potentially reveal treatment assignments.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4c5c0822-c5b8-477a-8384-ba50918ccef1",
                "childbox": "3b89aee3-7500-4d3b-95b8-b254468453f2",
                "subtext": "491329c8-e5cf-4bd3-a07e-c834f9e6d2b5"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Sample Size",
            "4.8.2",
            "3",
            1035,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The review may result in an adjustment of sample size.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4c5c0822-c5b8-477a-8384-ba50918ccef1",
                "childbox": "90fb44c3-1edc-4cd4-b841-95c386f321ee",
                "subtext": "491329c8-e5cf-4bd3-a07e-c834f9e6d2b5"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Sample Size",
            "4.8.2",
            "3",
            1036,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Since this review will be performed in a blinded fashion, no adjustment for the Type I error is needed.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4c5c0822-c5b8-477a-8384-ba50918ccef1",
                "childbox": "0a528193-31fe-4190-9fd6-85ece9a269f7",
                "subtext": "491329c8-e5cf-4bd3-a07e-c834f9e6d2b5"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Sample Size",
            "4.8.2",
            "3",
            1037,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Efficacy",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "8c05424a-6770-4621-af35-3c37deac5880",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Efficacy",
            "4.8.3",
            "3",
            1038,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The primary and secondary efficacy hypotheses will be assessed in the primary analysis by a hierarchical order.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4a70566d-1505-4985-ad14-ee21050f57f7",
                "childbox": "47119675-3e05-4d7c-a051-1cf3779fc302",
                "subtext": "7ae9d629-a555-41d8-a009-7aebca158693"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Efficacy",
            "4.8.3",
            "3",
            1039,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "That is, the secondary hypothesis will be tested at a significance level of 0.05 only if the treatment effect on the primary efficacy endpoint is demonstrated at the significance level of 2-sided 0.05.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4a70566d-1505-4985-ad14-ee21050f57f7",
                "childbox": "17377e78-fbea-47d6-93fb-7c33f7443b4b",
                "subtext": "7ae9d629-a555-41d8-a009-7aebca158693"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Efficacy",
            "4.8.3",
            "3",
            1040,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "With that, the overall Type I error is controlled at 0.05.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4a70566d-1505-4985-ad14-ee21050f57f7",
                "childbox": "6f2b9f43-8753-4686-a7ae-b8f0cd982849",
                "subtext": "082d0e9b-c819-4816-96c0-10513c918a61"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Efficacy",
            "4.8.3",
            "3",
            1041,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Therefore, no further multiplicity adjustment is necessary.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "4a70566d-1505-4985-ad14-ee21050f57f7",
                "childbox": "2fc4e688-eb53-444d-8f74-1f1ed5075670",
                "subtext": "082d0e9b-c819-4816-96c0-10513c918a61"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Efficacy",
            "4.8.3",
            "3",
            1042,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.8.3.1 Primary Efficacy Analysis",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "6bf9dc29-f4b4-476e-ad9b-e7125955bbe0",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1043,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The primary endpoint is the incidence of medically attended RSV LRTI (inpatient and outpatient) through 150 days post dose.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3f0c7740-7144-4cb2-b5b8-5ca71ff0ee80",
                "childbox": "47f32d4a-259d-43a9-b1dd-001410d15377",
                "subtext": "d9ba746b-b443-4599-8f29-09ecd85ad546"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1044,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "For subjects with multiple events, only the first occurrence will be used in the primary analysis.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3f0c7740-7144-4cb2-b5b8-5ca71ff0ee80",
                "childbox": "306b2e94-5e59-4fb5-9d43-2f4e2de61af1",
                "subtext": "d9ba746b-b443-4599-8f29-09ecd85ad546"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1045,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The determination of medically attended RSV LRTI will be based on RSV test results (performed centrally using RT-PCR) and protocoldefined objective clinical LRTI criteria.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3f0c7740-7144-4cb2-b5b8-5ca71ff0ee80",
                "childbox": "53950803-808f-43a4-b6b5-78302d252fe9",
                "subtext": "d9ba746b-b443-4599-8f29-09ecd85ad546"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1046,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The primary efficacy analysis of the primary endpoint will be performed on the ITT",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2b543890-ffa4-4f5a-a41b-89547ddfddbd",
                "childbox": "6671c1d3-3172-4045-b4e7-c79f89a16f61",
                "subtext": "5e8b0fad-7434-4aa0-bb97-e26c99bb18b1"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1047,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Population using a Poisson regression model with robust variance (Zou 2004).",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 66,
                  "end_idx": 68,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Zou"
                }
              ],
              "roi_id": {
                "para": "c3073a57-43c7-49b8-8ec7-abc59e24f501",
                "childbox": "af874899-6358-48e3-89cc-feb1e2a5b47c",
                "subtext": "9ba1cbe8-1b3a-408c-98c0-134a0c499fba"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1048,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The model contains the term of treatment group and age at randomization (ie, age ≤ 3 months, age > 3 to ≤ 6 months, age > 6 months) and GA group (< 35 wGA, ≥ 35 wGA) as covariates.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c3073a57-43c7-49b8-8ec7-abc59e24f501",
                "childbox": "eecfe707-9688-43d7-9539-34d17e8be9c1",
                "subtext": "bbd460c2-7c0a-4008-9787-a0c0d90453e8"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1049,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The RRR, defined as 1-Relative Risk, and its corresponding 2-sided 95% CI, will be estimated from the model.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c3073a57-43c7-49b8-8ec7-abc59e24f501",
                "childbox": "7c675ac8-854c-45fd-b84b-cf1a05a703fc",
                "subtext": "58f22001-bd65-4d3e-8152-c1ff80898433"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1050,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "In addition, the 2-sided p-value testing null hypothesis that the incidence of medically attended RSV LRTI between nirsevimab and placebo groups are the same will be obtained from the model.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 115,
                  "end_idx": 124,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "c3073a57-43c7-49b8-8ec7-abc59e24f501",
                "childbox": "8d758ead-ec0e-42e6-8760-7c309010013c",
                "subtext": "3b622307-3c0f-47c5-8518-7cc95de843a8"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1051,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Statistical significance will be achieved if the 2-sided p-value is ≤ 0.05.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c3073a57-43c7-49b8-8ec7-abc59e24f501",
                "childbox": "ead8db47-065d-44b8-a60d-a7256f1624e7",
                "subtext": "a7f47eb5-077c-4cdc-afbb-52fd62e345f7"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1052,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "RSV LRTI that occurs through 150 days post dose will contribute to the primary efficacy analysis.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c8999d23-1d23-43b0-9c20-2f8417f3c9ae",
                "childbox": "f0e4ab61-4f15-4f38-80fc-839d522009e0",
                "subtext": "6745e98a-5d70-4bc1-b732-0af9aedf32d0"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1053,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "For subjects who do not have a medically attended RSV LRTI and are not followed through 150 days post dose, their event status will be imputed assuming the observed placebo RSV LRTI rate conditional on stratification factors using multiple imputation techniques and will be described in the statistical analysis plan.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c8999d23-1d23-43b0-9c20-2f8417f3c9ae",
                "childbox": "83bbd17b-964e-4b8f-9597-ef8959557c76",
                "subtext": "6745e98a-5d70-4bc1-b732-0af9aedf32d0"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1054,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If convergence cannot be achieved using the Poisson regression analysis model, the stratified Cochran-Mantel-Haenszel (CMH) test will be used as the primary analysis model.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "3cee5fe4-7679-4fbf-af6f-119d06bb552a",
                "childbox": "f18b55d2-fbfc-465a-b258-a57c65b9bc1c",
                "subtext": "82f2c9dd-382e-40b4-8eb7-db2dfe9c4ab4"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1055,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The above described analysis on the primary efficacy endpoint will also be conducted on the Per-protocol Population.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "9407510f-0124-4833-8e95-399259a500bb",
                "childbox": "1b8ebc3a-04d8-4f7b-af11-6f75a38db50e",
                "subtext": "77db79c3-7082-449a-b6a2-9d0bab284331"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Primary Efficacy Analysis",
            "4.8.3.1",
            "4",
            1056,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.8.3.2 Secondary Analyses of the Primary Endpoint",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "3cbc03a5-3f81-4507-b7f4-c598b0d3e677",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Analyses of the Primary Endpoint",
            "4.8.3.2",
            "4",
            1057,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "A CMH test stratified by the 2 stratification factors will be used to compare the incidence of RSV LRTI through 150 days post dose between treatment groups as a secondary analysis for the primary endpoint.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "82b9262e-2967-433d-a025-4d2b6920f78f",
                "childbox": "3151787d-4fc3-4340-aa8f-f7d7aee20fbf",
                "subtext": "75cdec63-9392-43ac-a16d-939838390b1e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Analyses of the Primary Endpoint",
            "4.8.3.2",
            "4",
            1058,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The RRR and its associated 95% CI will be provided.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "82b9262e-2967-433d-a025-4d2b6920f78f",
                "childbox": "b3ead8fb-c777-4bf4-b747-51b442b3ecd9",
                "subtext": "1c67fa67-48cb-4fd8-a84a-cb09c5aaa32b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Analyses of the Primary Endpoint",
            "4.8.3.2",
            "4",
            1059,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "This analysis will be performed without imputation.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "82b9262e-2967-433d-a025-4d2b6920f78f",
                "childbox": "0a62314a-8037-4066-9316-9254e0a8a262",
                "subtext": "1c67fa67-48cb-4fd8-a84a-cb09c5aaa32b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Analyses of the Primary Endpoint",
            "4.8.3.2",
            "4",
            1060,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The Breslow-Day test and Zelen’s exact test will be used to test the homogeneity of the odds ratios across strata and the corresponding p-values will be presented.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "82b9262e-2967-433d-a025-4d2b6920f78f",
                "childbox": "c7a4ff4a-ec46-43da-8150-db0d5afcd65d",
                "subtext": "1c67fa67-48cb-4fd8-a84a-cb09c5aaa32b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Analyses of the Primary Endpoint",
            "4.8.3.2",
            "4",
            1061,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.8.3.3 Supplementary Analyses of the Primary Endpoint",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "3d345f39-3492-49c4-a057-01187c66fb6f",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1062,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "A Kaplan-Meier curve for time to first medically attended RSV LRTI will be generated based on observed events.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "41fbdda4-6127-497e-b80d-d117b1c658cf",
                "childbox": "e795ee9e-6d68-4c25-8188-9ebba1469147",
                "subtext": "9d951510-1af1-4953-996b-057909f47b40"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1063,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Treatment group differences in time-to-first medically attended RSV LRTI will be compared using the stratified log-rank test with the 2 stratification factors (ie, age at randomization, GA group) as the strata.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "41fbdda4-6127-497e-b80d-d117b1c658cf",
                "childbox": "40a98b0f-7d77-4edb-9d7f-77561c4fc4c9",
                "subtext": "9d951510-1af1-4953-996b-057909f47b40"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1064,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Additional analyses, including summaries for age at onset of the first medically attended RSV LRTI, inpatient/outpatient visit settings, and RSV subtypes associated with the primary endpoint will be provided.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "62661e01-6621-45dd-b486-885112fd173b",
                "childbox": "05bd8705-6fad-4092-ae21-af7a4318d79d",
                "subtext": "d4f6cd3c-c6f7-48e0-8ea4-3ad36c7baeb6"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1065,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "An analysis may also include all RSV positive LRTI endpoints, using results from either the central laboratory or local laboratory.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d0b78e32-8d12-4556-ada6-4de20da7126d",
                "childbox": "173cbe84-a1e7-42fd-9f64-46f2fe924d10",
                "subtext": "48ce2e77-b977-48b1-8992-940af44d3136"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1066,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "To evaluate the impact of the missing data on the primary analyses, the following supplementary analyses will be conducted.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2e700906-9941-400c-945d-4595e3711eaa",
                "childbox": "f4b7f30f-2627-4e7f-8437-697e21fc5b41",
                "subtext": "cc03ec1e-3415-411c-bf62-99227ed0e03d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1067,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "For subjects who do not have an RSV LRTI and are not followed through 150 days post dose:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "2e700906-9941-400c-945d-4595e3711eaa",
                "childbox": "496b3ef4-89b5-4142-90fc-4008a8df373b",
                "subtext": "0cc45e98-5e3f-4103-83a5-c867628109d4"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1068,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "1 Count these subjects as having not met the RSV LRTI endpoint within each treatment group",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6eaf3527-becf-40b6-abcf-00144585a244",
                "childbox": "1a2227fa-aa67-497f-b0f4-a5939e867632",
                "subtext": "da46fb63-dd3c-44f7-aa30-3af9f31dc9e2"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1069,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "2 Perform multiple imputations using the observed event rate per treatment group for their event status",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "adf02030-d530-4d2c-adef-fc87fa1997df",
                "childbox": "9510d1ef-fb73-4e33-87d6-5fff6d554312",
                "subtext": "b85ca797-192a-4a63-b8d6-15694ab4ff68"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1070,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "3 Perform single imputation using observed placebo rate for both groups",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "e51bd122-b9f7-48f9-b399-b7a4aa462d7f",
                "childbox": "bff8f13c-f0f3-4e00-b5b7-8ebed99c7e99",
                "subtext": "7e105891-d891-47d1-91ce-782427d74f6a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1071,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "fd7db76f-ed52-4224-94e7-954bc87e7178",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1072,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Subgroup analysis will be performed for the primary efficacy endpoint, the incidence of medically attended RSV LRTI.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0ae535e7-23f0-4a8f-911b-063719d5dcd9",
                "childbox": "0e255475-871b-4923-a79e-524f2f1d918f",
                "subtext": "e465a195-2567-403c-89e6-2b8acc0e9754"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1073,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Treatment-by-subgroup interaction will be tested using the Poisson regression with robust variance model with the terms of treatment, age group, GA, subgroup, and treatment-by-subgroup interaction.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0ae535e7-23f0-4a8f-911b-063719d5dcd9",
                "childbox": "ae558371-274b-461a-bbee-2714e2d6eda2",
                "subtext": "e465a195-2567-403c-89e6-2b8acc0e9754"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1074,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "If this full model does not achieve convergence, a reduced model of treatment, subgroup, and treatment-by-subgroup interaction will be used.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0ae535e7-23f0-4a8f-911b-063719d5dcd9",
                "childbox": "da10dcc2-fdd3-4d3e-a9c7-cc93c7efafe8",
                "subtext": "beb9e651-21f8-4bc8-9907-56931a3c5ab5"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1075,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Significant treatment-by-subgroup interaction is judged at the significance level of 0.10.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0ae535e7-23f0-4a8f-911b-063719d5dcd9",
                "childbox": "8ce0f539-7ad6-4b8c-86b0-89dcd8805c5d",
                "subtext": "3f923554-3476-43cb-baea-b36a2cf6db6e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1076,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Within each level of a subgroup, the RRR and its corresponding 95% CI will be estimated using a Poisson regression model with robust variance with the term of treatment.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0ae535e7-23f0-4a8f-911b-063719d5dcd9",
                "childbox": "aa6b6736-7bd0-4795-8175-0da7430c9799",
                "subtext": "3f923554-3476-43cb-baea-b36a2cf6db6e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1077,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "A forest plot of the RRR and the 95% CI will be presented.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "0ae535e7-23f0-4a8f-911b-063719d5dcd9",
                "childbox": "1e73ab6f-03ff-42e0-93eb-fab53fb29732",
                "subtext": "34e8418e-660d-49e4-b6d5-2019fe48b10d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1078,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "In the event that the Poisson regression model does not converge for any stratum of a subgroup, the exact conditional method based on the number of RSV LRTIs (Breslow and Day 1987) will be used as the analytical model to generate the RRR and its corresponding CI for all subgroup strata.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 159,
                  "end_idx": 165,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Breslow"
                },
                {
                  "start_idx": 171,
                  "end_idx": 173,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                }
              ],
              "roi_id": {
                "para": "0ae535e7-23f0-4a8f-911b-063719d5dcd9",
                "childbox": "a6e933c6-0fdd-474c-a9f3-9994fd0dc21e",
                "subtext": "34e8418e-660d-49e4-b6d5-2019fe48b10d"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1079,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The subgroup analysis will be conducted for the following subgroups on the ITT Population:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "289338de-1f2b-484e-9e9f-23ea1527aa06",
                "childbox": "3f88d06a-9680-4ca4-b531-1046a4ca3761",
                "subtext": "6fc76fee-50b4-4d71-9eb3-829f3a81df3a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1080,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Age at randomization stratum (age ≤ 3 months, age > 3 to ≤ 6 months, age > 6 months)",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "596e198f-90c8-4f17-93ab-ae1d3c63be19",
                "childbox": "ea91599c-c375-464b-965c-42dfebcfab9c",
                "subtext": "5ba6e63e-6793-4a33-8611-f0766177f6dd"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1081,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "596e198f-90c8-4f17-93ab-ae1d3c63be19",
                "childbox": "ea91599c-c375-464b-965c-42dfebcfab9c",
                "subtext": "0997d265-1ad8-4031-bfce-73436f24f674"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "Segoe UI Symbol",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1082,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "596e198f-90c8-4f17-93ab-ae1d3c63be19",
                "childbox": "ea91599c-c375-464b-965c-42dfebcfab9c",
                "subtext": "4e70a981-4645-4fd0-94ba-032731230aa2"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "Arial",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1083,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "596e198f-90c8-4f17-93ab-ae1d3c63be19",
                "childbox": "44818e9e-f045-4329-93bc-e3e8ac4edd17",
                "subtext": "828513c6-6598-48fb-bb69-3e5341d66f94"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "Arial",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1084,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "GA group (< 35 wGA, ≥ 35 wGA)",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "596e198f-90c8-4f17-93ab-ae1d3c63be19",
                "childbox": "92194557-5c3f-415e-985b-fad81ac73e6e",
                "subtext": "4d834301-feb2-4ab9-b1b8-4d69d7056290"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1085,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Gender",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "515c2365-7286-45d9-8e11-58f92bea3628",
                "childbox": "188a21c2-3148-40d7-9296-332195208476",
                "subtext": "5f378b53-d515-4362-a3bd-c52e8a502a31"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1086,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Weight at birth (weight ≤ 2.5 kg, weight > 2.5 kg to < 5 kg, weight ≥ 5 kg)",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "8a9c7504-521e-44b1-8f8c-0cefa45f613f",
                "childbox": "9bb734dd-11a2-46c1-937e-adfb4a6b9edc",
                "subtext": "0eb773f1-69bc-4258-9dec-ed5700a751b4"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1087,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Weight on Day 1 (weight < 5 kg, weight ≥ 5 kg)",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 12,
                  "end_idx": 14,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                }
              ],
              "roi_id": {
                "para": "23baf10d-0fe0-42e9-a301-f4723c8ae9fc",
                "childbox": "5b2d3413-f2c3-4b39-abea-a0dd031e2b16",
                "subtext": "387c5db8-7f89-486b-a3c5-574acc7c6c61"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1088,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Sibling also participating in the study (yes/no)",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d2e06b1f-3b1b-4772-8849-cfce74682396",
                "childbox": "4c919fa9-5d04-444f-942f-8e9d01081c2e",
                "subtext": "5d7cceb3-5d77-4603-a512-09da64da81a2"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1089,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "cdc4a5d1-fc39-4b7d-a160-03dfc97c99ec",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1090,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The details of the supplementary analyses will be described in the statistical analysis plan.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d301133f-eb7b-4ee7-ac3d-a5fbd94e88f1",
                "childbox": "871e95d5-f4d7-4985-9666-1b857ecbd00a",
                "subtext": "ce8dc85d-4e1d-46d3-a79c-4fc80d069661"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Supplementary Analyses of the Primary Endpoint",
            "4.8.3.3",
            "4",
            1091,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.8.3.4 Secondary Efficacy Analyses",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "70295ac7-cebb-402c-aaa3-e0d7bc4f1b43",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Efficacy Analyses",
            "4.8.3.4",
            "4",
            1092,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The secondary efficacy endpoint is the incidence of RSV LRTI hospitalization through 150 days post dose.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d49d87ee-c5bd-4d31-b051-8bf87cc9d58a",
                "childbox": "a3068026-202e-4fef-990e-fa01ba027231",
                "subtext": "a7fbc2c0-00a6-438d-86de-47d338013939"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Efficacy Analyses",
            "4.8.3.4",
            "4",
            1093,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "For subjects with multiple RSV LRTI hospitalizations, only the first occurrence will be used in the analysis.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d49d87ee-c5bd-4d31-b051-8bf87cc9d58a",
                "childbox": "ad9427d8-145d-4e24-9540-560b0f3d0d0b",
                "subtext": "a7fbc2c0-00a6-438d-86de-47d338013939"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Efficacy Analyses",
            "4.8.3.4",
            "4",
            1094,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "A Poisson regression model with robust variance (Zou 2004) using only the treatment term will be used to assess the treatment effect on the incidence of RSV LRTI hospitalization between nirsevimab and placebo groups in the ITT population.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 186,
                  "end_idx": 195,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                },
                {
                  "start_idx": 49,
                  "end_idx": 51,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Zou"
                }
              ],
              "roi_id": {
                "para": "1433001d-cee1-4da7-a598-ba6e034d3037",
                "childbox": "a07a0301-41ab-415b-b693-94b266f6a5e6",
                "subtext": "935542e8-0242-4110-b8ce-92e9a2c6c122"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Efficacy Analyses",
            "4.8.3.4",
            "4",
            1095,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "RRR and its corresponding 95% CI will be estimated from the model.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1433001d-cee1-4da7-a598-ba6e034d3037",
                "childbox": "be931214-1dca-48da-b7a9-e54ca697fef8",
                "subtext": "9dd42e10-1ef8-433b-8b31-8cb91cd17356"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Efficacy Analyses",
            "4.8.3.4",
            "4",
            1096,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "RSV LRTI hospitalization that occurs through 150 days post dose will contribute to the analysis.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1433001d-cee1-4da7-a598-ba6e034d3037",
                "childbox": "ae7dbd1a-d1ad-4fe4-9bdb-4b920e755058",
                "subtext": "9906726d-cd28-4222-801d-11cd7c4f8d65"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Efficacy Analyses",
            "4.8.3.4",
            "4",
            1097,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "For subjects who do not have an RSV LRTI and were not followed through 150 days post dose, their event status will be imputed using the observed placebo RSV LRTI hospitalization rate following the repeated imputation procedure without involvement of stratification factors.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1433001d-cee1-4da7-a598-ba6e034d3037",
                "childbox": "abb693a3-b772-4581-92cb-62160a40bba8",
                "subtext": "9906726d-cd28-4222-801d-11cd7c4f8d65"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Efficacy Analyses",
            "4.8.3.4",
            "4",
            1098,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The additional analyses, including the CMH test with the only term of treatment for the incidence of RSV LRTI hospitalization, and the Kaplan-Meier for time-to-first RSV LRTI hospitalization will be conducted.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "68822afe-8ca5-4500-a1a8-1ed8d5ca284e",
                "childbox": "3c81078b-2c6e-4d52-9ede-9e73fa7b785a",
                "subtext": "d0a65272-94ad-4d3a-94f4-d567e6bee0ba"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Efficacy Analyses",
            "4.8.3.4",
            "4",
            1099,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Treatment group differences in time-to-first RSV LRTI hospitalization will be compared using log-rank test.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "68822afe-8ca5-4500-a1a8-1ed8d5ca284e",
                "childbox": "b1bc5b58-35e9-42d5-a710-303b77ec1ec9",
                "subtext": "b95b2e34-3cdd-4cd3-848f-b30f2d844479"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Efficacy Analyses",
            "4.8.3.4",
            "4",
            1100,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "In addition, age at onset of the first medically attended RSV LRTI hospitalization through 150 days post dose will be analyzed similarly to that for the primary endpoint.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a351dd32-0136-42ef-b6b8-221bd115e9c2",
                "childbox": "78f45b77-6ad3-4e05-99a2-231a7c05f46e",
                "subtext": "6d921449-5406-48fc-8227-e83faafaa37e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Efficacy Analyses",
            "4.8.3.4",
            "4",
            1101,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Summary of incidence of RSV LRTI hospitalization by subgroup will also be provided.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a351dd32-0136-42ef-b6b8-221bd115e9c2",
                "childbox": "6950ef66-7940-4e70-8cdc-05ef40af0c7b",
                "subtext": "df05d88b-4511-4300-afb3-0d6e90b4d300"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Efficacy Analyses",
            "4.8.3.4",
            "4",
            1102,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The details of above analyses will be described in the Statistical Analysis Plan.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "35f72ed7-e46f-47c7-af28-c2f0720d6faf",
                "childbox": "57710b9c-45cb-4a03-80fd-411742ba7cd6",
                "subtext": "09bd7825-d83c-409f-b181-18b51b50ab81"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Secondary Efficacy Analyses",
            "4.8.3.4",
            "4",
            1103,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Safety",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "4ed60f40-15b3-4489-a85d-24eeb325bd42",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Safety",
            "4.8.4",
            "3",
            1104,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Safety of nirsevimab will primarily be assessed and measured by the occurrence of all TEAEs and TESAEs.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 10,
                  "end_idx": 19,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "c2919306-7301-432f-a7f2-779bf0d84bec",
                "childbox": "8896531e-7bd2-45bf-89bf-717d26157568",
                "subtext": "4f6d8940-d795-4111-badd-d630131c943b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Safety",
            "4.8.4",
            "3",
            1105,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "AEs will be graded according to the current version of the NCI CTCAE where applicable for pediatric assessments.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 59,
                  "end_idx": 61,
                  "standard_entity_name": "ANY: Organization",
                  "subcategory": "ANY: Organization",
                  "confidence": 37,
                  "text": "NCI"
                }
              ],
              "roi_id": {
                "para": "c2919306-7301-432f-a7f2-779bf0d84bec",
                "childbox": "20bf5ae3-399c-47a9-91e6-84545d7b88e1",
                "subtext": "4f6d8940-d795-4111-badd-d630131c943b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Safety",
            "4.8.4",
            "3",
            1106,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "AEs will be coded by MedDRA system organ class and preferred term.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c2919306-7301-432f-a7f2-779bf0d84bec",
                "childbox": "7254e739-0ae1-4be4-b7be-391f747d0c81",
                "subtext": "4f6d8940-d795-4111-badd-d630131c943b"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Safety",
            "4.8.4",
            "3",
            1107,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Specific AEs will be counted once for each subject for calculating rates but will be presented in total in subject listings.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c2919306-7301-432f-a7f2-779bf0d84bec",
                "childbox": "d5b2ea2a-887f-471a-933c-705a8cd5ab25",
                "subtext": "81b78098-df2e-4ba5-9c15-478ebff02aca"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Safety",
            "4.8.4",
            "3",
            1108,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "In addition, if the same AE occurs multiple times within a particular subject, the highest severity and level of causality will be reported.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c2919306-7301-432f-a7f2-779bf0d84bec",
                "childbox": "d93e3987-87c7-4004-8ba6-f8a277e44a11",
                "subtext": "81b78098-df2e-4ba5-9c15-478ebff02aca"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Safety",
            "4.8.4",
            "3",
            1109,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The type, incidence, severity, and relationship to study investigational product will be summarized by treatment group.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c2919306-7301-432f-a7f2-779bf0d84bec",
                "childbox": "163d2149-aaff-4dc8-a1f5-1f676cd5a277",
                "subtext": "748138f2-b3d1-4fd3-84fb-04c631ebd1ec"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Safety",
            "4.8.4",
            "3",
            1110,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "In addition, summaries of deaths and SAEs will be provided.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c2919306-7301-432f-a7f2-779bf0d84bec",
                "childbox": "60613c11-1624-4c5a-bd3c-e500f7452ed0",
                "subtext": "748138f2-b3d1-4fd3-84fb-04c631ebd1ec"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Safety",
            "4.8.4",
            "3",
            1111,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Other safety assessments will include:",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "c2919306-7301-432f-a7f2-779bf0d84bec",
                "childbox": "e909ad8b-28d6-4689-b3dd-debededbee8a",
                "subtext": "748138f2-b3d1-4fd3-84fb-04c631ebd1ec"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Safety",
            "4.8.4",
            "3",
            1112,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Occurrence of AESIs to include targeted AEs of anaphylaxis and other serious hypersensitivity reactions, including immune complex disease (eg, vasculitis, endocarditis, neuritis, glomerulonephritis), or thrombocytopenia following investigational product administration",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "82022795-e22e-41ed-85a1-c305d41b2ca6",
                "childbox": "4c795dbb-b948-4a74-8cd8-52d3e384380c",
                "subtext": "3a59b081-fab1-4ada-8498-384cd0dc0274"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Safety",
            "4.8.4",
            "3",
            1113,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "• Occurrence of NOCDs following investigational product administration",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "1c7008aa-0944-4110-bca9-aa576e2930a9",
                "childbox": "683168e4-7294-486c-87f5-9829e8fc2d62",
                "subtext": "b226f409-13a3-4a2c-8db2-9d3116cfe0a1"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Safety",
            "4.8.4",
            "3",
            1114,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "a5df22de-b087-495b-9801-39573375a069",
                "childbox": "",
                "subtext": ""
              }
            },
            "Study Design",
            "Safety",
            "4.8.4",
            "3",
            1115,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Analysis of Pharmacokinetics and Antidrug Antibody",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "bbd6a7be-460b-41ef-86fd-a0448fce5b46",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Analysis of Pharmacokinetics and Antidrug Antibody",
            "4.8.5",
            "3",
            1116,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.8.5.1 Pharmacokinetic Analysis",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "3c98a14e-cb3d-4a96-a298-1913cf8f004d",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Pharmacokinetic Analysis",
            "4.8.5.1",
            "4",
            1117,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Following a single dose of nirsevimab, individual nirsevimab serum concentration data will be tabulated by treatment group along with descriptive statistics.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 27,
                  "end_idx": 36,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                },
                {
                  "start_idx": 50,
                  "end_idx": 59,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "40e8e20d-d7f1-42e3-9100-1f149b56aebe",
                "childbox": "766f8a84-0f02-43aa-afd2-264aeeeceb4e",
                "subtext": "f14d1b3d-a1c8-49fd-bf76-353f64410704"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Pharmacokinetic Analysis",
            "4.8.5.1",
            "4",
            1118,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "PK parameters, eg, maximum observed concentration, AUC, apparent clearance, and t",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "40e8e20d-d7f1-42e3-9100-1f149b56aebe",
                "childbox": "9fee3303-a23c-4d3e-8bf9-5e8c554278a9",
                "subtext": "17e0cc9d-558d-483e-9398-01254b615be5"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Pharmacokinetic Analysis",
            "4.8.5.1",
            "4",
            1119,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "1/2",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "40e8e20d-d7f1-42e3-9100-1f149b56aebe",
                "childbox": "9fee3303-a23c-4d3e-8bf9-5e8c554278a9",
                "subtext": "46a1ad9c-5c2e-470b-ae8d-1529f782f78c"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": "subscript"
            },
            "Study Design",
            "Pharmacokinetic Analysis",
            "4.8.5.1",
            "4",
            1120,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "will be estimated using noncompartmental analysis, if data permit.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "40e8e20d-d7f1-42e3-9100-1f149b56aebe",
                "childbox": "9fee3303-a23c-4d3e-8bf9-5e8c554278a9",
                "subtext": "0b2abfd0-45a1-4bda-b473-17fb6afb1678"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Pharmacokinetic Analysis",
            "4.8.5.1",
            "4",
            1121,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Antidrug Antibody Analysis",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "bed88865-b2e8-48a8-979d-9d91eb22fa9b",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Antidrug Antibody Analysis",
            "4.8.5.2",
            "4",
            1122,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The incidence of ADA to nirsevimab will be assessed and summarized by number and percentage of subjects who are ADA positive by treatment group.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 24,
                  "end_idx": 33,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 100,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "ea2b0280-83ca-47de-b897-907d0c28447b",
                "childbox": "2a93326e-8c87-4d2b-a242-aa7a58006619",
                "subtext": "2bc425c3-f57e-4050-8040-789345d7c70e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Antidrug Antibody Analysis",
            "4.8.5.2",
            "4",
            1123,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The ADA titer will be listed by subject at different time points.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ea2b0280-83ca-47de-b897-907d0c28447b",
                "childbox": "60af12d2-ee3a-45c5-b09f-79fbf64ddf29",
                "subtext": "2bc425c3-f57e-4050-8040-789345d7c70e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Antidrug Antibody Analysis",
            "4.8.5.2",
            "4",
            1124,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The impact of ADA on PK, efficacy, and association with TEAEs and TESAEs, will be assessed.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "ea2b0280-83ca-47de-b897-907d0c28447b",
                "childbox": "56a33578-a007-4a5a-b63e-732b48562937",
                "subtext": "2bc425c3-f57e-4050-8040-789345d7c70e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Antidrug Antibody Analysis",
            "4.8.5.2",
            "4",
            1125,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "Exploratory Analysis",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "595d4c27-1191-4f70-ad31-754e8896a3f3",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Exploratory Analysis",
            "4.8.6",
            "3",
            1126,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.8.6.1 Healthcare Resource Utilization",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [],
              "roi_id": {
                "para": "e1e7edcc-3e80-40e4-b060-37e69bf8b7f7",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Healthcare Resource Utilization",
            "4.8.6.1",
            "4",
            1127,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The magnitude of HRU (eg, number of admissions to hospitals and ICUs and duration of stay; number of subjects who require respiratory support and supplemental oxygen and the duration of use; number and types of outpatient visits, eg, ER, outpatient clinic; and number of prescription and OTC medications and duration of use) will be summarized overall by treatment group, and for the following subgroups: subjects with at least one medically attended LRTI caused by RT-PCR-confirmed RSV, subjects with medically attended LRTI not caused by RSV, and subjects with non-protocol defined LRTIs, which may be further broken down by RSV status.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "20d7464a-dcdf-47cc-8def-88a992721f27",
                "childbox": "305c5770-fa2d-4ede-af07-0cab6005fe80",
                "subtext": "1c67c760-d871-4571-9947-b6806b135d3e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Healthcare Resource Utilization",
            "4.8.6.1",
            "4",
            1128,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.8.6.2 Monitoring RSV Resistance to Nirsevimab",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [
                {
                  "start_idx": 37,
                  "end_idx": 46,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 75,
                  "text": "Nirsevimab"
                }
              ],
              "roi_id": {
                "para": "dc090844-2402-460c-a7c6-2509977f5f8a",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Monitoring RSV Resistance to Nirsevimab",
            "4.8.6.2",
            "4",
            1129,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Genotypic analysis of the full-length mature F protein will be conducted on all RSV-positive isolates confirmed centrally using an RT-PCR assay.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "47db7adb-9d3d-4203-a317-47f8cbeb54e6",
                "childbox": "8ef6260b-303f-4969-9905-54e56760ebea",
                "subtext": "a832ba4d-e3a8-4a4d-b0c8-586b86f1af12"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Monitoring RSV Resistance to Nirsevimab",
            "4.8.6.2",
            "4",
            1130,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "RSV genotypic analysis will report the sequence changes in the mature F protein from all RSV positive isolates compared to contemporary RSV A and RSV B reference strains.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "47db7adb-9d3d-4203-a317-47f8cbeb54e6",
                "childbox": "fbef2b63-01b1-45a5-a25d-b1194667ce56",
                "subtext": "f8e5fac0-f5d0-4853-841c-e2e28a66a113"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Monitoring RSV Resistance to Nirsevimab",
            "4.8.6.2",
            "4",
            1131,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "Susceptibility of novel RSV variants to nirsevimab will be tested and compared to control viruses.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 40,
                  "end_idx": 49,
                  "standard_entity_name": "Molecule",
                  "subcategory": "Molecule",
                  "confidence": 100,
                  "text": "nirsevimab"
                }
              ],
              "roi_id": {
                "para": "47db7adb-9d3d-4203-a317-47f8cbeb54e6",
                "childbox": "919d0330-ee37-4ddb-be47-8e762573e437",
                "subtext": "f8e5fac0-f5d0-4853-841c-e2e28a66a113"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Monitoring RSV Resistance to Nirsevimab",
            "4.8.6.2",
            "4",
            1132,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.8.6.3 RSV LRTI Occurring from Day 152 to Day 361",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading4",
              "entity": [
                {
                  "start_idx": 32,
                  "end_idx": 34,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                },
                {
                  "start_idx": 43,
                  "end_idx": 45,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                }
              ],
              "roi_id": {
                "para": "67772206-ecbc-434c-8aee-6af576ff5bf2",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "RSV LRTI Occurring from Day 152 to Day 361",
            "4.8.6.3",
            "4",
            1133,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "The incidence of medically attended RSV LRTI (inpatient and outpatient) from Day 152 to Day 361 will be based on RSV test results (performed centrally via RT-PCR) and objective clinical LRTI criteria and will be summarized by treatment group.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [
                {
                  "start_idx": 77,
                  "end_idx": 79,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                },
                {
                  "start_idx": 88,
                  "end_idx": 90,
                  "standard_entity_name": "OTHER: Person Name",
                  "subcategory": "OTHER: Person Name",
                  "confidence": 100,
                  "text": "Day"
                }
              ],
              "roi_id": {
                "para": "f1440bea-d9d2-483b-82f1-100e18bb68d7",
                "childbox": "7ffec1fe-647c-4578-9e33-52b32b9f0cb2",
                "subtext": "b4354476-f39a-4b29-b067-95e8c4dbe21c"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "RSV LRTI Occurring from Day 152 to Day 361",
            "4.8.6.3",
            "4",
            1134,
            ""
          ],
          [
            "",
            "Unmapped",
            "header",
            "4.8.7 Data Monitoring Committee",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "cc787a5d-d6f0-42b1-9c67-f9250158d384",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Data Monitoring Committee",
            "4.8.7",
            "3",
            1135,
            ""
          ],
          [
            "",
            "Unmapped",
            "text",
            "An independent data monitoring committee will review safety data regularly and make recommendations regarding further study conduct.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "6133badf-3bcb-4bdd-b5d0-d688103b6219",
                "childbox": "dcadec42-c1a2-44ad-908f-49f3ca11186f",
                "subtext": "8b189aaf-e0c4-4c85-b2bc-1f6bf363cb6e"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Data Monitoring Committee",
            "4.8.7",
            "3",
            1136,
            ""
          ],
          [
            "2",
            "Interim Analysis",
            "header",
            "4.8.8 Interim Analysis",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "Heading3",
              "entity": [],
              "roi_id": {
                "para": "74143899-19db-4f4a-88db-118587025a58",
                "childbox": "",
                "subtext": ""
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Interim Analysis",
            "4.8.8",
            "3",
            1137,
            ""
          ],
          [
            "2",
            "Interim Analysis",
            "text",
            "No interim analyses are planned.",
            {
              "IsBold": false,
              "font_size": -1,
              "font_style": "",
              "entity": [],
              "roi_id": {
                "para": "d801009c-e1ed-4268-9d56-909f136a0f65",
                "childbox": "ba8b4632-9adc-4fed-b543-039f0222ecd2",
                "subtext": "9a549dd9-2119-4795-87b3-2de2e18b829a"
              },
              "Bold": false,
              "Caps": false,
              "ColorRGB": 0,
              "DStrike": false,
              "Emboss": false,
              "Highlight": "",
              "Imprint": false,
              "Italics": false,
              "Outline": false,
              "rFonts": "",
              "rStyle": "",
              "Shadow": false,
              "Size": -1,
              "SmallCaps": false,
              "Strike": false,
              "Underline": "",
              "Vanish": false,
              "VertAlign": ""
            },
            "Study Design",
            "Interim Analysis",
            "4.8.8",
            "3",
            1138,
            ""
          ]
        ]
      }
    ],
    "page": "26"
  }
]
